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ABSTRACT 
Enamides and allenamides are two versatile functional groups that offer a wide variety of 
alternatives for the inclusion of nitrogen-based moiety into an organic system.  Nitrogen-
containing structures are prevalent among medicinally interesting natural and unnatural 
products and, thus, are useful in developing new therapeutics. Their chemical utilities have 
been exploited by a number of research groups. They represent interesting functional groups 
and useful in organic synthesis. 
Photoredox catalytic approach was develop to synthetically transform enamides into useful 
products, N-acyl-N’-aryl-N,N’-aminals.  A novel approach using iridium polypyridyl complex 
photoredox catalyst to initiate a three-component domino transformation of enamides to N-
acyl-N’-aryl-N,N’-aminals via photoredox catalysed β-alkylation of enamide intermediates 
and their subsequent trapping with an arylamine was successfully developed. The N-acyl-N′-
aryl-N,N′-aminal structural motif is prevalent within a wide range of biologically important 
compounds and have attracted considerable attention as building blocks for the synthesis of 
drug candidates. 
This method uses the addition of a radical precursor to an enamide, with subsequent 
interception of the cationic iminium intermediate with an arylamine. The reaction was found 
to be compatible with both electron-rich and electron-deficient arylamines, and moderate to 
good levels of diastereoselectivity were attained using a chiral enamide. The N-acyl-N’-aryl-
N,N’-aminals formed were used as precursors to synthesis of valuable γ-lactams building 
blocks under a mild condition by cyclization. The γ-lactams were obtained by intramolecular 
cyclization of the N,N’-aminals with the lone pair of the nitrogen atom of the arylamine as the 
nucleophilic centre attacking the electrophilic carbon of the carbonyl carbon of the ester in 
the molecule.  This is a novel synthetic route to these valuable γ-lactams. 
The photoredox reaction procedure developed was also applied on allenamides. There are 
limited reports of radical reactions on allenamides, the major and seemingly single 
intermolecular radical cyclization involving allenamides was the one reported by Hsung. 
There are no reports of radical photoredox reactions on allenamides in the literature. The 
addition reaction was initiated by the electrophilic malonate radical generated by irradiation 
with blue light in the presence of iridium photoredox catalyst.  The malonate radical attacked 
the central carbon of the allenic group which led to the formation of β-alkyl allenamide 
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radical that was oxidized to an iminium ion intermediate.  The iminium intermediate was 
subsequently trapped with an arylamine giving rise to α,β-addition product (N-acyl-N’-aryl-
N,N’-aminals) with exo-methylene or β,γ-addition product leading to the formation of double 
bond substituted enamides. It was found that the α,β-adduct product is more favourable, 
however, the alternative product was formed when the α-position is sterically hindered by the 
substituents on the allenamide or the arylamine nucleophile. 
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CHAPTER ONE 
1.0 Introduction 
1.1 Photocatalysis 
Catalysis, the action of a catalyst, is a process in which the rate of a reaction is altered 
(usually enhanced) by the presence of a different substance (catalyst) that does not undergo 
any permanent change itself in the course of the reaction.  Thus, catalysis is simply the 
"acceleration of a chemical reaction by the presence of a catalyst".  A catalyst does not 
change in itself or being consumed in the chemical reaction.  A substance can be thought to 
be a catalyst when it alters the rate of a chemical reaction without being consumed as a 
reactant; though it appears in the rate expression describing a thermal reaction without 
appearing in the stoichiometric equation. 
According to Castellote M. and Bengtsson N. in 2011, in a book titled Application of 
Titanium Dioxide Photocatalysis to Construction Materials: State-of-the-Art Report of the 
RILEM Technical Committee 194-TDP, edited by Ohama Y. and Van Gemert D.,[1] catalysis 
refers simply to a “process in which a substance (the catalyst) accelerates, through intimate 
interaction(s) with the reactant(s) and concomitantly providing a lower energy pathway, an 
otherwise thermodynamically favoured but kinetically slow reaction with the catalyst fully 
regenerated quantitatively at the conclusion of the catalytic cycle.”  A catalyst alters the rate 
of a reaction by providing an alternative pathway that lowers the free activation enthalpy 
necessary for the reaction to proceed along the reaction pathway.  It increases the rate of a 
reaction without modifying the overall standard Gibbs energy change (the driving force for a 
reaction to occur) of the reaction.  A catalyst will not ordinarily make a reaction that is not 
thermodynamically favoured to occur.  It can only alter the rate of a reaction that is 
thermodynamically feasible.  
When photons (discrete packets of energy associated with electromagnetic radiation (light)) 
are involved in the acceleration of a reaction, without the implication of any specific 
mechanism, the expression photocatalysis can be used to describe the acceleration. 
Photocatalysis can then be described as a change in the rate of chemical reactions under the 
action of light in the presence of substances -called photocatalysts- that absorb light quanta 
and are involved in the chemical transformations of the reaction participants.[2]  A 
photocatalyst is a substance that is able to produce, by absorption of light quanta, chemical 
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transformations of the reaction participants, repeatedly coming with them into the 
intermediate chemical interactions and regenerating its chemical composition after each cycle 
of such interactions.[2]   The catalyst may accelerate the photoreaction by interacting with the 
substrate(s) either in its ground state or in its excited state or with the primary product (of the 
catalyst), depending on the mechanism of the photoreaction.[3,4]   Chlorophyll of plants is a 
type of photocatalyst (Figure 1).  Photocatalysis compared to photosynthesis, in which 
chlorophyll captures sunlight to turn water and carbon dioxide into oxygen and glucose.  
Therefore, photocatalysis, as a part of photochemistry, refers to reactions promoted by 
synergetic effect of light and a catalyst but keeping the same essence as a thermal reaction. 
 
Clarification needs to be made between a sensitized and a catalysed photoreaction.  A 
photosensitization is a process in which a photochemical alteration occurs in one molecular 
entity as a result of initial absorption of radiation (light) by another molecular entity called 
the photosensitizer.  This is catalytic in photons.  Whereas in a catalysed photoreaction which 
is non-catalytic in photons, either the nominal catalyst or the substrate or both are in an 
excited state during the catalytic step. 
Depending on the specific photoreaction, the catalyst may accelerate the photoreaction by 
interaction with the substrate in its ground or excited state and/or with a primary 
photoproduct.  When the light is absorbed by the catalyst ([cat]), the system represents a 
sensitized photoreaction, the reaction may occur through two different ways: 
1. via energy transfer, by forming an activated state of the reactant of interest (R), which is 
more reactive than its ground state:[1] 
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In this case, when the photocatalyst absorbs photon quanta, it is activated and raised to 
its excited state.  This activated or excited entity interacts with the reactant of interest R 
and in the process, energy is transferred between them.  The activated catalyst loses 
energy to the reactant and returns to its ground state in the process called quenching 
whereas the reactant R becomes energized and activated.  The excited reactant then 
undergoes transformations that lead to the formation of the product(s). 
2. via electron transfer, by acting either as an electron donor or electron acceptor.[1] 
 
In the case of energy transfer, the product P is formed from the activated substrate along the 
potential energy curve, while a new reaction path is opened when the photosensitizer 
transfers an electron to the substrate.[1] In considering excited-state redox reactivity, 
particularly that involved in organic photocatalysis, the direct occurrence of electron transfer 
will be of greater concern than involving energy transfer.  Chemical reactions involving 
electron(s) transfer are referred to as oxidation-reduction (redox) reactions and when it 
involves photocatalysis it is referred to as photoredox catalysis.  Photoredox catalysis is 
therefore a branch of catalysis that harnesses the energy of visible light to accelerate a 
chemical reaction via electron transfer, most often a single-electron transfer (SET).  
1.2 Need for Photoredox Catalysis 
Carbon-carbon bond formation is the core of organic synthesis. Many organic synthetic 
methodologies are based on the ease of generation of radicals.  Generation of a radical is 
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achieved traditionally by heating, irradiation by light or a redox reaction.  These conventional 
methods of radical generation often need the use of harmful or explosive reagents, use of 
high-energy UV radiation etc.[5,6]  In addition, the traditional methods often have a poor atom 
economy.  During the process, considerable amounts of waste are generated which may cause 
environmental problems, and sometimes special equipment is required.  Clearly, the use of a 
catalyst rather than a stoichiometric reagent is preferable.  However, most of the catalysts 
used often are labile compounds and require that carefully controlled conditions are used 
(e.g., with regard to the exclusion of air, moisture, impurities), as well as in many cases co-
catalysts or additives.  Considering the environmental factor, the atom economy and energy 
requirement, new methods for the formation of the C-C bond have to be developed.  These 
methods/protocols, according to the principles of “Green Chemistry”, need to be easy and 
safe to use and are expected to be efficient (both in terms of energy and atoms) and selective 
in their outcomes.[7] 
Nature’s ability to use various visible light absorbing chromophores/photocatalysts for 
converting solar energy to chemical energy has inspired various research groups to develop a 
plethora of hosts involving photoredox systems in an effort to mimic natural photosynthesis.  
However, despite the obvious, practical advantages of visible light as an “infinitely available” 
promoter for chemical synthesis, the simple inability of most organic molecules to absorb 
light in the visible range of the spectrum has greatly limited the potential applications of 
photochemical reactions. 
The challenge to mimic and understand enzymatic transformations, organocatalysis has now 
become an important tool in modern organic synthesis with new reactivity that complements 
that of enzyme and metal catalysis.  The major driving force being the increasing need for 
more efficient synthetic methods, sustainable processes.  It also stimulates the creative 
rethinking of known concepts, which, in turn, will lead to the development of innovative 
chemistry.[4,6,7] 
Photochemical transformations/reactions, using photocatalysts, generally require mild 
conditions for substrate activation—ideally light alone—and are suitable for “green 
reactions”.[4]  These systems have provided a platform to understand and elucidate the 
electron or energy transfer pathways involved in natural photosynthesis.[8-12] This, therefore, 
is employed as a strategy to overcome the barrier posed by the inability of most organic 
compounds to absorb visible light.  Hence, the development of new efficient processes using 
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photosensitizers and/or photocatalysts.[13]  This involves the employment of visible light 
absorbing photocatalysts and utilizing their electron/energy transfer processes to sensitize 
organic molecules to carry out required photochemical reactions. Photocatalysts, unlike 
thermal catalysts, are only effective while in the excited state, activate the substrate through a 
chemical process, such as photoinduced electron transfer (PET), in lieu of a physical energy 
transfer such as photosensitization.  In particular, photoredox catalysis employs small 
quantities of a light-sensitive compound that, when excited by light, can mediate the transfer 
of electrons between chemical compounds that otherwise would not react.[14] 
Photocatalysis involves an ever-increasing number of generic activation modes in which 
photonic energy is selectively targeted to a specifically designed photon-absorbing catalyst (a 
photocatalyst) which, upon excitation by irradiation with visible light of the appropriate 
wavelength, is able to induce an accompanying substrate, reagent, or secondary catalyst to 
participate in unique reaction pathways that were previously unattainable under thermal 
control.[15,16]  Upon irradiation, these molecules are converted into their photoexcited states, 
which are chemically more reactive because of the significantly altered electronic 
distribution. 
In the recent development of photocatalysis is the recognition that readily accessible 
(transition) metal polypyridyl complexes and organic dyes can facilitate the conversion of 
visible light into chemical energy under exceptionally mild conditions[15-17] and as such they 
can be used as photocatalysts.  Most of the commonly employed transition metal polypyridyl 
complex visible light photocatalysts are those of ruthenium and iridium metals. These 
complexes can be represented by the general formula ML3
n+, where M is the metal, L the 
ligand and n is the oxidation state of the metal.  In fact, these complexes have played and are 
still playing a key role in the development of photochemistry, photophysics, photocatalysis, 
electrochemistry, photoelectrochemistry, chemi- and electrochemi-luminescence, and 
electron and energy transfer.   They allow access to unique chemistries and a broad range of 
substrates that are unreactive in most synthetic contexts. 
The most common mechanisms by which photocatalysts are able to convert light into 
chemical energy and at the same time perform selective molecular activation include (i) 
energy transfer, (ii) organometallic excitation, (iii) light-induced atom transfer, and (iv) 
photoredox catalysis involving single electron transfer.[17]  The photophysical properties of an 
electronically excited molecule in the end determine its photochemical reactivity. 
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Accordingly, consideration of the properties of a photoredox catalyst in both the excited and 
ground states is crucial in effecting a desired reactivity. 
The first act of any photochemical and photophysical process, including photocatalysis, is the 
absorption of a photon by a molecule.   Absorption of light (+hv) produces an electronically 
excited molecule, the promotion of an electron in the molecule to a higher energy level, from 
a ground state singlet to a singlet excited state.   The excited state that is formed in this way is 
a high energy, unstable species that must undergo some type of deactivation. As shown in 
Figure 2 below, the excited state deactivation can occur via (i) disappearance of the original 
molecule (photochemical reaction), (ii) emission of light (−hv) (luminescence), (iii) 
degradation of the excess energy into heat (nonradiative deactivation), and (iv) some type of 
interaction with other species (R) present in the reaction mixture (quenching process).[18] 
 
The probability of light (photon) absorption (and thus the intensity of the correspondent 
absorption band) is related to the characteristics of the states involved and particularly to their 
spin quantum number. Transitions from the ground state to excited states having the same 
spin value are allowed and give rise to intense bands, whereas transitions to excited states of 
different spin value are forbidden and can hardly be observed in the absorption spectra 
(Figure 3). 
Upon absorption of a photon in the visible region, an electron in one of the photocatalyst’s 
metal-centered (Mn+) orbitals, the highest occupied molecular orbital HOMO, (e.g. a d 
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orbital),  is excited to a ligand-centered π* (L) orbital, the lowest unoccupied molecular 
orbital, LUMO, (e.g. the π* orbital of an aromatic ligand), having the same spin allowed 
value.[8,19,20]  This transition is thus termed a metal to ligand charge transfer (MLCT) and 
results in a species in which the metal has effectively been oxidized (due to a loss of an 
electron) and the ligand framework has undergone a single-electron reduction (an electron 
gain).[21]  In most molecules, the ground state is a singlet and the lowest excited state is a 
triplet that cannot be directly populated by light absorption but can be obtained from the 
deactivation of upper excited states. For this reason, at least three states (e.g., ground state 
singlet and excited singlet and triplet) are involved in a photochemical process. 
 
As stated above, the excited state that is formed in this way is a high energy, unstable species 
that must undergo some type of deactivation to be stabilized.  Deactivation of the excited 
singlet can occur by a number of familiar routes including emission (radiative deactivation), 
internal conversion, IC or intersystem crossing, ISC (nonradiative deactivation/radiationless 
decay).  Emission of light (luminescence) which could be fluorescence or phosphorescence 
depending on whether the excited state has the same or different spin compared to the ground 
state respectively. In the same way, radiationless deactivation is called internal conversion 
when it occurs between states of the same spin and intersystem crossing when it occurs 
between states of different spin. Fluorescence and internal conversion are spin-allowed steps, 
whereas phosphorescence and intersystem crossing are spin-forbidden steps.  All these are 
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referred to as intramolecular deactivation processes or steps.  They occur at a very high rate, 
i.e. they occur very fast within picoseconds. 
However, when the intramolecular deactivation steps are not too fast, i.e. when the lifetime of 
the excited state is sufficiently long, the excited molecule may have a chance to encounter a 
molecule of another solute in the reaction mixture.  In such a case, some specific interaction 
may occur and the process taking place is called a bimolecular process (Scheme 3) [18]. 
 
Simple kinetic arguments show that only those excited states that live longer than 10 -9 s may 
have a chance to be involved in encounters with other substrate molecules.[19]  For transition 
metal complexes, only the lowest spin-forbidden excited state satisfies this requirement.  The 
triplet state is the long-lived photoexcited species that engages in single-electron transfer; its 
long lifetime derives from the fact that decay to the singlet ground state is spin-forbidden.  
These complexes absorb light in the visible region of the electromagnetic spectrum to give 
stable, long-lived photoexcited states.[19]  The lifetime of the excited species is sufficiently 
long (e.g. 1100 ns for Ru(bpy)3
2+)[19] that it may engage in bimolecular electron-transfer 
reactions in competition with intramolecular deactivation pathways.[18]  Photoinduced 
electron transfer, or PET, is a term used to refer to the overall process of excitation and 
electron transfer between the excited state molecule and a ground state molecule. 
The most important bimolecular processes are energy transfer and electron transfer [22,23]; the 
latter process may involve either the oxidation or the reduction of the excited state. 
 
9 
 
The unique pathway involving complete electron transfer with concomitant radical ion 
formation offers a way to return the excited molecule to the ground-state manifold. 
It is the conversion of these bench stable transition metal polypyridyl complex, benign 
catalysts to redox-active species upon irradiation with simple household light bulbs that 
triggered the use of these transition metal-ligand complexes to induce unique and valuable 
catalytic processes.[19]  In addition, the technological progress and broad commercial 
availability of light-emitting diodes (LED) that are able to provide high-intensity visible light 
in a narrow wavelength range arouse the interest of many research groups in the study.[6] 
1.3 Mechanism of Photocatalysis 
As stated above, most organic compounds, especially the aliphatic derivatives, do not absorb 
in the near UV. Their excitation requires the use of high-energy radiation (e.g., λ < 220 nm), 
for which cheap lamps are presently not available. Furthermore, because of their high energy, 
the corresponding excited states often undergo various fragmentation processes, scarcely 
useful in synthesis.  These compounds can, however, be activated using photochemical 
methods.  Irradiation in the UV or visible region is a convenient way for generating 
electronically excited states and exploiting their high energy and different electronic structure 
for useful chemical reactions (as shown for compound R in Scheme 4a).[24]  However, 
activation of a compound by light does not necessarily imply that the reagent is directly 
irradiated. A variation that is often used in photochemistry, for example, when a reaction 
from the triplet is desired and the reagent considered intersystem crosses inefficiently, is the 
use of a sensitizer, a photocatalyst such as organic photocatalysts or a transition metal 
polypyridyl complex of the type ML3
n+ (M for simplicity), that absorbs light and transfers 
energy to the reagent (R), so that the (triplet) excited-state of the latter is reached indirectly 
(photosensitization, Scheme 4b). 
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Apart from energy transfer, there are other ways through which the light-absorbing molecule 
M, which might then generically be indicated as a photomediator, activates the reagent R. In 
particular, some chemical reaction may transform inactive R into a highly reactive 
intermediate RA that will give the final products, possibly via further intermediates (e.g., RI, 
see Scheme 4c; this mode of action has also been included among photosensitizations, but is 
distinguished because activation is based on a chemical reaction, as opposed to energy 
transfer, a physical phenomenon).[24]  Differently from direct irradiation or energy transfer, 
here the excited-state surface of reagent R is never attained, and, as far as this is concerned, 
the reaction path involves the lowest potential energy surface at any configuration, as it 
occurs in thermal reactions and contrary to photochemical reactions, where part of the path 
occurs on an excited surface. However, at least one photon is consumed per every molecule 
converted in all of the three cases (Scheme 4a-c). In the favourable case, the further 
condition applies that (one of) the intermediate(s) thus formed (RI) interact(s) with the 
deactivated photomediator MD giving the final product(s) and regenerate(s) M in the initial 
state. Then, M is not consumed in the overall process, exactly as it happens with a thermal 
catalyst (Scheme 4d). It seems, therefore, appropriate to label such a process as 
photocatalytic.[24]  As mentioned, M is used in an amount lower than stoichiometric, but light 
is a stoichiometric reagent. 
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Activation by a photocatalyst (M) results through one of the following three mechanisms. In 
the first one, an atom, or a group, is transferred from the reagent R-X to the excited 
photocatalyst generating a radical R•. This intermediate undergoes some reaction (e.g., 
coupling, addition), which leads to the desired product (Scheme 5a). In the process, the 
photocatalyst is regenerated, typically by back atom transfer to a reaction intermediate. 
 
In the second mode, an electron is transferred, forming the radical cation or anion of the 
substrate (electron transfer, ET).  Thus, redox processes, a rare occurrence when only ground 
state organic molecules are involved, are often operating in photoinduced reactions and are a 
typical mechanism in photocatalysis (Scheme 5b).[24] The ensuing reactions of the radical 
ions, for example, (cyclo)addition reactions, or of further intermediates result ing from them 
may give useful reactions, obviously including at some stage of the process a back electron 
transfer (BET) step regenerating the photocatalyst. In some cases, ‘sacrificial’ donors or, 
respectively, acceptors, have to be used to regenerate the starting photocatalyst. 
Finally, in the third mode, the reaction occurs on a metal centre.[18,24] As an example, a 
reagent adds onto a metal centre that has been activated by a photochemical reaction, and 
under these conditions, a C-C bond is formed. Then, liberation of the final product 
regenerates the starting metal catalyst so that the absorption of a further photon is required for 
initiating a second cycle.  This distinguishes photocatalysis from photogeneration of a 
thermal catalyst. 
Our present concern is the second mode that involves single electron transfer (SET), forming 
the radical cation or anion of the substrate (electron transfer, ET).  Here photoredox catalysis 
relies on the general property of excited states to be both more easily reduced as well as more 
easily oxidized than their corresponding ground states, and so the photocatalyst can serve 
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either as an electron donor or an electron acceptor to be regenerated in the catalytic cycle 
(Scheme 6). The photocatalyst undergoes two distinct electron-transfer steps; both the 
“quenching” and the “regenerative” electron transfer.  The two can be productive with respect 
to a desired chemical transformation.[7]  Ideally, the two electron transfer processes are 
connected by the substrates or intermediates of the catalysed reaction and therefore do not 
require any sacrificial electron donor or acceptor. 
 
1.4 Common Photoredox Catalysts 
A potential photochemical reaction can be induced (or sensitized) by a species which 
possesses specific redox, spectroscopic, and excited state properties upon light absorption. 
Such species or compounds can be called light absorption sensitizers (LAS)[18] or simply as 
organic photocatalysts (M). Juris and co-workers[19] opined that such a compound must 
perform as shown schematically below (Scheme 7): (i) it must absorb light so as to give an 
excited state; (ii) this excited state must be able to oxidize (or reduce) one of the reactants; 
(iii) the reduced (or oxidized) form of the photosensitizer must be able to reduce (or oxidize) 
the other reactant in order to complete the redox process and to regenerate the LAS.   
According to this group of researchers, the requirements for an ideal LAS should include the 
following: (1) reversible redox behaviour; (2) suitable ground and excited state potentials; (3) 
stability towards thermal and photochemical decomposition; (4) intense absorption in a 
suitable spectral region; (5) small energy gap between relevant excited states; (6) high 
efficiency of population of the reactive excited state; (7) suitable lifetime of the reactive 
excited state; (8) high energy content of the reactive excited state; (9) good kinetic factors for 
outer sphere electron transfer reactions. 
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Fagnoni, et. al [24] explained further that for a compound to be useful as a photocatalyst M, it 
obviously must undergo neither a thermal reaction nor a monomolecular photochemical 
reaction. Most importantly, the ‘deactivated’ state MD (in Scheme 4 above) form, resulting 
from the initial photochemical step, must be a persistent species that is sufficiently stable to 
avoid interfering with the (on the contrary highly reactive) activated substrate RA and with 
the other intermediates involved in the process, yet capable of being reconverted into the 
original form at some stage, so that absorption of a new photon initiates a new cycle. 
Classes of chemical compounds that have been shown to operate efficiently in this role, with 
little or no photodecomposition, and to be able to function for many catalytic cycles include 
the following: transition metal-ligand complexes and aromatic compounds, in particular those 
bearing strongly electron-withdrawing (to a lesser degree, donating) substituents: 
cyanoarenes; quinones; benzophenones; thiazines; electron-poor heterocycles. These 
compounds act via electron transfer (ET).  Electron transfer to organic molecules can occur 
both ways, to the valence band or from the conduction band, and generates both (single 
electron) oxidized and reduced intermediates, respectively.  Semiconductor oxides and 
sulfides such as TiO2, ZnS, and CdS may also act via ET, being both strong oxidant and 
strong reducing agents. 
However, most of the photoredox catalysts used in recent times are metal-ligand complex 
molecules.  Metals, especially the transition metals, like ruthenium (Ru), iridium (Ir), 
chromium (Cr), rhodium (Rh), and cobalt (Co). The ligands mostly in use include 2,2'-
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bipyridine (bpy), 2-phenylpyridine (ppy), 4,4'-di-tert-butyl-2,2'-bipyridine (dtbpy), 2,2'-
bipyrimidine (bpm), 2,2'-bipyrazine (bpz), and 1,10-phenanthroline (phen).  The recent 
literature reviews on photoredox catalysis focus mainly on transition metal chromophores 
with ruthenium and iridium polypyridyl complexes standing out.  They are well studied and 
employed in organic synthesis.[18]  Among them, Ru(bpy)3
2+ is the most studied one-electron 
photoredox catalyst.  Some commonly used photoredox catalysts are shown in Figure 4.[24-26] 
Figure 4: Some commonly used photoredox catalysts 
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While each class of materials has advantages, soluble transition-metal complexes are used 
most often.  The reasons for this is that this class of photoredox catalysts are often less toxic 
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than other reagents frequently used to generate free radicals, such as organotin reagents.  In 
addition, they generate potent redox agents while exposed to light, they are innocuous under 
ordinary conditions.  Their photoredox catalytic properties can be modified by changing 
ligands and the metal (Table 1), reflecting the somewhat modular nature of the catalysts. 
Table 1. Redox potentials of some visible-light photocatalysts.[25] 
Photocatalyst (M) E1/2 M
+/M* E1/2 M*/M
- E1/2 M
+/M E1/2 M/M
- 
Ru(bpy)3
2+ -0.81 +0.77 +1.29 -1.33 
Ru(bpz)3
2+ -0.26 +1.45 +1.86 -0.80 
Ru(phen)3
2+ -0.87 +0.82 +1.26 -1.36 
fac-Ir(ppy)3 -1.73 +0.31 +0.77 -2.19 
Ir(ppy)2(dtbbpy)
+ -0.96 +0.66 +1.21 -1.51 
Rose Bengal -0.68 +0.99 +1.09 -0.78 
Eosin Y -1.60 +1.18 +0.72 -1.14 
In V in CH3CN vs. SCE. 
 
1.5 Applications of Photoredox Catalysis in Organic Synthesis 
Since the beginning of scientific chemistry, chemists have been interested in light as an 
energy source to induce chemical reactions.[27] Harnessing visible light as the driving force 
for chemical transformations generally offers a more environmentally friendly alternative 
compared with classical synthetic methodology.[28]  Absorbing light, molecules reach an 
electronically excited state. As a result, the distribution of electrons in the molecules is 
significantly different at these states when compared to the ground state.  The transition 
metal-polypyridyl complexes based photocatalysts commonly employed in photoredox 
catalysis absorb efficiently in the visible spectrum allowing for orthogonal excitation.  The 
chemical properties and more particularly the reactivity of the molecules also change, and the 
reaction spectrum of a family of compounds is considerably broadened.  In some instances, 
using photochemical steps significantly shortens a total synthesis, and frequently complex, 
polycyclic, or highly functionalized structures can be obtained from simple substrates. New 
product families or libraries difficult to achieve with ground-state reactions are thus available, 
opening new perspectives in the search of biologically active compounds. 
Irradiation of a chemical reaction components or mixture with UV or visible light frequently 
improves the yields of metallocatalysed reactions.[29] For instance, ligand-exchange steps are 
often accelerated, and irradiation with light has become part of the standard reaction 
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conditions.  Irradiation is also used to initiate radical chain processes under mild 
conditions.[29]  Molecular chlorine and bromine, for example, undergo homolytic cleavage to 
form radicals when irradiated with UV light. Halogenated amide N-bromosuccinide (NBS 
also form radicals when exposed to light (Scheme 8).  Thus, particularly complex radical 
reactions such as certain radical tandem or multicomponent transformations can be made 
possible.[29] 
 
The use of photocatalysis in organic synthesis continues to receive the attentions of many 
research groups.  The applications range from simple transformation of compounds to 
complex multicomponent transformations with very high selectivity.  These include natural 
products syntheses[8] to late-stage pharmaceutical functionalization and polymer synthesis.[4]  
There are several reasons researching into the application of photocatalytic methods to 
synthetic issues such as carbon-carbon bond formation and carbon-heteroatom bond 
formation. First, it is a useful way to take advantage of the high energy of the photon.  
Second, the reactive intermediates involved (radicals, ions, radical ions) are the same that are 
generated in thermal reactions (though generally from different precursors) or can be likened 
with them (as it may be the case for the photocatalytic generation of an ion, which is similar 
to imparting an ionic character to a group in an organic molecule by forming a metal 
complex). The advantages of this are twofold.  From the mechanistic point of view, obtaining 
the same intermediates under conditions that are much milder than in thermal reactions and 
more easily amenable to the characterization of the path followed may help in the 
rationalization also of alternative thermal processes. On the other hand, because the course of 
the reaction is (at least partially) the same, this enables chemists to exploit the available 
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knowledge on thermal reactions (much larger than that on photochemical reactions) for 
making the best synthetic use of the photocatalytic methods.[6]  Another fascinating aspect of 
photochemistry, according to Cambie et al., is the use of photons as “traceless and green 
reagents”, hence rendering photochemical processes green and sustainable.[30] 
Much of the promise of visible light photoredox catalysis hinges on its ability to achieve 
unique exotic bond constructions that are not possible using established protocols.  For 
instance, photoredox catalysis may be employed to perform overall redox neutral reactions. 
As both oxidants and reductants may be transiently generated in the same reaction vessel, 
photoredox approaches may be used to develop reactions requiring both the donation and the 
reception of electrons at disparate points in the reaction mechanism. This approach stands in 
contrast to methods requiring stoichiometric chemical oxidants and reductants, which are 
often incompatible with each other, as well as to electrochemical approaches, which are not 
amenable to redox neutral transformations. Furthermore, single-electron-transfer events often 
provide access to radical ion intermediates having reactivity patterns fundamentally different 
from those of their ground electronic or excited states.[31]  Access to these intermediates using 
other means of activation is often challenging or requires conditions under which their unique 
reactivity cannot be productively harnessed. 
At the same time, these photoredox catalysts such as those of Ru- and Ir-polypyridyl 
complexes may also be employed to generate radicals for use in a diverse range of 
established radical chemistries.  The irradiation source is typically a commercial household 
light bulb, a significant advantage over the specialized equipment required for processes 
employing high-energy ultraviolet (UV) light. Additionally, for the fact that organic 
molecules generally do not absorb visible light, there is little potential for deleterious side 
reactions that might arise from photoexcitation of the substrate itself.  Finally, photoredox 
catalysts are employed at very low loadings, with 1 mole % or less.  
The application of photocatalysis in organic synthesis can be grouped into two broad classes: 
reactions involving electron transfer (i.e., photoredox catalysis) and the energy transfer 
reactions.  Most photoredox catalysis involving electron transfer follow one of the two 
mechanistic schemes depicted in Scheme 9 below.  Each of these photoinduced electron 
transfer cycles is categorized by the primary direction of the electron transfer with respect to 
the excited state catalyst M*.  Based on the stronger reduction or oxidation capability of the 
excited state than the corresponding ground state, photoredox catalyst takes advantage of the 
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electron transfer pathway of photocatalysis, donating an electron to an oxidative quencher or 
accepting an electron from a reductive quencher: in an oxidative quenching cycle, the excited 
state M* is quenched by donating an electron either to a substrate R or an oxidant [ox] 
present in the reaction mixture; in a reductive quenching cycle, M* is quenched by accepting 
an electron from the substrate R or a reductant [red].  The catalyst turnover step involves 
reduction of the oxidized [M]•+ in the oxidative cycle and oxidation of the reduced [M]•− in 
the reductive cycle. In either case, the substrate R, an external redox-active reagent, or an 
intermediate may be responsible for catalyst turnover.[17]  
Radical ion intermediates (e.g. both quenchers) that are formed from a single-electron 
transfer step through either oxidative quenching or reductive quenching, subsequently 
undergo the second chemical step to transform into either radicals or ions quite fast, serving 
as the real key reactive species to react with other molecules. However, some radical ions still 
do remain as key species directly participating in some chemical reactions. Overall, 
photoredox catalytic reactions typically involve a radical ion, a radical, or an ion as the key 
reactive intermediate.[15] Radical ion mediated transformations are a unique and valuable type 
of organic reaction because of their umpolung nature, especially in organic synthesis. 
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Regardless of whether the substrate undergoes an electron transfer ET reaction in the 
photoinduced electron transfer PET step or in the turnover step, there are three general redox 
outcomes possible for the substrate in either quenching manifold: net oxidative, net reductive, 
and net redox-neutral.  A net oxidative reaction requires an external oxidant, which can 
accept electrons in either the PET step or the turnover step. Likewise, net reductive reactions 
involve an external reductant donating electrons during the PET or turnover steps. Net redox-
neutral processes are more complex and often involve return electron transfer with the 
oxidized or reduced catalyst, sometimes mediated by a redox-active co-catalyst.[17] 
The mechanism explained above are idealized representations of reactions through PET 
manifolds, but in reality, however, an intermediate may be capable of donating or accepting 
an electron to initiate a new chain thereby rendering the quantum yield of reactions values 
greater than unity which are observed in some photoredox catalysis (Scheme 10).  Yoon and 
Cismesia demonstrated that a number of transition metal photoredox reactions exhibit a 
significant component of chain transfer.[4] 
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1.6 Net Reductive Photoredox Reactions 
A net reductive photoredox reaction involves an external reductant donating electrons during 
the photoinduced electron transfer PET or turnover steps (Scheme 11).  The first reactions 
demonstrating the potential utility of visible light photoredox catalysis in organic synthesis 
were net reductive reactions, in which an electron donor is required to serve as the 
stoichiometric reductant.[14,19,31] 
 
1.6.1 Reduction of Electron-Poor Olefins[14] 
Pac and co-workers in 1981 demonstrated the potential utility of visible light photoredox 
catalysis and reported the Ru(bpy)3
2+-mediated reduction of electron deficient olefins.[19] The 
terminal reductant employed in these studies, 1-benzyl-1,4-dihydronicotinamide (BNAH, 1), 
was of interest for its analogy to the biological reductant 1,4-dihydronicotinamide adenine 
22 
 
dinucleotide (NADH), with both molecules sharing the redox-active 1,4-dihydropyridine 
moiety.  The research group found that a catalyst system comprising 2 equiv. of BNAH and 
catalytic quantities of Ru(bpy)3
2+ was capable, upon irradiation with visible light, of reducing 
dimethyl maleate (2) to the saturated product dimethyl succinate (3) (Scheme 12). 
They proposed that as in all photoredox reactions, this process is initiated by absorption of 
visible light by the photocatalyst Ru(bpy)3
2+ (M) to give the photoexcited species 
*Ru(bpy)3
2+ (M*). Photoexcitation renders this species sufficiently oxidizing to accept an 
electron from BNAH, generating the BNAH radical cation 4 and concurrently reducing the 
photocatalyst to Ru(bpy)3
+ (M-). This Ru(I) intermediate is highly reducing, enabling transfer 
of an electron to dimethyl maleate. This event oxidizes the photocatalyst back to Ru(bpy)3
2+ 
(M) and completes the photocatalytic cycle (Scheme 12). Meanwhile, single-electron 
reduction of 2 gives the radical anion 5, which may be protonated to yield α-carbonyl radical 
6.  This radical is then believed to undergo a second single-electron reduction followed by 
protonation to give dimethyl succinate (3). The single-electron donor for this step may be 
another equivalent of Ru(bpy)3
+ (M-), or it may be dihydropyridyl radical 7, the product of 
deprotonation of radical cation 4 and itself a strong reductant.[19]  Upon loss of an electron, 
radical 7 is converted to pyridinium 8, the ultimate product of two-electron oxidation of 
BNAH.  BNAH (1) was observed to quench *Ru(bpy)3
2+ (M*), while dimethyl maleate (2) 
did not. This observation provided strong evidence that the reaction proceeded via reductive 
quenching of *Ru(bpy)3
2+ (M*) to give a Ru(bpy)3
+ (M-) intermediate, rather than via 
oxidative quenching to give a Ru(bpy)3
3+ (M+) intermediate. The reaction was additionally 
found to be amenable to the reduction of alkenes bearing a range of electron-withdrawing 
groups, such as esters, ketones, arenes, and nitriles.[19]  
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1.6.2 Reductive Dehalogenation 
Reductive dehalogenation reactions, mediated by visiblelight photoredox catalysis, were 
pioneered by Kellogg and co-workers, as well as others since 1978.[32]  The photoredox-
mediated reductive dehalogenation, in which a C−X bond is reduced to a C−H bond, first 
observed by Fukuzumi for α-haloacetophenones,[27] was later developed by Stephenson and 
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co-workers into a synthetically useful transformation.[24]  Fukuzumi and co-workers in 1990 
demonstrated the reduction of phenacyl bromides using visible light, Ru(bpy)3
2+ as a 
photocatalyst, and 9,10-dihydro-10-methylacridine as the stoichiometric reductant.[27]   In the 
net transformation, the phenacyl bromide (9) is reduced by two electrons to give 
acetophenone (10), while the dihydroacridine (11) is oxidized by two electrons to give the 
acridinium by-product (12) (Scheme 13).   Halogens α- to a carbonyl, electron withdrawing 
or aryl group could be selectively reduced under these conditions.  Halogens α- to a carbonyl, 
electron withdrawing or aryl group are considered to be activated, because the radical they 
produce upon fragmentation is stabilized by conjugation with these groups. 
 
Conceptually, this reaction proceeds via reductive quenching of photoexcited *Ru(bpy)3
2+ to 
Ru(bpy)3
+ and subsequent electron transfer to C–X bond α- to an electron-withdrawing 
group, followed by hydrogen abstraction.  The reductive dehalogenation using photoredox 
catalysis at this stage was only limited to activated halogen compounds.  Stephenson and co-
workers extended it to the reduction of less activated (or un-activated) halogen substrates 
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such as alkyl iodides by simply modifying redox potentials of the photocatalysts using the 
strongly reducing photocatalyst tris-(2,2’-phenylpyridine)iridium (Ir(ppy)32+).[33]  This 
updated reaction is mechanistically distinct from the previous transformation of activated 
bromides and chlorides. The increased reduction potential of this catalyst compared to 
Ru(bpy)3
2+ allows direct reduction of the carbon-iodine bond without first interacting with a 
stoichiometric reductant. Thus, the iridium complex transfers an electron to the substrate, 
causing fragmentation of the substrate and oxidizing the catalyst to the Ir(IV) oxidation state. 
The oxidized photocatalyst is then easily returned to its original oxidation state through 
interaction with one of the reaction additives, tributylamine (Scheme 14).  This shows that 
photocatalytic generation of a radical by the reduction of a C–X bond has great potential as 
an alternative for C–C bond forming reactions via the chemistry of alkyl free-radicals. 
 
Just as Sn-mediated radical dehalogenation reactions can be used to initiate cascade 
cyclizations to rapidly generate molecular complexity, the photocatalytic reductive 
dehalogenation allows access to the same types of complex products.  Visible-light-mediated 
dehalogenation reactions, when compared with those that employ conventional radical-based 
methods, not only provide the desired products in excellent yields under mild reaction 
conditions, but also exhibit superior chemoselectivity and excellent functional-group 
tolerance (Scheme 15 (a)).  In the work of Stephenson,[34] a radical cascade cyclization that 
closed two five-membered rings and formed two new stereocenters with good yield was also 
achieved using visible light photoredox catalyst (Scheme 15 (b)).  It was observed that the 
reductive dehalogenation protocol could be a key step in a total synthesis of the natural 
product (+)-gliocladin C (Scheme 15 (c)).[32,35] 
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1.6.3 [2 + 2] Photocycloadditions:  Formation of Cyclobutanes 
Cycloadditions and other pericycle reactions are powerful transformation in organic synthesis 
because of their potential to rapidly generate complex molecular architectures and 
particularly because of their capacity to set multiple adjacent stereocenters in a highly 
controlled manner.  Cycloadditions that are not thermally allowed, such as the [2+2]-
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cycloaddition, can be enabled by photochemical activation of the reaction.  Among 
photochemical reactions, the [2+2]-photocycloaddition of α,β-unsaturated ketones or esters to 
alkenes, alkynes, or allenes leading to cyclobutanes is certainly the most applied reaction in 
organic synthesis.[14,29,31,36]   With α,β-unsaturated ketones, the reaction can be induced by 
simple light absorption. In contrast, a sensitized reaction is preferred in the case of α,β-
unsaturated esters. The transformation is then frequently performed with acetone as solvent 
and sensitizer. In many cases, the unsaturated carbonyl compounds react at the 3ππ* state 
with alkenes and 1,4-biradical intermediates are generated.[29]  As shown in the following 
example, complex structures are accessible in only one step without using expensive and/or 
toxic reagents. This considerably simplifies the total synthesis of complex molecules such as 
natural products. 
 
Yoon and co-workers in 2008 reported a visible-light photocatalytic [2+2] cycloaddition 
reaction of αβ-unsaturated ketones (enones), inspired by Krische’s pioneering work on metal-
catalysed formal [2+2]-cycloaddition.[36] By irradiation in the presence of 5 mol% 
Ru(bpy)3Cl2 (a photoredox catalyst), 
iPr2NEt as a terminal electron donor, and LiBF4 as a 
mild Lewis acid, intramolecular [2+2]-cycloaddition reactions could be achieved in high 
yield together with promising diastereoselectivity (d.r. > 10 : 1). In their initial report, Yoon 
demonstrated that introducing lithium salt as the additive effectively promoted the reaction by 
not only activating the carbonyl group toward oxidation but also stabilizing the radical anion 
intermediate. Unfortunately, only aryl enones underwent this type of transformation while 
aliphatic enones remained intact, presumably attributable to the more negative reduction 
potential. The proposed mechanism of this visible-light photocatalytic formal [2+2]-
cycloaddition of enones is shown in Scheme 17.[15] 
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The sensitized [2+2]-photocycloaddition of various α,β-unsaturated lactones such as 20 has 
been studied and reported in the context of an application to the total synthesis of 
solanoeclepin A.[29]    
A [2+2] photocycloaddition was also used by Crimmins and co-workers as one of the key 
steps in the synthesis of ginkgolide B1.[37] This natural product possesses a propellane core 
structure, and photochemical reactions have frequently been applied for the synthesis of such 
derivatives.[29]  Cyclobutane 27 was obtained in quantitative yield from the nonsensitized 
photocycloaddition of 26. Under similar conditions, the cinnamic acid derivative 28 was 
transformed in high yields via a [2+2]-photocycloaddition followed by hydrogenation into 
littoralisone.[38] The reaction also occurs but less efficiently with visible light, which may 
indicate that the photochemical generation of the cyclobutane ring is part of the biosynthesis 
of this compound.[33] Currently, the acetone-sensitized [2+2]-photocycloaddition is studied as 
a key step in the synthesis of bielschowskysin, a diterpene possessing a [9.3.0.0]-tetradecane 
ring system with 11 stereocenters.[34] 
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A versatile variant of the [2+2]-photocycloaddition in synthetic applications is the DeMayo 
reaction.  The DeMayo reaction is a photochemical reaction in which the enol of a 1,3-
diketone (a β-diketone) reacts as an α,β-unsaturated ketone with an alkene (or another similar 
species with a C=C bond) resulting in the formation of a cyclobutane ring.  This step is 
followed by a retro-aldol reaction by the resulting cyclobutane ring to yield a 1,5-diketone.  
The ensuing retro-aldol cleavage is favoured by the relative instability of the cyclobutane 
ring. 
An example is presented below. In its enol form, a β-diketone reacts as an α,β-unsaturated 
ketone with an alkene. This step is followed by a retro-aldol reaction. In the compound 29, 
the mono-enolized β-diketone chromophore adds to the enamine part of the isoquinolone 
moiety and the tetracyclic aldol 30 is obtained as an intermediate.[29]  Due to the cyclobutane 
ring strain, the intermediate is immediately transformed to 31 and the more stable tetracyclic 
hydroxyketone derivative 32 is isolated. This compound possesses the galathane skeleton 
which is encountered in lycorine alkaloids isolated from Amaryllidaceae. 
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1.6.4 Reduction of Nitrogen Functional Groups 
Photoredox catalysis has also been employed in the reduction of some nitrogen-containing 
functional groups. Hirao and co-workers were reported to use the method in the reduction of 
nitrobenzenes to anilines using either Ru(bpy)3
2+ or the related photocatalyst 
Ru(bpy)2(MeCN)2(PF6)2.
[19] In these reactions, hydrazine was employed as the stoichiometric 
reductant, the source of the electrons that were ultimately transferred to the nitro-arene. The 
reduction of nitrobenzenes to anilines has also been achieved using a resin loaded with the 
organic photocatalyst Eosin Y.  Liu was also able to accomplish the reduction of azides to 
amines by using a catalytic system comprising Ru(bpy)3
2+, Hünig’s base, and Hantzsch 
ester.[39] The reaction was proposed to proceed first via reductive quenching of *Ru(bpy)32+ 
by the tertiary amine i-Pr2NEt to give Ru(bpy)3
+. Single-electron reduction of the azide by 
Ru(bpy)3
+ gives an azide radical anion, which upon expulsion of dinitrogen and protonation 
affords the aminyl radical. This intermediate may then abstract a hydrogen atom (from either 
Hantzsch ester or the radical cation of Hünig’s base) to furnish the primary amine product 
(Scheme 20). Aryl as well as aliphatic azides may be reduced following this protocol. The 
reaction was also shown to be compatible with biomolecules, as demonstrated by the 
reduction of an azide tethered to a DNA oligonucleotide.[19] 
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Zheng also reported the reduction of hydrazides and hydrazines under visible light 
photoredox catalysis using Ru(bpz)3
2+, a tris(bipyrazyl) analogue of Ru(bpy)3
2+.[39]  Using the 
photoredox catalyst, N-phenyl-N-benzoylhydrazine (33) undergoes efficient reduction to N-
phenylbenzamide (34), and N-methyl-N-phenylhydrazine (35) is reduced to N-methylaniline 
(36) (Scheme 21). 
 
1.6.5 Reductive Epoxide and Aziridine Opening 
Although an epoxide functional group is not readily reduced, MacMillan and co-workers 
exploited the ability to reduce carbonyls using photoredox catalysis to achieve the reductive 
opening of epoxides and aziridines.  Epoxides and aziridines containing an α-carbonyl moiety 
undergo epoxide and aziridine ring-opening reactions through visible-light-mediated 
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electron-transfer pathways a photocatalyst and Hantzsch ester (HE) (diethyl 1,4-dihydro-2,6-
dimethyl-3,5-pyridinedicarboxylate) as the stoichiometric reductant.[20,31]  In the catalytic 
cycle, reductive quenching of the excited photocatalyst, *Ru(bpy)3
2+, generates Ru(bpy)3
+ 
(Scheme 22). Ru(bpy)3
+ is sufficiently reducing to donate an electron to α-ketoepoxide 37 to 
give ketyl radical 38.  The cleavage of C−O bond that follows provides radical anion 39, 
which after protonation and abstraction of a hydrogen atom gives the β-hydroxyketone 
product 40.  Hantzsch ester (HE) may potentially act as a hydrogen atom donor and reductive 
quencher as described in Scheme 22, ultimately undergoing conversion to Hantzsch pyridine 
(HP). This reductive protocol was additionally found to ring-open α-ketoaziridines such as 41 
to provide β-aminoketones such as 42. However, in both cases of the ring-opening, an aryl 
substituent is required on the ketone, probably to facilitate single-electron reduction to the 
ketyl radical.  [Ir(dtb-bpy)(ppy)2]PF6 as a single-electron transfer (SET) photosensitizer, was 
utilized to bring about the ring-opening reactions of the sterically hindered β-epoxyketones. 
 
1.7 Net Oxidative Photoredox Reactions 
Photoredox catalysis has also been used to perform net oxidative reactions as it is used to 
achieve net reductive reaction.  A net oxidative reaction requires an external oxidant, which 
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can accept electrons in either the photoinduced electron transfer (PET) step or the catalyst 
turnover step.  Reactions in this category typically hinge on the single-electron oxidation of 
particularly electron-rich functional groups, such as electron-rich arenes and amines.[18,24,39] 
The Ru(II) polypyridyl complex (RL3
2+) effectively catalysed the photo-oxidation by visible 
light of some carbinols to aldehydes in the presence of a diazonium salt as quencher and a 
basic agent in acetonitrile. 
1.7.1 Functional group oxidation 
Single-electron oxidation pathways have enabled the oxidation of several common functional 
groups via photoredox catalysis.  In 1984, Cano-Yelo and Deronzier reported the use of 
ruthenium(II) photocatalyst to effect the oxidation of benzylic alcohols to their corresponding 
aldehydes using aryldiazonium salts as sacrificial electron acceptors (quencher).[40] The 
reaction was carried out in acetonitrile in the presence of a basic agent, collidine. (Scheme 
23) 
 
Cano-Yelo and Deronzier observed that the efficiency of alcohol oxidation by the method 
largely depends on the redox properties of the photocatalyst that can be modulated via the 
instalment of substituents on the ligand framework of the catalyst.  The presence of electron-
withdrawing groups on the bipyridine ligands renders the catalyst RuL3Cl3 significantly more 
oxidizing than Ru(bpy)3
2+. 
34 
 
Much more later after the Deronzier’s first application of photoredox catalysis for the 
synthesis of organic compounds, Zen and co-workers reported the selective and efficient 
photocatalytic oxidation of sulfides to sulfoxides.[19] For this oxidation, a Nafion membrane 
doped with a lead ruthenate pyrochlore (Pyc) catalyst and Ru(bpy)3
2+ (designated as |NPycx–
Ru(bpy)|) was used.  When the sulphide 46 was irradiated with visible light in the presence of 
the catalyst in CH3CN/H2O and continuous purging with O2 for 3 h the sulfoxide 47 was 
obtained in 97% yield (Scheme 24). No over oxidation of sulfoxide to sulfone was observed. 
A proposed reaction mechanism is shown in Scheme 24, where Pyc plays a dual catalytic 
role as the reducing agent in the oxygen reduction reaction (ORR) to produce H2O2 and also 
as an electron acceptor from the excited *Ru(bpy)3
2+ to form Ru(bpy)3
3+. Hydrogen peroxide 
generated in situ oxidizes the sulfide to sulfoxide while regenerating Ru(bpy)32+ to complete 
the catalytic cycle of the catalyst. 
 
1.7.2 Oxidative Generation of Iminium Ions 
Sequel to their previous work on reductive quenching cycle of photoredox catalysis, 
Stephenson and co-workers in 2012 reported their achievement of Friedel−Crafts 
amidoalkylation 51 by oxidation of dialkylamides 48 using persulfate (S2O8
2−) in the 
presence of the visible light catalyst, Ru(bpy)3Cl2, at room temperature, via a reactive N-
acyliminium intermediate 50.  Alcohols and electron-rich arenes served as effective 
nucleophiles, forming new C−O or C−C bonds. Though the same reaction could be carried 
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out by mild heating of the dialkylamides and persulfate, photocatalysis provided higher yields 
and better selectivities.[41]  N-Acyliminium ions are very important in the synthesis of 
alkaloid natural products. 
 
There is precedence that persulfate (S2O8
2−) is an effective oxidative quencher of 
*Ru(bpy)3
2+, and the generated sulfate radical anion (SO4
·−) is a reactive intermediate known 
to abstract activated hydrogen atoms and also to be a strong oxidant.[41] 
1.7.3 Aza-Henry Reactions 
Stephenson and co-workers reported in 2010, the use of photoredox reductive reaction to 
achieve Aza-Henry reactions, oxidative coupling of nitroalkanes with tertiary N-arylamines, 
by taking the advantage of the iminium ions generated in the reaction using tertiary amines as 
reductants.  With an appropriately chosen oxidant, the iminium ion generated in the reductive 
quenching cycle of the photoredox catalyst could be trapped by a variety of nucleophiles 
under the photoredox conditions.  In their study, the group used nitroalkanes (as 
nucleophiles) and N-arylamines to achieve the oxidative coupling using visible-light 
photoredox catalysis.  The photocatalyst employed is the iridium complex 
Ir(ppy)2(dtbbpy)PF6, which upon photoexcitation is capable of oxidizing N-
phenyltetrahydroisoquinoline 52 to its radical cation 53 (Scheme 26). The intermediate Ir(II) 
species is proposed to reduce dioxygen to complete the photoredox cycle. Superoxide may 
then abstract a hydrogen atom at the α-position of the amine to generate the key iminium 
intermediate 54. Addition of the nitromethane anion 55 yields the aza-Henry adduct 56.[19,42] 
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1.7.4 Azomethine Ylide [3+2] Cycloadditions 
Iminium ions generated via photoredox catalysis had been used to achieve azomethine ylide 
[3+2] cycloadditions by some research groups. Azomethine ylides are nitrogen-based 1,3-
dipoles, consisting of an iminium ion next to a carbanion.  They are usually used in 1,3-
dipolar cycloaddition reactions to form 5-membered heterocycles,[43] including pyrrolidines 
and pyrrolines by reacting them with electron-deficient alkenes.  Xiao and co-workers were 
reported[19] to couple this reaction with an oxidative aromatization sequence to convert 
tetrahydroisoquinolines to polycyclic adducts such as 57 (Scheme 27). In the transformation, 
tetrahydroisoquinoline 58 undergoes single-electron oxidation by *Ru(bpy)3
2+ to give radical 
cation 59. Hydrogen atom abstraction, presumably by superoxide generated during catalyst 
turnover, then furnishes iminium 60. Deprotonation adjacent to nitrogen forms the 
azomethine ylide 61, which may engage a host of electron-deficient alkenes in [3+2] 
cycloaddition reactions. Thus, cycloaddition with N-phenylmaleimide 62 furnishes the 
pyrrolidine-containing adduct 63.[19] 
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1.8 Net Redox-Neutral Reactions 
In both the net reductive and net oxidative reactions discussed above, there is a need for the 
use of a stoichiometric quantity of a molecule that can serve as a source or reservoir of 
electrons, respectively.  However, there are situations where the substrate or substrates 
undergo both a single-electron oxidation and a single-electron reduction at separate points in 
the reaction mechanism.  As a result, there is no net oxidation state change between starting 
materials and products, and no stoichiometric external components are required to turn over 
the photocatalytic cycle.  Net redox-neutral processes are more complex than the net 
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reductive and net oxidative reactions and are sometimes mediated by a redox-active co-
catalyst.[17] 
1.8.1 Atom Transfer Radical Addition (ATRA) 
The redox neutral approach is perhaps best exemplified by atom transfer radical addition 
(ATRA) reactions.[19] In ATRA reaction, an atom transfer reagent formally undergoes σ bond 
cleavage and addition across a π bond of an alkene or alkyne, in the process forming two new 
σ bonds.[44]  In 1994, Barton, et al reported an atom transfer radical addition of Se-phenyl p-
tolueneselenosulfonate to a range of vinyl ethers using Ru(bpy)3
2+ photoredox catalyst 
producing β-phenylselenosulfones in high yields.[45]  Stephenson and co-workers[44] 
accomplished similar results using the photoredox catalyst [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 (M) 
on a broader range of atom transfer reagents to olefins using α-halocarbonyls such as diethyl 
2-bromomalonate and ethyl bromodifluoroacetate and haloalkanes such as 
trifluoromethyliodide and perfluoroalkyl iodides.  Their protocol is capable of coupling a 
wide variety of halogenated compounds to terminal olefins and disubstituted olefins under 
mild conditions.[19] Based on their findings, Stephenson and co-workers proposed the 
mechanism outlined in Scheme 28.  Oxidative quenching of the visible light-induced excited 
state of the photoredox catalyst, M* by the haloalkane 70 generates an electrophilic radical 
71 along with the M+ complex, bearing the halide as a counterion. This radical then 
undergoes an addition to the alkene 72. The ATRA product 74 can then be formed via two 
potential pathways. First, oxidation of the alkyl radical 73 by M+ generates the carbocation 
73, pre-associated with the halide, which combine to provide the final product 74 selectively. 
Alternatively, a radical chain transfer mechanism may also be operative.[44]  The reactions are 
amenable to addition across a range of terminal alkenes, as well as cyclic internal alkenes and 
terminal alkynes.[46] 
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CHAPTER TWO 
2.0 Aims 
Alkenes and allenes represent versatile functional groups that can be utilized as a useful 
precursors in a variety of synthetic transformations, leading to complex structures that are 
useful for constructing natural and unnatural products.[47,48]  When one of the hydrogen atoms 
of these functional groups is replaced with an amine, enamines and allenamines are obtained 
respectively.  Both enamines and allenamines are unsaturated compounds and are highly 
nucleophilic due to the electron-donating ability of the nitrogen lone pair to the C=C double 
bond which increases its electron density.  This electron rich C=C double bond makes them 
powerful synthetic intermediates and find wide applications in organic synthesis.[49]  
However, this factor also makes enamines and allenamines very difficult to handle. 
If the nitrogen functionality containing an electron withdrawing group, such a carbonyl group 
in particular, is the substituted group on the alkenes or allenes, enamides or allenamides, 
respectively, are obtained.  In comparison to enamines, enamides exhibit a much diminished 
enaminic reactivity, because the N-electron-withdrawing group, the carbonyl group, alleviates 
the delocalization of the lone-pair electrons of the nitrogen atom into the C=C double bond.  
The lone pair conjugates with the carbonyl group leading to decreasing electron density of the 
C=C double bond.  Therefore, enamides show a good balance of stability and reactivity, a 
combination which accounts for their increasing importance in organic synthesis and 
medicinal chemistry.[50]  The stability of enamides is well demonstrated, for instance, by the 
occurrence of stable enamide structures in many natural products and drug candidates.[51] The 
enamide group is an important substructure that is often found in natural products and 
synthetic drugs. 
Similarly, allenamides possess the right balance between stability and reactivity that are more 
rewarding than allenamines for the same reasons that make enamides more stable than 
enamines.  These nitrogen-containing structures represent a versatile functional group that 
can be utilized as a useful building block in a variety of synthetic transformations, leading to 
complex structures that are useful for constructing natural and unnatural products. 
Both enamides and allenamides offer a wide variety of alternatives for the inclusion of 
nitrogen-based moiety into organic systems.  Nitrogen-containing structures are prevalent 
41 
 
among medicinally interesting natural and unnatural products and, thus, are useful in 
developing new therapeutics.  For instance, the enamide group is an important substructure 
that is often found in natural products and synthetic drugs that have, amongst others, sedative, 
cytotoxic, or anti-inflammatory, anti-parasitic and anti-cancer properties.[50,52]  Therefore, 
efforts in developing the chemistry of these compounds can be significant and rewarding, 
especially to synthetic chemists and medicinal chemists.[10] 
Detailed reviews of enamides are given in chapter three while that of allenamides are in 
chapter four.  These include the synthetic routes for the two functional groups and some of 
the significant reactions each of the two undergoes. 
Carbon–carbon and carbon-heteroatom bond-forming reactions constitute one of the 
foundations in organic synthesis and have attracted extensive exploration since the dawn of 
organic chemistry.[1]  For instance, the direct C–H activation (or functionalization) of organic 
compounds with transition metals has recently received much attention across the chemistry 
fields.[2]  These C-H functionalization often involves generation of reactive radical 
intermediates. 
Reactions via radical intermediates are widely used in organic synthesis.[1] However, the 
generation of these highly reactive species under mild conditions and in a predictable way, in 
accordance with the general principles of Green Chemistry,[2] is not an easy task. The 
principles of green chemistry include, among others, prevention of waste or by products, maximum 
incorporation of the reactants into the final product and prevention of hazardous products. 
Photochemistry is the elective method, since the absorption of a photon leads to the selective 
delivery of a large amount of energy into an absorbing molecule and leaves no waste to get 
rid of after the process, thus offering a smart way to generate reactive intermediates under 
controlled conditions.[3] Moreover, the emerging strategy for the visible-light photoredox-
catalysed C–C bond forming reactions further enrich the realm of this transformation,[3] such 
as the visible-light photoredox catalysis.  It is the intention of this research to evolve a 
reaction method to transform enamides and allenamides into synthetically useful compounds 
by the use of photoredox catalysis. 
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2.1 Enamides 
We intended to explore the area of radical/cationic pathway using iridium 2-phenylpyridine 
4,4’-di-tert-butyl-2,2’-bipyridine complex [Ir(ppy)2(dtbbpy)]PF6 as a photoredox catalyst to 
access the N-acyl-N’-aryl-N,N’-aminals in a one-pot three components reaction under mild 
reaction conditions and their subsequent cyclization to γ-lactams. 
Studies made by Courant and Masson[53] have demonstrated that iridium polypyridyl 
complexes could be used as photoredox catalyst to initiate three-component domino synthesis 
of N-carbamoyl α-alkylated imines under mild conditions. In their work, Courant and Masson 
were able to initiate a non-reductive radical alkylation of secondary enamides using iridium 
poly pyridyl photoredox catalyst to obtain N-acyliminium cation intermediate which was 
trapped by ethanol as a nucleophile to generate β-alkylated β-amido ether (Scheme 29).[53] 
With this in mind, we envisaged that the same procedure could be used with tertiary 
enamides using arylamines as nucleophiles to trap the N-acyliminium cation intermediate that 
might be formed to obtain N-acyl-N’-aryl-N,N’-aminals. In other words, we intend to develop 
a novel approach using iridium polypyridyl complex photoredox catalyst to initiate a three-
component domino transformation of enamides to N-acyl-N’-aryl-N,N’-aminals via 
photoredox catalysed β-alkylation of enamide intermediate and their subsequent trapping 
with an arylamine.  It is our desire to obtain N-acyl-N’-aryl-N,N’-aminals of the type 81 by 
combining the enamide, diethyl 2-bromomalonate and arylamine via a one-pot three-
component reaction conditions (Scheme 30). We thought, if this could be achieved, the N,N’-
aminals so obtained would be first of its kind accessed through this approach.   The N-acyl-
N’-aryl-N,N’-aminals would be synthetically useful precursors to valuable γ-lactams building 
blocks under a mild condition (Scheme 30). 
 
43 
 
 
The N-acyl-N′-aryl-N,N′-aminal structural motif is prevalent within a wide range of 
biologically important compounds and have attracted considerable attention as building 
blocks for the synthesis of drug candidates.  For example, the natural product evodiamine is 
an aminal-containing molecule with anti-inflammatory, antiobesity, and antitumor activities 
(Figure 5).  In addition, aminal-containing molecules have also found a wide range of 
applications in optoelectronic materials.[54] 
 
Typical approaches to the N-acyl-N′-aryl-N, N′-aminal motifs, whether cyclic or acyclic, have 
relied on the addition of an arylamine to an N-acyliminium species, or conversely, the 
addition of an amide or an equivalent to an N-aryliminium which are predicated on the 
successful formation of an N-acyl and N-aryliminium species.  Another approach had been by 
means of Curtius and Hoffman rearrangements of protected amino acid derivatives.  
However, this often-multistep strategy has a limited substrate scope.[54]  Therefore, the 
development of efficient and convenient methods for synthesizing aminals should be of great 
importance to the synthetic community. 
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The γ-lactams should be obtained by intramolecular cyclization of the N,N’-aminals with the 
presence of a nucleophile via the lone pair of the nitrogen atom of the arylamine and an 
electrophilic carbon of the carbonyl carbon of the ester in the molecule (Scheme 32). 
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The γ-lactam moiety is part of the important structure of a large number of natural and non-
natural compounds covering a broad spectrum of biological activities.[56]  They are included 
in a large number of pharmaceutically active compounds with antibiotic, anti-inflammatory, 
and anti-tumoral functions.[57]  The γ-lactam moiety is, therefore, a privileged structural 
subunit for the design of several pharmaceutical agents.[58,59]   γ-Lactams also served as 
valuable building blocks for the synthesis of complex molecules due to their latent reactivity 
and the large panel of highly selective transformations they can undergo.[58] Figure 6 shows 
rolipram, a selective inhibitor of phosphodiesterase (PDE) type IV possessing anti-
inflammatory and antidepressant activities,[58] and some valuable γ-lactam ring containing 
natural products and pharmaceutical agents.  Accordingly, products containing the γ-lactam 
core are important synthetic targets. 
 
 
 
2.2 Allenamides 
Allenamides possess the right balance between stability and reactivity of allenamines.  The 
stability and reactivity are the result of the effects of the electron-withdrawing group, such as 
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carbonyl group, on the nitrogen atom which reduces the electron density on the allene moiety.  
Though it is less reactive than the allenamines, allenamides are more stable and still retain 
most of the allenaminic reactivities.[60] 
Recently, allenamides with the similar classes of compounds have attracted considerable 
attention of the synthetic community due to their unique reactivity profiles.[61,62]  The electron 
density on the central β-carbon is relatively higher than on the α- and γ-carbon atoms of the 
allene group of the allenamide as a result of the controlled electron donating ability of the 
nitrogen atom.  This effect makes the central β-carbon a point of attack by a suitable 
electrophile.  This can be harnessed in subsequent chemical transformation of allenamides 
leading to regiochemical confidence in the resulting products. 
Importantly, this unique reactivity has led to the development of a variety of innovative 
transformations, including cycloadditions, Aldol additions, intramolecular cyclizations and 
intermolecular addition reactions, as well as the use of the allenamide building block in 
natural product synthesis.  Despite this versatility of the allenamides to the synthetic 
community, no one has subjected these useful class of compounds to photoredox catalysis, at 
least to the best of our knowledge. 
With the above in mind, we aimed to establish a novel atom-efficient and general photoredox 
catalyst mediated β-alkylation of allenamides building blocks utilising a one pot-component 
reaction. Then formation of a general route of arylamination at the α-position or γ-position 
forming a new carbon-nitrogen bond which may lead to N,N’-aminals in the case of α,β-
addition products (Scheme 33). The presence of a C=C bond in the resulting adduct products 
can also be utilized in the subsequent transformations.  We plan to achieve this by using 
iridium polypyridyl complex photoredox catalyst to initiate a three-component domino 
transformation of allenamides to N-acyl-N’-aryl-N,N’-aminals via photoredox catalysed β-
alkylation and the  subsequent trapping of the intermediate radical ion with a suitable 
nucleophile, namely an arylamine. 
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CHAPTER THREE 
3.0 Enamides 
3.1 Enamides: an Introduction  
Enamines are unsaturated compounds derived by the condensation of aldehydes or ketones 
with secondary amines.  If one of the nitrogen substituents of the enamine is a hydrogen 
atom, it is the tautomeric form of an imine (Scheme 34). This usually will rearrange to the 
imine; aniline being one of several exceptions to this. The enamine-imine tautomerism may 
be considered analogous to the keto-enol tautomerism.  In both cases, a hydrogen atom 
switches its location between the heteroatom (oxygen in keto-enol or nitrogen in enamine-
imine) and the second carbon atom.  The high nucleophilicity of enamines can be ascribed to 
the electron-donating ability of the nitrogen lone pair to the C=C double bond, increasing its 
electron density. 
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This electron rich C=C double bond makes enamines powerful synthetic intermediates and 
find wide applications in organic synthesis.[49] When one of the N-alkyl groups (R4 or R5 in 
Figure 7) of enamines is replaced by an electron-withdrawing group, such as an acyl, 
enamides are generated (Figure 7).  Enamides are stable, highly polarized, electron rich 
double bonds that are excellent substrates for incorporation of nitrogen functionality.[50]  In 
comparison to enamines, enamides exhibit a much diminished enaminic reactivity, because 
the N-electron-withdrawing group, the carbonyl group, alleviates the delocalization of the 
lone-pair electrons of the nitrogen atom into the C=C double bond.  The lone pair conjugates 
with the carbonyl group leading to decreasing electron density of the C=C double bond.  For 
this reason, enamides show a good balance of stability and reactivity, a combination which 
accounts for their increasing importance in organic synthesis and medicinal chemistry.[50]  
The stability of enamides is well demonstrated by the occurrence of stable enamide structures 
in many natural products and drug candidates.[49] 
The enamide group is an important substructure that is often found in natural products and 
synthetic drugs that have, amongst others, sedative, cytotoxic, or anti-inflammatory, anti-
parasitic and anti-cancer properties.[50,52]  A majority of enamides bearing hydrogen on 
nitrogen are stable under air, are solid at room temperature, and can be purified by 
chromatography on silica gel.  This stability contrasts with the corresponding enamines 
bearing hydrogen on nitrogen.[51]  
The vast majority of synthetic applications of enamides documented in literature relate to 
their asymmetric reduction reactions. Indeed, enamides or dehydroamino acid derivatives are 
used as a testing ground for the study of the efficiency and enantioselectivity of the catalytic 
asymmetric hydrogenation of the carbon–carbon double bond.[49]  Enamides offer a wide 
variety of alternatives for the inclusion of nitrogen-based moiety into organic systems. 
50 
 
 
3.2 Synthetic Methods for Enamides 
Retrosynthesis of enamides can theoretically be made in three major approaches as shown in 
Figure 9 below. 
 
The first disconnection is straight forward.  There is carbonyl group providing the 
electrophilic centre while the other section which is an enamine moiety provides the 
nucleophilic centre through the nitrogen atom.  This suggests acylation of an enamine 
(Scheme 35(a)).  The second disconnection involves the cleavage of an N-C bond.  This gave 
an amide and an alkene synthons.  This can be achieved by coupling reactions particularly 
transition metal coupling reactions like palladium catalysed N-C cross coupling reaction 
(Scheme 35(b)).  The third scission is across the double bond.  This may be achieved by 1,2-
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elimination reaction from a saturated precursor, by metal catalysed isomerization of N-
allylated amides or by Wittig reaction (Scheme 35(c)). 
 
Several synthetic methods for enamides have been reported.[51]  However, many of these 
synthetic methods have often been centered around condensation of an amide equivalent with 
the corresponding carbonyl functionality (Scheme 36).[51]  One of such methods starts from 
nitriles, which are subjected to a Grignard reagent followed by treatment with acyl or alkoxy 
carbonyl cation equivalents (method I).  This method can be used for the syntheses of 
aromatic ketone derived enamides and enecarbamates. Another method starts from α,β-
unsaturated carboxylic acids, which are converted to acid azides followed by Curtius 
rearrangement to give isocyanates, which are treated with alcohols (method II). Most 
enecarbamates can be prepared via this method, although some of the corresponding α,β-
unsaturated carboxylic acids are difficult to synthesize. An alternative method starts from the 
corresponding aldehydes, which are converted to N,S-acetals, followed by desulfonylation by 
treatment with bases (method III). 
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However, more elaborate and novel methods such as organocuprate addition to isocyanates, 
acylation of in situ prepared imines and an N-acylation/Peterson elimination process have 
also been developed.[60] Complementing these methods, a number of transition-metal-
catalysed approaches based on C-N bond-forming reactions (Pd, Cu), isomerizations of allyl 
amides (Fe, Rh, Ru), addition of amides to alkynes (Ru), organometallic additions to 
ynamides (Rh), Heck couplings (Pd), co-oligomerization of N-vinyl amides (Ru), and 
oxidative conjugate additions (Pd) have also been reported (Scheme 37).[60] 
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3.2.1 Palladium-Catalysed C-N Cross-coupling Reactions 
Recent developments in palladium(0)-catalysed carbon-nitrogen bond formation have led to 
numerous useful synthetic methodologies, particularly for the cross-coupling of allyl, aryl, 
and vinyl halides and related electrophiles with amine and amide nucleophiles.  Stahl et 
al.,[63] in 2004, reported the synthesis of enamides via vinyl transfer from vinyl ether to 
amides using the (DPP)Pd(OCOCF3)2 catalyst.  Stahl et al. observed that ethyl vinyl ether 
undergoes nonoxidative transfer to the nitrogen nucleophile of the amides under the condition 
of the reaction.  This reaction represents a C-N cross-coupling reaction with the vinyl ether as 
the electrophile partner.   
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3.2.2 Conversion of Alkenylsilanes to Enamides 
Fürstner et al reported, in 2001, the stereoselective synthesis of enamides under mild, aprotic 
and basic conditions. Fürstner’s methodology is based on a silicon-directed epoxide ring 
opening with sodium azide, followed by reduction of the resultant azide to the corresponding 
amine, N-acylation and Peterson elimination to afford enamide (Scheme 39).  The Peterson 
olefination (also called the Peterson reaction) is the chemical reaction of α-silyl carbanions 
with ketones (or aldehydes) to form a β-hydroxysilane that eliminates to form alkenes.  This 
methodology offers great stereocontrol and broad scope, but has the disadvantage of 
requiring a multi-step sequence.[64] 
 
3.2.3 Enamide Synthesis from Primary Amides and Propargyl Aldehydes 
In 2014, Hong et al reported a novel strategy for enamide synthesis from primary amides 123 
and propargyl aldehydes 124 via Au(I)-catalysed tandem amide addition and Meyer−Schuster 
rearrangement (Scheme 40).  In situ generated hemiaminals 126 were converted to the 
desired products under the optimized conditions. Enamide stereochemistry was controlled 
simply by changing solvents and adding a catalytic amount of acid. The developed synthetic 
strategy provides a new method to synthesize various β-substituted α,β-unsaturated carbonyl 
compounds.[65] 
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3.2.4 Hydroarylation of Allenamides 
Hsung[61] and Kimber[66] reported a highly stereoselective transition metal catalysed 
hydroarylation of allenamides 127 to obtain a series of achiral and chiral oxazolidinone-
derived E-enamides 129 via the 1,4-addition to N-acyl iminium intermediates 128 (Scheme 
41). Au-catalysed hydroarylation took place relatively faster than their Pd- and Ru-catalysed 
counterparts. 
 
3.2.5 Dehydroalkoxylation of Hemiaminal 
In 2002, Gaulon et al.[67] reported the preparation of cyclic enamides 96 in high overall yield 
by an easy two-step procedure based on the dehydroalkoxylation of an intermediate 
hemiaminal 131 using trimethylsilyl trifluoromethanesulfonate (TMSOTf) and triethylamine 
(TEA). The advantage of this method over others is that it is metal-free (Scheme 42). 
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3.2.6 Isomerization of N‑Allyl Amides To Form Substituted Enamides 
The synthesis of geometrically defined enamides is problematic, especially the highly 
substituted and Z-enamides.  In 2017, Trost and co-workers reported a general atom 
economic method for the isomerization of a broad range of N-allyl amides 132 to form Z-di-, 
tri-, and tetrasubstituted enamides 133 with exceptional geometric selectivity (Scheme 43). A 
highly unsaturated precatalyst CpRu(CH3CN)3PF6 was used.  The report represented the first 
examples of a catalytic isomerization of N-allyl amides to form nonpropenyl disubstituted, 
tri- and tetrasubstituted enamides with excellent geometric control.  The method was applied 
in the synthesis of cis vicinal amino alcohols and tetrasubstituted α-borylamido complexes.[50] 
 
3.3 Chemistry of Enamides 
Enamide moieties are contained in a number of natural product frameworks such as the 
chondriamides and salicylihalamides and within cyclic peptides.[66] The significant chemical 
stability of enamides as a result of the electron withdrawing functionality upon the nitrogen 
atom makes it less reactive than the enamines in spite the noticeable feature of nucleophilic 
character of the enamine.  Enamides often react similar to simple C=C bonds and offer 
further options for the incorporation of N-functionality into complex systems.[68]  They are 
commonly utilized in asymmetric hydrogenations, cycloadditions, cyclopropanations, halo 
functionalizations, heterocycle synthesis, carbonyl and imine additions, and transition metal 
mediated C−C bond formations. In addition, enamides are important pharmacophores in 
various bioactive natural products that display a range of anticancer, antifungal, and cytotoxic 
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properties.[48]  The unique reactivity that enamides display has led to the development of a 
number of general and E/Z selective syntheses. 
3.3.1 Enamides as nucleophiles  
Enamides can be viewed as tuneable enamines and as such, it is no surprise that they 
participate in a number of interesting transformations with electrophiles. Ground breaking 
work in this area originated from the Kobayashi laboratory,[51] who reported the first 
enantioselective use of enamides as nucleophiles in reactions with aldehydes under Cu-
catalysis.  The Kobayashi laboratory has since demonstrated the use of C2 symmetric diamine 
ligands with a range of electrophiles and enamides as nucleophiles, promoted by Cu(II)-
catalysts in conjunction with iminophosphonates for the enantioselective formation of 
phosphonic acid systems,[69] diazodicarboxylates for enantioselective α-aminations and 
eventually demonstrated that some aldehydes (α-oxo-aldehydes) will participate as useful 
electrophiles. [51] 
Addition of Enamides or Enecarbamates to Imines 
The Kobayashi research group reported the first catalytic enantioselective nucleophilic 
addition of enamides and enecarbamates to imines. [70] Reaction of enamides 135 with imines 
134 in the presence of a chiral copper catalyst prepared from Cu(OTf)2 and the chiral diamine 
136 gave the corresponding β-aminoimines 137 (Scheme 44).[71]  Kobayashi’s procedure 
proved to be a robust strategy for the synthesis of optically active 1,3-diamine derivatives, 
which are useful building blocks for the synthesis of natural products and drug candidates. 
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3.3.2 Nucleophilic Addition of 1,3-Dicarbonyl Compounds to Enamides 
Nucleophilic addition to imines provides a facile synthetic route to nitrogen-containing 
compounds, many of which are of biological and chemical importance.  Kobayashi and co 
workers reported, in 2006, that enamides and enecarbamates could be used as nucleophiles 
and that they react with several electrophiles in the presence of Lewis acids.  They found that 
enamides and enecarbamates isomerize into imines surrogates in the presence of Lewis acids.  
The imines so formed then attack another molecule of the enamide being a very good 
nucleophile.  Thus in the presence of Lewis acid such as TfOH, Sc(OTf)3, or Cu(OTf)2, 
enamides and enecarbamates undergo self-condensation or dimerise.  To prevent enamides 
and enecarbamates from dimerizing under the acidic conditions, it is necessary to use 
nucleophiles that are more reactive than enamides and enecarbamates themselves.  The group 
used 1,3-dicarbonyl compounds 139 such as β-ketoesters to trap the imine intermediate to 
form the adducts 140 (Scheme 45).  This is a Mannich-type reaction of 1,3-dicarbonyl 
compounds with enecarbamates.[72] 
 
3.3.3 Transition metal mediated alkene transformations 
Bennasar and co-workers[73], in 2006, reported the use of enamides in a number of transition 
metal mediated alkene transformations, especially in contexts where incorporation of 
nitrogen functionality is important, such as the ring-closing metathesis reaction (Scheme 46). 
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Bennasar demonstrated in this reaction that enamides could participate in ring closing metathesis 
reactions.  Indeed, this example is a one-pot Petasis-methylenation of 141 followed by ring 
closing metathesis with the second generation Grubbs catalyst forming dihydroquinoline 142. 
3.3.4 Pericyclic reactions 
Enamide substrates have also been used in many pericyclic reactions. Indeed, examples of 
cycloaddition, sigmatropic and electrocyclic chemistry have all been reported. In many 
instances, the Csp2–N bond is transformed to a Csp3–N bond as a result of the pericyclic 
reaction allowing the formation of new nitrogen stereocentres and an overall increase in 
molecular complexity.  Rawal,[74] in 2000, reported a highly efficient and stereoselective 
Diels–Alder reaction using the conjugated enamide 145 as the reactive diene (Scheme 47). 
The reaction is promoted by Cr-salen complex 148 and yields synthetically useful 
cyclohexenyl carbamate 147 in high eneantiomeric excess. 
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3.3.5 Radical reactions 
In recent years there have been a number of reports detailing the utility of enamides in radical 
based transformations. In particular, Ishibashi (2008)[75] clearly showed the synthetic value of 
these enamide substrates through the synthesis of lennoxamine 151.  Enamide 149 was 
observed to undergo a regioselective 7–endo cyclization followed by subsequent homolytic 
aromatic substitution (Scheme 48).  This single-pot process allows for the isolation of 
lennoxamine in 41%. 
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The Ishibashi group further demonstrated the value of enamide substrates in radical reactions 
by accomplishing syntheses of (±)-stemonamide and (±)-isostemonamide where the skeleton 
is formed through a key enamide radical reaction.  In this instance, substrate 152 undergoes a 
double radical cascade cyclization initiated by 1,1'-azobis-cyclohexanecarbonitrile and 
terminated by Bu3SnH (Scheme 49). Diastereomeric tricycles 153 are formed in moderate 
yield, albeit in a 1:1 ratio. Further elaboration of these tricycles allowed for succinct 
syntheses of these natural products.[76] 
 
3.3.6 Photochemical reactions 
Bach[77] demonstrated that enamides participate particularly well in the Paterno–Büchi 
photochemical reaction, forming amino oxetanes 156 in good yield with significant diastereo-
selectivity (Scheme 50).  Paterno–Büchi photochemical reaction is a photochemical reaction 
that forms four-membered oxetane rings 156 from a carbonyl 154 and alkene 155. 
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3.4 Enamides: Reactions, Results and Discussion  
Our objective was to investigate the addition of bromide 77 to the electron rich enamide 79 
by using photoredox catalysis. It was envisaged that upon formation of the malonate radical 
from 157, and its addition to the enamide, that the subsequent radical would be oxidized in-
line with Masson’s findings to deliver the the iminium 160. This iminium 146 can then be 
trapped with an arylamines to furnish the N,N’-aminal 81; this can then be cyclized to deliver 
synthetically valuable -lactams (96) (Scheme 51). 
 
These -lactams have become sought after heterocycles and are ubiquitous molecular 
scaffolds in biologically-active natural products, including polyketides, alkaloids, steroids, 
and terpenes.  Due to their occurrence in many biologically active compounds such as the 
acetogenins, lignans, and macrolides therefore they represent important synthetic targets.   
In the proposed compound, there are nitrogen heterocycle, N,N’-aminal motif, γ-lactam 
moiety that are part of vitamins, and an aryl group.  Levetiracetam, for example, an 
anticonvulsant drug used in the treatment of epileptic seizures contains pyrrolidinone moiety.  
Glimepiride is an antidiabetic sulfonylurea drug that increases insulin production in the 
pancreas and the activity of intracellular insulin receptors also contains some of the 
functional groups in the proposed molecule.  Reutericyclin is a product of Lactobacillus 
reuteri bacteria that shows promising antibacterial activity against Grampositive strains, 
including Clostridium difficile, and is believed to have potential therapeutic value.[78]  
Another example is linezolid. Linezolid, an oxazolidinone antibacterial, is active against 
63 
 
Gram-positive bacteria including meticillin-resistant Staphylococcus aureus (MRSA), and 
glycopeptide-resistant enterococci.[79]  Linezolid is used for serious infections which are 
difficult to treat with other antibiotics.  It is used to treat pneumonia, which is a serious lung 
infection. It is also used to treat skin and soft tissue infections caused by infection with 
MRSA bacteria. [79] 
 
As stated above, we aimed to establish a novel atom-efficient and general photoredox catalyst 
mediated β-alkylation of enamide utilising a one pot-component reaction. Then formation of 
a general route of arylamination at the α-position and its subsequent cyclization, thus forming 
a new nitrogen containing heterocycle into the molecule without the use of metal assisted 
cyclization reactions. 
Therefore, our retrosynthetic route meant that we should first prepare the enamides 79 for the 
synthesis. Other components of the adducts are commercially available: the arylamines 80 
and diethyl bromomalonate 77 (Scheme 52). 
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The initial reactions were to synthesize the enamides in sufficient quantities adopting the 
standard methods reported in the literatures by Gaulon et al.[67] and  Liu.[80] 
3.4.1 Enamides Synthesis 
Synthesis of N-Vinyl-2-oxazolidinone (117) 
In the preparation of the enamides, there are many options in the literature such as the use of 
palladium (II) catalysed reaction,[63] copper (I) catalysed reaction[81,82] and many other metal 
catalysed reactions.  We opted for the procedure reported by Gaulon et al.[67] for its simplicity 
and high yield. The reaction was a two-step procedure based on the dehydroalkoxylation of 
the intermediate hemi-aminal obtained in the first step using trimethylsilyl 
trifluoromethanesulfonate (TMSOTf) and triethylamine (TEA).  The first step as stated was 
the preparation of the N,O-acetal (or hemi-aminal) 161 (Scheme 53) that would be the 
starting material in the second and final step. 
The desired product was obtained by the reaction of oxazolidin-2-one (114) and acetaldehyde 
diethyl acetal (acetal) in the presence of catalytic amount of DL-camphorsulfonic acid (CSA), 
with the acetal serving as both the reagent and solvent.  It will be observed from Table 1 
below that the optimum conditions for the reaction to obtain the highest yield was at 
temperature 55 oC with 7.0 mol% of CSA for a minimum of 18 h (98%, Table 1, entry 5), an 
increase in the amount of CSA to 10.0 mol% did not lead to any significant change in the 
yield (Table 1, entry 7).  Getting the highest yield at 7.0 mol% was not in agreement with the 
5.0 mol% reported in the literature (Table 1, entry 4 versus 5).  When the reaction was carried 
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out at room temperature for 8 h, no product was obtained Table 1, (entry 1).  We observed 
that the longer the reaction time the higher the yield until the maximum of 98% was obtained 
even when the reaction was run for 24 h which gave a comparable yield as at 18 h (Table 1, 
entry 5 versus 8).  When the reaction was run in the absence of CSA, no product was formed 
the reactants were recovered; additionally, the TLC showed no significant change (Table 1, 
entry 9).  One important observation was the huge reduction in the yield when the 
temperature was raised to 80 oC (34%, Table 1, entry 11). 
 
Table 1: Preparation of N,O-Acetal (161) Intermediate 
Entry Temp.  [oC] Time [h] 
CSA 
(mol%) 
Yield [%] 
1 r.t. 8 5.0 0 
2 55 5 5.0 18 
3 55 8 5.0 46 
4 55 18 5.0 86 
5 55 18 7.0 98 
6 55 18 1.0 32 
7 55 18 10.0 92 
8 55 24 7.0 97 
9 55 16 -- 0 
10 80 6 7.0 10 
11 80 16 5.0 34 
The crude product was obtained as a colourless liquid and used without further purification 
for the second step of the reaction as indicated in the literature.  The product was 
characterized and confirmed to contain the desired N-O-acetal (161) by the 1H-NMR 
spectroscopy. The hydrogen atom near the nitrogen atom appeared at δ 5.12 ppm as a quartet 
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due to the coupling effect of the nearby methyl group hydrogen atoms which appeared at δ 
1.26 ppm. 
The mechanism of this reaction begins with the protonation of the oxygen of the ethoxy 
groups of the acetal 162, thus making the carbon bearing the two oxygen atoms more 
electrophilic.  The lone pair on the second oxygen now eliminates ethanol, as a leaving group, 
forming the intermediate oxonium ion 163.  Then the nucleophile, oxazolidin-2-one 114, via 
its nitrogen lone pair, attacks the oxonium forming the N-acyl iminium ion 164.  This ion 
then loses a proton to the conjugate base of the acid CSA thereby completing the catalytic 
cycle of the acid CSA and the product 161 is formed (Scheme 54). 
 
The second step in the synthesis of the enamide 117, involves the use of the crude product 
obtained from the first step without its purification (Scheme 55).  However, efforts were 
made to remove the solvent as much as possible from the reaction mixture.  It was observed 
that if this solvent was still present in the reaction mixture in a substantial quantity, the final 
yield of the product would be significantly affected, and the reaction would not go into 
completion.  The solvent, acetaldehyde diethyl acetal, will compete with the product in the 
reaction with trimethylsilyl triflate (trimethylsilyl trifluoromethanesulfonate, TMSOTf). 
Initial attempts resulted in very low yields as a result of the residual solvent in the reaction 
mixture.  The desired enamide 117 was eventually obtained as a pale yellow oily liquid.  The 
optimum overall yield obtained was 76% with reaction time of 18 h.  When the reaction was 
run at room temperature for 4 h, TLC did not indicate any change in the reaction mixture, no 
new spots were found on the plate (Table 2, entry 1). An increase in the reaction time to 16 h 
at room temperature gave only traces of the product (Table 2, entry 2) as indicated by the 1H-
NMR.  The reaction proceeded to a relatively high yield at temperature of a mixture of ice 
and water (0 oC) to 35% when run for 18 h (Table 2, entry 4).  The best result were obtained 
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at temperature below -10 oC when the reaction flask was placed in a pot containing some dry 
ice and allowed to rise to room temperature gradually after the addition of all the reagents 
 
In addition to the temperature control and reaction time conditions, the status of the reagents 
used also affected the yield.  The reaction performs well when the triethylamine (TEA) is 
distilled, fresh and importantly dry.  We observed that trimethylsilyl 
trifluoromethanesulfonate (TMSOTf) has to be added in a dropwise manner to ensure that the 
reaction temperature remained low giving reproducible yields.  Likewise, the rate at which 
the reaction temperature is brought to room temperature after the addition of TMSOTf 
affected the yield (Table 2, entry 7). 
Table 2: Final Step Reaction Conditions for the Preparation of Enamide (117) 
Entry Temp. (oC) 
Reaction 
Time [h] 
Yield 
[%] 
1 r.t. 4 0 
2 r.t. 16 5 
3 0 8 5 
4 0 18 35 
5 < -10 8 28 
6 < -10 18 76 
7a < -10 18 44 
a the temperature quickly brought to room temperature 
After the completion of the reaction, the reaction was worked-up to remove the excess 
TMSOTf and the ammonium triflate salts by first treating the mixture with basic alumina 
followed by filtration through a pad of silica gel.  Further purification was done by flash 
chromatography to afford the product.  The purified liquid was characterized and confirmed 
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as the desired enamide by 1H-NMR and 13C-NMR analysis supported by IR and MS analysis.  
The 1H-NMR resonance (signals) at δ 6.84, 4.40 and 4.27 ppm, respectively, confirmed the 
formation and presence of the terminal -CH=CH2 alkenyl group with the two germinal 
protons showing at δ 4.40 and 4.27 ppm, respectively.  The proton on the carbon bonded to 
the nitrogen atom resonates at δ 6.84 ppm.  
This reaction is believed to start with the attack on the lone pair on the oxygen of the ethoxide 
group by the electrophilic end of TMSOTf (the TMS) forming the TMS-oxonium ion 165.  
This ion now eliminates TMS-OEt, as a leaving group, giving way to the formation of 
oxazolidinium ion 166.  Triflate ion or triethyl amine (TEA) then abstracts a proton from the 
oxazolidinium ion 166 to afford the product N-vinyl-2-oxazolidinone 117 (Scheme 56). 
 
Synthesis of (S)-4-benzyl-N-vinyl-2-oxazolidinone (169) 
Compound 169 is the chiral derivative of compound 117.  Its synthesis is very similar to the 
achiral derivative.  The same method was used but with a little modification or variations in 
the reaction conditions.  The reaction was also a two-step procedure based on the 
dehydroalkoxylation of the intermediate hemi-aminal as obtained in the achiral derivative.  
The first step was the preparation of the hemi-aminal, the reaction of (S)-4-benzyl-2-
oxazolidinone 167 with acetaldehyde diethyl acetal in the presence of DL-camphorsulfonic 
acid (Scheme 57). 
The desired product was obtained by the reaction of the reactants (S)-4-benzyloxazolidin-2-
one (167) and acetaladehyde diethyl acetal (acetal) 162 in the presence of catalytic amount of 
DL-camphorsulfonic acid (CSA).  The acetal 162 served as both reagent and solvent.  From 
Table 3 it shows that the optimum conditions for the reaction was at temperature 55 oC with 
7.0 mol% of CSA and 3 h reaction time (100%, Table 3, entry 3), an increase in the amount 
of CSA to 10.0 mol% has no significant effect on the yield (99% Table 3, entry 6).  When the 
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reaction was carried out at room temperature for 20 h, no product was formed (Table 3, entry 
1).  In this case longer reaction time had great negative effect on the yield (56%, Table 3, 
entry 4).  When the reaction was run in the absence of CSA, no product was formed the 
reactants were recovered and the TLC showed no discernable change (Table 3, entry 7).  A 
higher temperature above 55 oC did not lead to an increase in the yield (60%, Table 3, entry 
8). 
 
Table 3: Preparation of N,O-Acetal of the chiral Intermediate 
Entry Temp.  [oC] Time [h] 
CSA 
(mol%) 
Yield [%] 
1 r.t. 20 7.0 0 
2 40 20 7.0 5 
3 55 3 7.0 100 
4 55 18 7.0 56 
5 55 3 2.0 32 
6 55 3 10.0 99 
7 55 16 -- 0 
8 80 4 7.0 60 
9 80 16 5.0 36 
The crude product was obtained as a colourless liquid and used without further purification in 
the second step of the reaction (Scheme 58).  The 1H-NMR of the crude revealed the 
presence of the proton N-CH- at δ 5.32 ppm (q, J = 6.2 Hz, 1H), which coupled with CH3 at 
δ 1.52 ppm (d, J = 6.2 Hz, 3H) confirming the formation the N,O-acetal 168. 
70 
 
The second step in the synthesis of compound 169, the chiral enamide involves the 
conversion of 168 by reacting it with TMSOTf in the presence of TEA in dry DCM.  The 
reaction conditions are similar to the transformation of 161 to 117.  The chiral enamide 169 
was obtained as a white semi-solid.  The optimum over all yield obtained was 72% with 
reaction time of 18 h.  The reaction gave good result when run in inert atmosphere of 
nitrogen. Addition of dry TEA and TMSOTf was done in drop-wise manner and in that order 
at temperature -10 oC.  After the addition of the reagents, the reaction mixture temperature 
was allowed to rise to room temperature gradually by itself. The 1H-NMR analysis confirmed 
the formation of the product with the presence of the terminal -CH=CH2 group. The proton 
on the carbon bonded to the nitrogen atom appeared at δ 6.80 ppm while the two germinal 
protons of the methylene group showing at δ 4.57 and 4.54 ppm respectively. 
 
Synthesis of (E)-3-(hex-1-en-1-yl)oxazolidin-2-one (171) 
A different synthetic route was used for the preparation of (E)-3-(hex-1-en-1-yl)-oxazolidin-
2-one as the Gaulon’s method could not be used.  The synthetic route used as reported by Liu 
and Floreancig[80] offers a good avenue for the synthesis of enamides with substituent on the 
alkene group. It involves the condensation of aldehydes (hexanal in this case) with the 
carbamate, oxazolidin-2-one 114 to give enamide with the release of a water molecule 
(Scheme 59).  This reaction occurs in the presence of an acid catalyst and it is reversible.  To 
drive the reaction towards the product formation, the water molecule has to be removed from 
the reaction mixture.  This was achieved with the use of a Dean-Stark trap apparatus and the 
enamide was obtained as pale yellow oily liquid. 
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The formation of the product was confirmed from the 1H NMR spectrum obtained, the 
terminal methyl -CH3 group hydrogen atoms on the hexyl moiety appeared at δ 0.83 ppm in 
triplet as a result of their coupling with the nearby –CH2-. The hydrogen atom on the C=C 
bond next to the nitrogen atom in the ring -N-CH=C appeared at δ 6.56 ppm as doublet due 
to the coupling effect of the nearby hydrogen atom on the second sp2 carbon which appeared 
at 4.81 – 4.70 ppm as multiplet, the coupling constant (J = 14.4 Hz) of this proton showed 
that it is trans to the coupled hydrogen, and the two –CH2- groups of the ring were seen at δ 
4.36 and 3.63 ppm as triplets, respectively.  These were in agreement with literature reports. 
The mechanism of the formation of the substituted enamide starts with the nucleophilic attack 
of the oxazolidin-2-one (114) on the aldehyde hexanal (170) with the lone pair of the nitrogen 
atom, on the electrophilic carbonyl carbon forming the intermediate ion 172. The 
intermediate ion then rearranges via a proton transfer from the nitrogen atom to the oxygen 
atom to form 3-(1-hydroxyhexyl)-oxazolidin-2-one 173.  This is then protonated through the 
-OH group leading to the expulsion or removal of water and N-acyl iminium ion 174 
formation.  The deprotonation of the iminium ion by the conjugate base of the acid completes 
the catalytic cycle of the acid and the product, (E)-3-(hex-1-en-1-yl)-oxazolidin-2-one 171, is 
obtained (Scheme 60). 
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3.4.2 Enamides: Photoredox Catalytic Transformation Reactions 
Carbon-carbon bond formation is the core of organic synthesis. Many organic synthetic 
methodologies to achieve this are based on the ease of generation of radicals.  Generation of a 
radical is achieved traditionally by heating, irradiation by high-energy UV-light or a redox 
reaction.[5,6]  These conventional methods are sometimes harmful and some are explosive as a 
result of uncontrollable rate of chain reactions that occur.  In addition, the traditional methods 
often have a poor atom economy.  During the process, considerable amounts of waste are 
generated which may cause environmental problems.  In order to alleviate some of the 
problems mentioned above with the traditional methods of radical generation in organic 
synthesis, the use of a catalyst rather than a stoichiometric reagent is preferable.  However, 
most of the catalysts used often are labile compounds, they react too fast, and require that 
carefully controlled conditions are used (e.g., with regard to the exclusion of air, moisture, 
impurities).  In many cases co-catalysts and additives are also required. 
Considering the environmental factor, the atom economy and energy requirement, new 
methods for the formation of the C-C bond have to be developed.  These methods/protocols, 
according to the principles of “Green Chemistry”, need to be easy and safe to use and are 
expected to be efficient (both in terms of energy and atoms) and selective in their outcomes.[6] 
Nature’s ability to use various visible light absorbing chromophores/photocatalysts for 
converting solar energy to chemical energy is a great option.  The challenge to mimic and 
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understand enzymatic transformations, organocatalysis has now become an important tool in 
modern organic synthesis with new reactivity that complements that of enzyme and metal 
catalysis.[4,5,7] 
Photochemical transformations/reactions, using photocatalysts, generally require mild 
conditions for substrate activation—ideally light alone—and are suitable for “green 
reactions”.[4]  This, therefore, is employed as a strategy especially with the recent 
development of photocatalysis that made (transition) metal polypyridyl complexes and 
organic dyes readily accessible to facilitate the conversion of visible light into chemical 
energy under exceptionally mild conditions.[15-17] 
Literature reports have shown that small amounts of transition-metal polypyridyl complexes 
could be used as photoredox catalysts to accelerate photochemical transformations of 
compounds that ordinarily would not have undergone reactions under mild conditions.  These 
complexes upon irradiation with visible light are excited and are involve in single electron 
transfer with some compounds thus making them strong oxidizing or reducing agents.  
Studies made by Courant and Masson[53] have demonstrated that iridium polypyridyl 
complexes could be used as photoredox catalyst to initiate three-component domino synthesis 
of N-carbamoyl α-alkylated imines under mild conditions. 
In their previous work, Masson and co-workers[83] established that radical photoredox 
mediated addition of a -CF3 equivalent, using the trifluoromethylating reagent 176, to 
electron-rich styrene  113 derivatives followed by trapping of the intermediate carbocation by 
an electron-poor arylamine could lead to modest to good yields of the addition product of the 
type 175 (Scheme 61).  In that report, they explored the use of easily oxidizable anilines such 
as p-anisidine where poor or little conversion to the desired products was observed. 
 
With this in mind, we therefore set to explore this area of radical/cationic pathway using 
iridium 2-phenylpyridine 4,4’-di-tert-butyl-2,2’-bipyridine complex [Ir(ppy)2(dtbbpy)]PF6 as 
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a photoredox catalyst starting with our enamides in the presence of arylamines, especially 
electron-rich arylamines to access N,N’-aminals.  The N,N’-aminal structural motif is 
prevalent within a wide range of biologically important compounds.[84] 
The initial experiment was focused on replicating the work of Courant and Masson[53] 
(Scheme 62 and Table 5) on our prepared enamide, N-vinyl-2-oxazolidinone 117 using a 
strip of LED blue light instead of fluorescent light.  We were able to get the desired three-
component adduct after running the reaction for 16 hours, though the yield was very low at 
the first attempt.  The reaction mixture was very difficult to purify because of the low yield of 
the product. The product 177 was confirmed by comparison of the its 1H NMR with that 
previously reported by Masson.[53] A change of the lamp from the blue LED strip light to the 
Kessil® LED blue light (λ = 465 nm) gave the desired result as against low yield obtained 
from the former (12% Table 5, entry 1 vs 3).  Then different reaction conditions: reaction 
time, bases and solvents were screened.  To our delight the reaction proceeded in the two 
screened solvents: acetonitrile and dichloromethane. Higher yields were obtained in dry 
forms of both solvents than in bench stock solvent.  However, higher yield was obtained in 
acetonitrile than in dichloromethane (42%, Table 5, entry 4 versus 8).  The change in the 
nature of base from triethylamine to disodium hydrogenphosphate (Na2HPO4) greatly 
lowered the yield to nearly nothing (Table 5, entry 4).  A reduced reaction time less than 6 h 
did not give reasonable yield, even in acetonitrile (Table 5, entry 6).  The highest yield was 
obtained in about 15 h and it was in dry acetonitrile (Table 5, entry 8).  Increase in the 
amount of the catalyst, [Ir(ppy)2(dtbbpy)]PF6 from 1.5 mol% to 2.0 mol% had no significant 
effect on the yield (Table 5, entry 10).  The reaction was found not to occur in the dark (Table 
5, entry 12), similarly it did not proceed without the photoredox catalyst (Table 5, entry 11).  
The presence of the base, triethylamine was essential as no reaction was recorded without it. 
(Table 5, entry 13). 
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Table 5: Screening for the optimum conditions for photoredox reaction of N-Vinyl-2-
oxazolindinone and ethanol. 
Entry 
Amount of 
Ir-Cat 
[mol%] 
Light Solvent Base Time [h] Yield [%] 
1 1.5 LED strip CH2Cl2 Et3N 6 2 
2 1.5 LED strip CH2Cl2 Et3N 16 10 
3 1.5 Kessil CH2Cl2 Et3N 6 12 
4 1.5 Kessil CH2Cl2 Et3N 18 30 
5 1.5 Kessil CH2Cl2 Na2HPO4 18 0 
6 1.5 Kessil CH3CN Et3N 5 -- 
7 1.5 Kessil CH3CN Et3N 7 8 
8 1.5 Kessil CH3CN Et3N 15 42 
9 1.5 Kessil CH3CN Na2HPO4 15 4 
10 2.0 Kessil CH3CN Et3N 15 41 
11 0.0 Kessil CH3CN Et3N 20 0 
12 1.5 No light CH3CN Et3N 15 0 
13 1.5 Kessil CH3CN ---- 15 0 
14 1.5 Kessil CH3CN Et3N 15 -- 
Each of the experiments was carried out at least two times and the highest isolated yield was 
recorded.  In the case where no light was stated, the reaction vessel was wrapped with three 
layers of aluminium foil.  In entry 14, the bench trimethylamine solvent was used instead of 
dried/anhydrous solvent.  Finally, (--) means no signal of the product could be obtained from 
the 1H-NMR of the small residue obtained after the removal of the solvent from the reaction 
mixture. 
The formation of the desired product was confirmed by 1H-NMR with the disappearance of 
the signals at δ 6.84 ppm, 4.40 ppm, 4.27 ppm of the hydrogen atoms of the alkenyl moiety 
CH=CH2 of the enamide 117, new signal at δ 5.08 ppm of the hydrogen atom of the carbon 
bearing the nitrogen atom of the ring and oxygen atom of the ethoxy group, the N,O-acetal 
carbon emerged in their place. This hydrogen appeared as triplet due to its coupling effect 
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with the two neighbouring hydrogen atoms that appeared at δ 2.37-2.28 (m, 1H) and 2.20-
2.11 (m, 1H) ppm, respectively. 
Having identified the optimum reaction conditions and confirming that the reaction worked 
within our laboratory environment, we then extended the scope of the reaction to different 
arylamines as the nucleophiles with aniline as our starting compound.  To our delight we got 
the desired three-component adduct. The identification of the product was done using a 
combination of 1H-NMR and 13C-NMR with key diagnostic signals for the hydrogen and 
carbon atoms of -CH- aminal moiety with the hydrogen atom seen at δ 5.37 ppm appearing as 
triplet due to the coupling effect of the neighbouring two hydrogen atoms and δ 62.61 ppm 
for the carbon atom.  This hydrogen signal appeared upfield of the spectrum than that of the 
hydrogen atom on the N,O-acetal carbon as a result of the electron withdrawing effect of the 
benzene ring.  
We began by screening for the optimum conditions for the reaction with aniline 178 (Table 
6).  We found out that reaction went into completion at a very shorter time than for ethanol 
(Table 6, entry 1 vs 4).  The reaction time reduced from 18 h to 3 h (Table 6, entry 5) and the 
amount of the nucleophile, aniline also reduced from 10.0 equivalent to 5.0 equivalent (Table 
6, entries 3 and 5), ultimately giving the product in a higher isolated yield of 72%. A 
reduction to 2.0 equivalent of aniline had a detrimental effect in the yield (Table 6, entry 6). 
 
Table 6: Screening for the optimum condition for Photoredox Alkylation Enamide Using 
Aniline as the Nucleophile 
Entry Substrate Time [h] Amount [Equiv.] Yield [%] 
1 Ethanol 18 10.00 42 
2 Aniline 18 10.00 56 
3 Aniline 18 5.00 54 
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4 Aniline 6 5.00 61 
5 Aniline 3 5.00 72 
6 Aniline 3 2.00 38 
 
Having established the optimum conditions for the reaction with aniline for the synthesis of 
179, the reaction was then extended to a range of arylamines to ascertain the substrate scope 
of the reaction. The results are as shown in Table 7. We started with p-toluidine which 
delivered the product 181 in a significantly higher yield (84%) than aniline, possibly due to 
its increased nucleophilicity; additionally, we were able to obtain suitable crystals for single 
crystal X-ray analysis.  m-Toluidine also reacted giving 183 in 88% isolated yield. The 2,3- 
and 2,6-dimethylaniline gave 185 and 189 in 71% and 60% yields, respectively; furthermore, 
the sterically encumbered 2,4,6-trimethylaniline gave 187 in 64%.  o-Anisidine furnished 
N,N′-aminal 203 in 76% yield, although, it was found that this product slowly degraded upon 
standing to give the imine, possibly due to the electron-rich nature of the aniline. However, 
we were able to obtain crystals of 203, suitable for single-crystal X-ray analysis, which 
definitely assigned the structure as shown. The o-trifluoromethoxy (2-OCF3) analogue 205 
could also be obtained in 77% isolated yield, and this product 205 also demonstrated 
increased stability compared to 203. The reaction accommodated electron withdrawing 
groups, highlighted by 3-trifluoromethylaniline and 3,5-bistrifluoromethyl aniline giving 
derivatives 191 and 193 in 62% and 61% yields, respectively.  Anilines with halogen 
substitutions such as 3,4-dichloro, 4-bromo, 2-fluoro and 4-bromo-2-fluoro all performed 
well in this reaction with 58%, 70%, 75% and 79% isolated yield respectively, with the 4-
bromoaniline and 2-fluoroaniline generating products with suitable crystals for single-crystal 
X-ray analysis. 3-(Ethoxycarbonyl)aniline also gave the desired adduct N,N′-aminal 207 in 
70% isolated yield.  N-alkyl substituted arylamines were also tolerated within the reaction 
conditions with no observed oxidation of the alkyl groups.   N-Methylaniline gave the desired 
adduct 209 in 61% without oxidation of the methyl group; and finally, diphenylamine gave 
211 in 56% isolated yield illustrating that sterically encumbered anilines were also tolerated.  
The ORTEP structures for 181, 195, 197, 203 and 209 are shown in Figure 10. 
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Table 7: Results of the photoredox reactions of enamide 117 with different arylamines 
 
Entry Arylamine Product Yield (%) 
1 
 
 
178 
 
179 
72 
2 
 
 
180 
 
181 
84 
3 
 
 
182 
 
183 
88 
4 
 
 
184 
 
185 
71 
5 
 
 
186 
 
187 
64 
79 
 
6 
 
 
188 
 
189 
60 
7 
 
 
190 
 
191 
62 
8 
 
 
192 
 
193 
61 
9 
 
 
194 
 
195 
70 
10 
 
 
196 
 
197 
75 
11 
 
 
198 
 
199 
79 
80 
 
 
 
 
 
 
 
 
 
 
12 
 
 
200 
 
201 
58 
13 
 
 
202 
 
203 
76 
14 
 
 
204 
 
205 
77 
15 
 
 
206 
 
207 
70 
16 
 
 
208 
 
209 
61 
17 
 
 
210 
 
211 
56 
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However, the reaction did not give the required result with p-methoxy-aniline (p-anisidine) 
212, whereas with o-anisidine 202 a yield of 76% was obtained. The p-anisidine reacts with 
the diethyl 2-bromomalonate rather than giving the desired three-component adduct 213.  The 
enamide was recovered unreacted (Scheme 64).  This may be as a result of the electron 
donating property of the methoxy group on the ring that increases the electron density on the 
nitrogen atom.  The lone pair on the nitrogen atom of the amino group are now much more 
readily available for nucleophilic attack in the p-anisidine than in o-anisidine due to the 
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relative steric hindrance of the methoxy group at the ortho position (the ortho effect). Diethyl 
2-((4-methoxyphenyl)amino)malonate 214 was formed instead of diethyl 2-(2-((4-
methoxyphenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (Scheme 64). 
 
To investigate the diastereoselectivity of this transformation reaction, chiral enamide (169) 
and double bond substituted enamide (171) were then exposed to the reaction conditions and 
chiral bromide akylating agents were also employed.  The chiral enamide, (S)-4-benzyl-3-
vinyloxazolidin-2-one 169 reactions are shown in Scheme 65 while those of the substituted 
enamide, (E)-3-(hex-1-en-1-yl)oxazolidin-2-one 171  and chiral bromide alkylating agent (1-
bromoethyl)benzene 225 are shown in Scheme 66. 
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The reaction of (S)-4-benzyl-3-vinyloxazolidin-2-one 169 with aniline delivered the product 
216 as a 52:48 mixture of diastereoisomers in overall yield of 56%. The diastereoisomers 
ratio was determined by the 1H NMR using the chemical shift δ of the two hydrogen atoms of 
the bridging methylene between the aminal carbon and the carbon with the two carbonyl 
groups of the malonate moiety.  The δ of these bridging methylene hydrogen atoms for the 
two diastereoisomers do not overlap.  The ratio of the integration of their signals corresponds 
to the diastereoisomer ratio of the mixtures. Similar techniques and integrations were used to 
obtain the diastereoisomeric ratio of other adducts.   p-Toluidine reacted to give the adduct 
217 with the isolated yield of 58%, while m-toluidine and 2,4-dimethylaniline gave the 
products 218 and 219 in good isolated yields of 61% and 53% in that order with appreciably 
improved levels of diastereoselectivity.  p-Toluidine gave product as a 87:13 mixture of 
diastereoisomers, m-toluidine gave 70:30 ratio and 2,4-dimethylaniline gave 50:50, 
respectively.  A high level of diastereoselectivity was observed for electron withdrawing 
arylamine with 3-trifluoromethylaniline giving the product 220 as a mixture of 95:5 
diastereoisomers with the total yield of 54% and 3,5-bistrifluoromethyaniline with product 
221 isolated in 60% yield essentially as one single stereoisomer.  o-(Trifluoromethoxy)aniline 
and ethyl 3-aminobenzoate gave the adducts 222 and 223 with isolated yields of 58% and 
61% as mixtures of diastereoisomers of 75:25 and 55:45 ratios, respectively as shown by 1H-
NMR spectroscopy. 
Table 8: Products of photoredox reaction of chiral enamide 155 with different arylamines 
Entry Arylamine Product 
Diastereomer 
Ratio (dr) 
Yield (%) 
1  
 
178 
 
216 
52:48 69 
2  
 
180 
 
217 
87:13 58 
84 
 
3  
 
182 
 
218 
70:30 61 
4  
 
184 
 
219 
50:50 53 
5 
 
 
190 
 
220 
95:5 54 
6 
 
 
192  
221 
95:5 60 
7 
 
 
204  
222 
75:25 58 
8 
 
 
206 
 
223 
55:45 61 
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Additionally, the double bond substituted enamide derived from hexanal, (E)-3-(hex-1-en-1-
yl)oxazolidin-2-one 171 gave surprisingly good levels of diastereoselectivity in this reaction, 
giving 224 in 53% yield as a single stereoisomer as shown in Scheme 66(a). 
Further diastereoselectivity investigation with the use of chiral alkylating agents, (1-
bromoethyl)benzene 225 and ethyl α-bromophenylacetate 228 were employed.  The reaction 
was carried out with p-Toluidine 180 and enamide 117.  The chiral alkylating agent 225 gave 
the product 226 as a mixture of diastereoisomers in 50:50 ratio with the overall yield of 58% 
(Scheme 66 (c)) and 228 reacted, though at much longer time, to give the adduct 229 as a 
mixture of diastereoisomers in 50:50 dr with the overall isolated yield of 38% (Scheme 66 
(b)).  The product 227 obtained from the reaction of the sterically encumbered aniline, 
diphenylamine 210 was a mixture of diastereoisomers in 95:5 ratio with the overall yield of 
53% (Scheme 66(d)). 
In all of the additions described, the separation of the two diastereoisomers could not be 
undertaken, and the diastereoisomeric ratio most likely represents an equilibrium.  One can 
then conclude from the observed diastereoselectivity that the stereoselectivity of the reaction 
is influenced by the nature of the substituents on the benzene ring of the aniline. 
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Proposed Mechanism of the Reaction 
The proposed mechanism (Scheme 67) of the reaction starts with the absorption of photon by 
the photocatalyst Ir(ppy)2(dtbbpy)PF6 (represented as Ir-Cat
+) causing its excitation, then 
single electron transfer to the excited catalyst *Ir-Cat+ from triethylamine 230, forming the 
reduced Ir-Cat, a reductive quenching process, and the radical cation of triethylaminium 231 
is also formed alongside. Reduction of the C–Br bond of the diethyl bromomalonate 77 by 
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the reduced photocatalyst Ir-Cat, a strong reducing agent, forms radical 157 while 
regenerating the catalyst Ir-Cat+ thereby completing the catalytic cycle of 
Ir(ppy)2(dtbbpy)PF6.  Ir-Cat donates a single electron to the C–Br bond for easy exit of 
bromine, a good leaving group. The interaction of the enamide, N-ethenyl-2-oxazolidinone 
(117) with the electrophilic radical 157 produces the radical 232. This radical could be 
oxidized by either the exited photocatalyst, *Ir-Cat+ or the triethylaminium ion 231 by 
removing one electron from it to provide the intermediates N-acyl iminium cation 234.  The 
cation generated under this condition is then intercepted by the nucleophile, arylamine, as 
hypothesized by Stephenson and co-workers[34] to give the product 235. 
 
However, when tert-butyl 1H-indole-1-carboxylate (236) was used in place of N-vinyl-2-
oxazolidinone (117) as an enamide in the above reaction, the compound 237 was not 
observed (Scheme 68).  This might be as a result of the involvement of the π-electrons of the 
C=C bond and the lone pair on the nitrogen atom in the aromatic system of the ring.  Going 
into such a reaction will destabilize the aromatic ring, which is highly un-favourable. 
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The reaction did not also give the expected results with (bromomethylene)dibenzene 238 and 
2,2-diphenylacetic acid 240 as the alkylating agents under the reaction conditions.  The 
adduct 239 and 241 were not obtained as products.  The starting material, enamide was 
recovered unreacted even after running the the reaction for over 30 hours. 
 
3.4.3 Cyclization of the Enamides Photoredox Catalysed Products to γ-lactams 
The synthetic utility of the photoredox reaction products was tested by cyclizing some of the 
products to their corresponding γ-lactams (Scheme 70). The γ-lactam ring, also known as γ-
butyrolactam, is part of the important structure of a large number of natural and non-natural 
compounds covering a broad spectrum of biological activities.[56]  γ-Lactams find several 
applications in medicinal, synthetic, and material chemistry. They are included in a large 
number of pharmaceutically active compounds with antibiotic, anti-inflammatory, and anti-
tumoral functions.[57]  γ-Lactam moiety is a structural subunit for the design of several 
pharmaceutical agents.[58,59]   γ-lactams also served as valuable building blocks for the 
synthesis of complex molecules due to their latent reactivity and the large panel of highly 
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selective transformations they can undergo.[58]  Accordingly, products containing the γ-lactam 
core are important synthetic targets, so many synthetic strategies have been attempted and 
reported to make this valuable structural moiety and it is of primary interest in medicinal 
chemistry(Figure 11).[58,59,85,86] 
 
Initial attempt to cyclize these products into γ-lactams by stirring the adduct product in 
anhydrous toluene and heating to reflux for 24 hours resulted in zero yield as the starting 
material was recovered almost completely unreacted.  Similarly, the addition products did not 
cyclize with the addition of potassium hydroxide, a base. The cyclization was however 
achieved with the addition of acetic acid and heating at 80 oC overnight. 
 
The yield of the corresponding γ-lactams, the products of cyclization, obtained ranges from 
53% to 65%. The products were confirmed and characterized by 1H NMR, 13C NMR, and 
mass spectrometry techniques. X-ray crystallography, in addition to the NMR spectroscopy, 
was also used to analyze the product that formed crystals. 
In each case, the cyclization proved effective, but regrettably, the products could not be 
separated into the different diastereoisomers.  The major and minor diastereoisomers were, 
however, identified using a combination of 1H-NMR and NOE experiments, and the 
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diastereoisomeric ratios of the mixtures were determined by the integration of the diagnostic 
signals in the γ-lactam ring.  The NOE occurs through space thus enabling one to differentiate 
two diastereoisomers through the space interactions of protons that are not connected by 
chemical bonds.  Using the γ-lactam 243 obtained from the photoredox reaction product 181 
as a representative, the diastereomeric ratio was determined to be 53:47.  The hydrogen atom 
on the carbon bearing the aminal moiety appear at δ 6.27 ppm and 6.23 ppm, respectively for 
the two diastereoisomers. The hydrogen atom on the carbon that bears the ester group appears 
at δ 3.65 ppm for a diastereoisomer while the signal for the other diastereomer appears at δ 
3.47 ppm.  The two hydrogen atoms of the methylene bridge in the lactam ring are 
diastereotopic.  The diastereotopic methylene bridge hydrogen atoms of one the 
diastereoisomer appear at δ 2.93 ppm and 2.24 ppm while those of the other diastereoisomer 
appear at δ 2.78 ppm and 2.42 ppm. 
Having confirmed the formation of the γ-lactam product 243 formed by the adduct product 
181, other adducts from tables 7 and 8 were treated under the same conditions to determine 
the scope of the reaction (Table 9, entry 2).  The treatment of adducts 179 and 183 delivered 
the desired γ-lactams 242 and 244, in 64% and 65% yield, respectively as 50:50 and 55:45 
mixtures of diastereoisomers in that order (Table 9, entries 1 and 3).  The adduct products 
with electron withdrawing substituents groups on the benzene ring also delivered their 
corresponding γ-lactam products in comparable yields.  The adduct product with m-
trifluoromethyl group 193 delivered γ-lactam 245 (Table 9, entry 4) with 65% yield while p-
bromo derivative 195 gave lactam 246 in 53% yield (Table 9, entry 5) as mixtures of 
diastereoisomers with ratio 50:50 for the two.  The treatment of adduct products o-fluoro- 
(197) and 4-bromo-2-fluoro derivatives (199), with acetic acid, delivered the desired γ-
lactams 247 and 248, in 61% and 60% yields, respectively and isolated as 57:43 and 57:43 
mixtures of diastereoisomers. 
Some chiral adduct products were also subjected to this acetic acid treatment and they 
delivered the desired γ-lactam products.  Chiral adduct product 220 gave lactam 249  (54% 
yield) while adduct product 221 delivered the corresponding γ-lactam 250 (51% yield) with 
diastereoisomeric mixtures of 53:47 and 54:46, respectively (Table 9, entries 8 and 9). 
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Table 9: Products of cyclization of the adduct products of photoredox reaction 
Entry Adduct product Cyclized Product 
Diastereoisomeric 
ratio (dr) 
Yield (%) 
1 
 
179 
 
242 
50:50 64 
2 
 
181 
 
243 
53:47 60 
3 
 
183 
 
244 
55:45 65 
4 
 
193 
 
245 
50:50 65 
92 
 
5 
 
 
195 
 
246 
50:50 53 
6 
 
197 
 
247 
57:43 61 
7 
 
199 
 
248 
57:43 60 
8 
 
220 
 
249 
55:45 54 
9 
 
221 
 
250 
58:42 51 
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Essentially, all the cyclized products exhibited a slight preference for the syn-product, with 
the one exception being the p-tolyl γ-lactam 243. The diastereoselectivity ratio could also be 
partially influenced by the inclusion of an ortho substituent on the aryl ring, as exemplified 
by the 2-fluoroaryl γ-lactam 247.  We are delighted to obtain the 4-bromo-2-fluoro-tolyl γ-
lactam 248 in crystal form upon standing overnight.  The ORTEP structure for 248 is shown 
in Figure 12.  There is possibility that the cyclized compound might epimerize in 
chloroform-d from the fact that when the crystal sample used for the X-ray analysis was re-
run for the 1H-NMR same diastereoisomeric ratio as when the sample was freshly isolated 
from the reaction mixture was observed. 
 
Plausible Mechanism of the Acid Catalysed Cyclization of the Adducts. 
The reaction begins with the protonation of one of the lone pairs on the oxygen of one of the 
carbonyl carbons of the malonate moiety thereby making the carbon more susceptible to 
nucleophilic attack.  The carbon atom is attacked by the lone pair on the nitrogen atom of the 
arylamine group forming arylaminium ion 252.  Next there is a proton transfer from the 
arylaminium ion to the oxygen atom of the ethoxy group which aids the loss of a molecule of 
ethanol as a leaving group and an oxonium ion 255 is formed.  Then the oxonium ion loses 
the hydrogen atom to the ethanoate ion, the conjugate base of the acetic acid, to complete the 
catalytic cycle of the acid and the product, γ-lactam 242 is formed.  All these processes or 
steps are reversible (Scheme 71). 
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3.4.4 In situ Bromination of Malonate 
Use of bromomalonate derivatives in photoredox additions is ubiquitous within the literature.  
A report by Stephenson[87] on the photoredox catalysed Appel reaction, suggested that an in 
situ bromination of malonate by use of an external brominating reagent could be used as an 
alternative.  With the successes achieved from the above reactions, we thought of trying some 
other alkylating agents/groups, especially non-activated alkyl groups, if the reaction 
conditions would accommodate them.  Attempt was made to explore the use of a different 
radical source for the reaction to generate bromomalonate in situ. The first attempt was to use 
tetrabromomethane 257 as a source of bromine radical for the reaction to generate diethyl 
bromomalonate in situ.  To our delight we obtained a desirable result of the adduct product 
when diethyl malonate 256 and tetrabromomethane were used in place of diethyl 2-
bromomalonate with the enamide 117 and p-toluidine (Scheme 72).  However, this has not 
been optimized. 
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CHAPTER FOUR 
4.0 Allenamides 
4.1 Allenamides: an Introduction 
Allenes, the cumulative dienes, is a functional group that can be exploited as a useful 
building block in synthetic transformations for the building of complex structures that are 
useful for constructing natural and unnatural products.[47,48,61] Subgroups of allenes are 
obtained when the terminal carbon has a heteroatom such as oxygen, sulfur, or nitrogen as a 
substuent (Figure 13).[48] When the heteroatom is nitrogen from an amine, we have an 
allenamine.  The π-donating ability of nitrogen atom renders allenamines more electron-rich 
than simple allenes, thereby predisposing them to electrophilic activations. Hence, 
allenamines are synthetically useful. When nitrogen atom donates its lone pair toward the 
allenic moiety it renders transformations involving additions of electrophiles [E+] and 
nucleophiles [Nu̅] highly regioselective.[48] 
 
Synthetic transformations involving allenamines should therefore be useful in organic 
synthesis. They are useful in many reactions which include α- or γ-lithiation of allenamines, 
additions, 1,3-dipolar, [2+2]-cycloadditions, and hetero [4+2]-cycloadditions (Scheme 73). 
Other examples are cyclizations, dimerizations, and rearrangement reactions.[61] 
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The extent of synthetic applications of allenamines is limited, because they are sensitive to 
hydrolysis, polymerization, and isomerization even at low temperatures, thereby creating 
serious difficulties in their preparation and handling. However, the transformations involving 
allenamines often result in products possessing nitrogen functionalities and more importantly 
they are regio- and stereoselective. 
Nitrogen-containing structures are prevalent among medicinally interesting natural and 
unnatural products and, thus, are useful in developing new therapeutics. Therefore, efforts in 
developing the chemistry of allenamines and identifying an allenamine-equivalent that 
possesses the right balance between stability and reactivity can be significant and rewarding, 
especially to synthetic chemists and medicinal chemists.  The desired stability and reactivity 
can be achieved by having the appropriate electron-withdrawing group on the nitrogen atom 
of allenamines.  One of such are the allenamides in which the nitrogen atom has the carbonyl 
group as the electron withdrawing group substituent (Figure 14). 
Allenamides are less reactive, but more stable, than the allenamines because of the electron-
withdrawing carbonyl group on the nitrogen atom that diminishes the electron donating 
ability of the nitrogen towards the allenic moiety.[48] 
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The first preparation of allenamide, 1,2-propadienyl-2-pyrrolidinone, was reported in 1967 by 
Dickinson.[47,88] Dickinson coined the term “allenamide” to describe 1,2-propadienyl-2-
pyrrolidinone he prepared based on the analogy of using enamides for Stork’s N-acylated 
enamines, and afterwards there has been increased interest in the chemistry of allenamides 
ranging from medicinal studies, to materials using living polymerization, to synthetic 
methodologies.  These efforts support the notion that allenamides are becoming a proven 
allenamine-equivalent with the right balance of stability and reactivity. 
 
4.2 Synthetic Methods for Allenamides 
There has not been a general reliable synthetic method for the preparation of various 
allenamides, however, the base-induced isomerization seems to be the most reliable and 
facile synthetic entry into these synthetically useful class of compounds.  In 1967, Dickinson 
demonstrated that treatment of 2-pyrrolidinone 265 with NaH and propargyl bromide 266 led 
to the preparation of allenamide 268 as the major and stable product via prototropic 
isomerization pathway (Scheme 74).[73]  It was also found that the same allenamide could be 
obtained from the ynamide 267, which is believed to be an intermediate of the Dickinson’s 
reaction, using NaOMe or NaH.[54]  Interestingly, the allenamide did not undergo further 
isomerization to the ynamide 270 as one would have expected, although with further 
treatment with NaOMe and pyrrolidine, the allenamide 268 reacts further to give the amide 
274 via ynamide intermediate.[89] 
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Bogentoft[90] in 1969 also reported the preparation of allenamide 276 via a base-induced 
isomerization of propargyl amide 275 in 50% yield. Oxazole 278 was also isolated, it is likely 
derived from allenamide 277 after ring opening of the quinazolone (Scheme 75). 
 
In 1976, Corbel[91] achieved the first synthesis of an acyclic allenamide 280 also via the base-
induced isomerization of N-propargyl phosphoramidate [X = OEt]/phosphoramide [X = 
NMe2] (Scheme 76). Ynamide 281 was found along with 280, as a mixture when X = NMe2. 
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Overman[92] in 1979 reported the isolation of allenamides as a result of Claisen rearrangement 
of propargyl trichloroacetyl imidates 282, though in a low yield of about 20%. Under the 
reaction condition, the allenamides 283 could further isomerize to 1-Z-3-E-dienamides 284 in 
a highly stereoselective manner. This method was used to synthesize highly substituted chiral 
allenamides. Similarly, Claisen-type rearrangement of propargyl thiol benzimidazole 285 
gives allenamide 286 as an intermediate in its transformation to the compound 287 (Scheme 
77). 
 
Recently, Morrill et al. reported the synthesis of a new class of allenamides, N-allenyl 
cyanamides in which the electron-withdrawing group on the nitrogen atom is the cyano 
group, through deoxycyanamidation-isomerization.[93] In their report, propargyl alcohol 288 
was used to react with the corresponding cyanamide 289 via deoxycyanamidation and its 
subsequent base induced isomerization to N-allenyl cyanamide 290. The two steps were 
carried out in one-pot (Scheme 78). 
 
In 1981, Tamura and co-workers[94] reported the first example of [2,3]-sigmatropic 
rearrangement of sulfimine 293, leading to allenamide 294 (Scheme 79). The rearranged 
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precursor 293 was obtained by acylating the propargyl sulfide 291 with N-triflate carbamate 
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Allenamide can also be prepared through base-induced isomerization of propargyl amides.  
Padwa[95] in 1982 reported that at high temperature under basic conditions, propargyl amide 
295 isomerizes to allenamide 296 (Scheme 80). Galons[96] also reported, in 1985, another 
example in which allenamides 298 and 300 were formed through a solid−liquid phase 
transfer catalyst-promoted reaction of imidazoles 297 and 299, respectively with propargyl 
bromide 266 (Scheme 81). 
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Hsung and co-workers in 2001 reported the isomerization of cyclic propargyl amides 301 to 
allenamides in their attempt to synthesize ynamides via the base-induced isomerization.  
They observed that instead of ynamides 303 to be formed, the isomerization gave allenamides 
302 (Scheme 82). This happened to be the first chiral allenamides to be synthesized.  
Propargyl amides in which the nitrogen atom is part of aromatic heterocycle most often 
isomerize to the corresponding allenamides. There are very few examples of isomerization of 
propargyl amides resulting into the formation of ynamides. In most cases, isomerizations of 
propargyl amides provided only allenamides.[48,97] 
 
Apart from the synthetic methods or approaches mentioned above, there are many other 
documented methods that have been used by different researchers for the preparation of 
allenamides, these include amongst others De Meijere’s isomerization for acyclic N-tosyl 
allenamide,[98] Tanaka[99] and Farina’s eliminations for preparations of β-lactam-based α,α-
disubstituted allenamides from enol triflates.[100] While synthetic approaches to these 
substrates have been well documented, it is the base-catalysed rearrangement of propargyl 
amides that has stood out as a method of choice for their synthesis.[101] This method has a 
major drawback of reliance on the formation of the propargyl amide from the reaction of 
propargyl bromide with the appropriate amide under basic conditions. This drawback is, 
however, circumvented by the one-pot approach reported in 2015 by Kimber and co-
workers[101] for the preparation of allenamides. The simple method involves one-pot 
preparation using a DMSO/tBuOK protocol. The procedure is experimentally simple and 
robust, and provides N-allenyl analogues, commonly used within the literature, in yields 
comparable to the two-step approach (Scheme 83). 
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In 2016, Evano et al. reported the synthesis of allenamides derived from oxazolidinones and 
hydantoins by copper-catalysed coupling of propargylic bromides and nitrogen 
nucleophiles.[102] Copper thiophene carboxylate (CuTC)-2,2’-bipyridine complex was used as 
the coupling catalyst in the presence of an inorganic base Cs2CO3 or K3PO4. This method is 
suitable for the synthesis of trisubstituted allenamides which the Trost[62] and Hung group 
methods could not be used for their synthesis (Scheme 84). 
 
4.3 Chemistry of Allenamides 
Allenamides are electron-deficient equivalents of allenamines. They represent interesting 
functional groups and useful in organic synthesis.  Their chemical utility have been exploited 
by a number of research groups.[103] Allenamide subunit undergoes several versatile chemical 
reactions including highly regio- and stereoselective transformations offering useful building 
blocks in organic synthesis. Some of the reactions are deprotonation, addition reactions, 
cycloaddition reactions and cyclization like radical cyclization, acid-catalysed cyclization, 
palladium-mediated transformations, base-catalysed CO2 capture, based-catalysed 
heterocyclizations, gold-mediated transformations and ruthenium-catalysed aminoallylations.  
When allenamides are involved in cyclization or cycloaddition transformation, they give rise 
to structurally diverse heterocycles, as well as to complex molecular architectures that are 
analogues of natural products and biologically relevant substrates.[103]   
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4.3.1 Deprotonations 
Allenamide can undergo deprotonation in either α- or γ- position.  The α-position seems to be 
more favourable than the γ-position. The reason could be as a result of the inductive effect of 
the α-carbon withdrawing the electrons on the bond toward itself thus making it relatively 
more nucleophilic than the γ-carbon.  The inductive effect is as a result of the nitrogen atom 
directly bonded with it. Corbel[104] documented the first example of α-deprotonation of 
allenamide 307 to generate the lithiated allenamide 308, which was trapped by electrophiles 
to afford α-substituted allenamides 309 (Scheme 85). Subsequent hydrolysis of 309 resulted 
in the corresponding unsaturated ketones 310. 
 
Hsung[105] also reported a regioselective α-deprotonation of allenamides 311 using n-BuLi 
(Scheme 86). The one-pot deprotonation/alkylation sequence that can be widely applicable to 
access a series of α-substituted allenamides 312; the γ-deprotonation product 313 was not 
observed. 
 
Hsung[105] further revealed that when t-BuLi was used, there was no α/γ selectivity. The 
deprotonation led to a 50:50 mixture of 315 and 316 (Scheme 87). However, the 
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deprotonation/D2O trapping sequence of allenamide with the α-position blocked would occur 
at γ-position to afford 318 with moderate diastereoselectivity. 
 
4.3.2 Addition Reactions 
Hydroalkoxylations 
Horino,[106] in 2008, found that hydroalkoxylations of allenamide 319 with alcohol 320 could 
take place at both γ- and α- positions to afford distal addition product 300 and proximal 
addition product 322, respectively (Scheme 88). With an Au(I) catalyst, the hydroxylation of 
319 could be achieved more selectively at the α-position to give 322 in high yield. Diene 322 
was subsequently used to construct the spirodihydrofuran 323 through ring-closing 
metathesis (RCM). In contrast, the distal addition product 321 was more favoured under 
thermal conditions. 
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Hydroamination 
In 2010, Kimber et al.[107] reported an intermolecular hydroamination of allenamides 324 
with arylamines 325 under mild Au(I) catalytic conditions delivering allylamino E-enamides 
326 stereoselectively in high yield via intermediate 327. The reaction is made possible via a 
convenient method for conjugated N-acyliminium formation. The products of this reaction, 
allyl-aminoenamides, have the potential to be valuable building blocks in organic synthesis 
since they contain two vital functionalities, allyl amines and enamides, within one framework 
(Scheme 89). 
 
Broggini[108] also, in 2009, reported an Au(III)-catalysed intramolecular hydroamination of 
allenamides 328, which afforded a mixture of cis- and trans 2-vinyl-imidazolidines 331 
through the 5-exo-trig transition states 329 and 330, respectively. Intriguingly, when R = Bn, 
only cis-331 was isolated in good yield (Scheme 90). 
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Broggini[109] also reported that allenamides 328 could be subjected to base-promoted 
intramolecular hydroamination, leading to heterocycles 332, 333, and/or 334 (Scheme 91). In 
most cases, the cyclization occurs effectively with microwave irradiation at the central allenic 
carbon to afford 333 thereby representing an umpolung addition reaction. However, no 
hydroamination products were observed when R = Ph. 
 
Hydroarylation 
Ohno developed the first Au-catalysed intramolecular hydroarylation of allenamides for the 
formation of dihydroquinolines.[61,66] Kimber, in 2010, reported a highly stereoselective 
hydroarylation of allenamides 335 to obtain a series of achiral and chiral oxazolidinone-
derived E-enamides 337 via the 1,4-addition to N-acyl iminium intermediates 336 (Scheme 
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92).[56] Bis-hydroarylation products could be obtained in some cases. For example, 
allenamide 335 reacted with furan twice through both 1,4- and 1,2-hydroarylation to give 
338. In another case, bis-hydroarylation afforded 339 when 2 equiv. of the allenamide 335 
was used. 
 
4.3.3 Cycloaddition Reactions 
Allenamides, being electron-deficient equivalents of allenamines, can participate in a range 
of cycloaddition reactions giving rise to novel heterocycles and diverse molecular 
architectures similar to those obtained in natural products.  Cycloadditions involving 
allenamides can be cycloadditions directly involving the allenamide olefin, and 
cycloadditions using the allenamides olefin as a precursor to a nitrogen-stabilized allyl cation. 
Several research groups have carried out and reported studies of different kinds of 
cycloaddition reactions involving allenamides.  These include [2+1]-cycloadditions by Hsung 
and co-workers,[110] [2+2]-cycloadditions by Tamaru,[111] Nair,[112] Chen,[113] Mascareñas[114] 
and González;[115] [2+2+1]-cycloadditions by Hsung[105] and Oh;[116] [3+2]-cycloadditions by 
Broggini and Zecchi;[117] and dipolar cycloaddition by Barluenga[118] and Piperno and 
Romeo.[119] 
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[2+1]-Cycloadditions. 
Hsung[110] reported the first detailed studies on epoxidations of chiral allenamides 340 
including 1H-NMR studies of these reactions (Scheme 93). When Oxone® was used, isolation 
of cyclic ether 343 suggested that a more acidic medium during the oxidation can promote 
rapid ring-opening of allene oxide or epoxyallene 341 to provide the α,β-unsaturated N-acyl 
iminium intermediate 342. 
 
In 2009, Hsung[120] reported a detailed account of Simmons−Smith cyclopropanation of 
allenamides to generate amido-spiro[2,2]-pentanes (Scheme 94). For α-unsubstituted 
allenamides 344, only bis-cyclopropanation products 345 were formed, while α-substituted 
allenamides resulted in mixtures of mono- and bis-cyclopropanation products 346 and 345, 
though there was a lack of selectivity in the reaction. 
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 [2+2]-Cycloadditions 
Studies of [2+2]-cycloaddition reactions involving allenamides were carried out by several 
research groups. Tamaru and co-workers[111] reported, in 1997, of the thermal [2+2] 
cycloaddition of allenamides was among the earliest of such reactions. Various allenamides 
347 underwent [2+2]-cycloaddition reactions chemoselectively at the allenic β,γ-position 
with alkenes or alkynes to respectively furnish cyclobutanes 350 or cyclobutenes 351 regio- 
and stereoselectively (Scheme 95).[121] This methodology was reportedly to be limited to 
terminal alkenes and alkynes bearing not only electron-withdrawing and conjugating groups 
but also electron-donating groups with complete retention of the alkene double bond 
geometries. 
 
Nair[112] published, in 2002, a unique [2+2]-cycloaddition of allenamides 352 with 
[60]fullerene 353 to afford novel cyclobutane annulated fullerene derivatives 354 (Scheme 
96). The reaction took place selectively on the internal double bond of allenamides. 
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Chen[113] also reported in 2012 the first Au-catalysed [2+2]-cycloadditions of allenamides and 
later same year, Mascarenas[113] independently reported a gold-catalysed intermolecular 
[2+2]-cycloaddition of allenamide 304 with various alkenes 356 for the synthesis of 
cyclobutanes 357.  This reaction is highly regioselective with only the exo-double bond of the 
allenamides involves in the reactions (Scheme 97). 
 
In addition, allenamides have also been reported to participate in many other types of 
cycloaddition reactions such as thermal intramolecular [4+2]-cycloadditions; torque-selective 
ring closures of allenamides; inverse-electron-demand Diel-Alder reactions; 
cycloisomerization like the Pauson-Khand reaction (PKR); cyclopropanation; and [4+3]-
cycloadditions using nitrogen-substituted oxyallylcations.[103] 
4.3.4 Cyclizations 
Allenamides have been reported to undergo several types of cyclization both transition metal 
mediated and non-transition metal cyclization transformations.  Some of the addition 
reactions of allenamides actually involve cyclizations, especially the intramolecular 
hydroamination and hydroarylation. 
Hacksell[122] reported the first cyclization involving an allenamide. His attempts to methylate 
propargyl amides 358 led to isolation of the oxazole 359 when R2 = p-NO2Ph, and the desired 
allenamides 360 were isolated when R2 = p-MeOPh or Ph (Scheme 93). This cyclization 
occurred for all substrates when MeI was not added, and presumably, 361 and 362 were key 
intermediates. Cyclization is actually faster than methylation when R2 = p-NO2Ph. 
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Motivated by the successes achieved in the Au(I) activation of allenamides and their 
subsequent reaction with electron-rich arenes and arylamines to give functionalised 
enamides, Kimber and co-workers then considered intramolecular arene cyclization of 
allenamides. Kimber,[123] in 2012, then reported the achievement of the construction of α-
vinyl-substituted tetrahydroisoquinolines 365, cyclized products, through an Au(I)-catalysed 
intramolecular hydroarylation of allenamides 364 (Scheme 99). 
 
Liu and co-workers, in 2017, reported the use of allenamides in the metallo-ene/Suzuki 
coupling reaction catalysed by palladium. In this reaction, two new Csp3–Csp2 bonds were 
constructed in one pot providing a variety of polyfunctionalized 2,3-dihydropyrrole 
derivatives (Scheme 100).  This reaction shows an excellent regioselectivity providing the 
terminal C1 position coupling product without detection of the internal C3 coupling product.  
The unique terminal alkene as one of the most easily functionalized groups endows these 
molecules with versatile transformations into much more complicated molecules.[124] 
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Shen and Hsung, in 2005, also reported the first radical cyclization reactions involving 
allenamides. The reactions are highly regioselective for the central carbon of the allenic 
moiety that led to the synthesis of nitrogen heterocycles such as isoquinolines and 
carbocycles such as indane and naphthalene (Scheme 101(a)). However, when highly 
constrained allenamides like 370 are used in the reaction, the formation of exo-cyclization 
products are favoured leading to the synthesis of isoindoles 371 (Scheme 101(b)).[125] 
 
In conclusion, allenamides are versatile compounds that undergo useful reactions leading to 
varieties of compounds that can be used in the synthesis of natural compounds and for the 
development of new therapeutics.  Therefore, efforts in developing the chemistry of these 
compounds can be significant and rewarding, especially to synthetic chemists and medicinal 
chemists as both offer a wide variety of alternatives for the inclusion of a nitrogen-based 
moiety into organic systems. 
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4.4 Allenamides: Reactions, Results and Discussion 
The presence of the electron withdrawing group, the carbonyl group, on the nitrogen atom of 
the allenamides attached to the α-carbon of the allene moiety leads to the distinct reactivities 
display by this class of compounds from the traditional reactions of allenes. This substituent 
can donate electron density through the lone pair on the nitrogen atom into the allene, 
principally onto the central β-carbon.  This can be harnessed in the chemical transformations 
of allenamides to obtain highly regioselective products.  This distinct reactivity profile of 
allenamides had contributed to the recent attention enjoyed by this unique class of 
compounds in the synthetic community.  They have been involved in variety innovative 
transformations, including cycloadditions, Aldol additions, intramolecular cyclizations and 
intermolecular addition reactions, as well as their uses as precursors in natural product 
synthesis. 
Radical reactions represent a powerful tool in organic synthesis.  The generation of radicals is 
achieved traditionally by heating, irradiation by light or a redox reaction.  These conventional 
methods of radical generation often need the use of harmful or explosive reagents, use of 
high-energy UV radiation etc.[6,7]  In other words, radical generation involves uncontrollable, 
harsh conditions and often have a poor atom economy.  However, these environmentally 
unfriendly conditions can be avoided by using photoredox catalysed techniques which are 
mild and mostly have high atom and energy economy.  The process generates less amounts of 
waste, environmentally friendly and above all no special equipment is required. 
Reports of reactions involving the use of allenamides in radical reactions are limited so the 
single intermolecular radical cyclization as reported by Hsung.[125] There are no reports of 
radical photoredox reactions on allenamides is in the literature, at least to best of our 
knowledge.  With this in mind, we intend to develop a general addition reaction for the 
transformation of allenamides using a mild condition of visible light photoredox catalysis as 
the main synthetic reaction. 
Addition reactions of allenamides are typically promoted by the electrophilic activation of the 
β-carbon of the allenamide. The reaction of the allenamide with the electrophiles can promote 
the formation of a conjugated N-acyliminium that can subsequently undergo an addition 
reaction with a suitable nucleophile. The outcome of this nucleophilic addition reaction can 
be grouped into three distinct regiochemically divergent products (Scheme 102); (a) addition 
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over the α, β-double bond of the allene (372); (b) addition over the β, γ-double bond of the 
allene (373); and (c) addition at both the α- and γ-positions (374) by two nucleophiles.  The 
thought process behind this approach is based on the intramolecular radical cyclization of 
allenamides reported by Hsung and co-workers. [125].     
 
We envisage that the photoredox catalysed addition developed on enamides can be used on 
allenamides. However, unlike enamides the addition of the malonate radical to the 
allenamide, followed by oxidation to the iminium should furnish the conjugated N-acyl 
iminium ion 379 (Scheme 103). This intermediate can then be intercepted by an appropriate 
nucleophile, but importantly, this can occur at either the α- or γ-position, therefore leading 
ultimately to the products 98 and 99 (Scheme 104).  Therefore, the three component domino 
reactions of allenamide, diethyl bromomalonate as the electrophile source and the 
nucleophile, which could be oxygen and nitrogen, will be examined. 
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Therefore to test our hypothesis above we required sufficient amounts of allenamides 
precurosrs, which would be synthesized using the standard method reported in the literature 
by Kimber et al.[101] 
4.4.1 Allenamides Synthesis 
Synthesis of N-Allenyl-2-oxazolidinone 
The allenamide was synthesized from oxazolidin-2-one 114 using the one-pot protocol 
reported earlier by the Kimber’s research group (Scheme 83). There was no need for the 
reaction optimisation since this had been done by the previous members of the research 
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group, except when some challenges arose and the integrity of the reagents used had to be 
verified. 
The reaction was carried out in dry/anhydrous dimethylsulfoxide DMSO under an inert 
atmosphere of argon.  It involves the combination of all the reagents, oxazolidin-2-one, 
potassium tert-butoxide (t-BuOK) and propargyl bromide in one reaction pot.  The yield was 
greatly affected by the dryness and freshness of the t-BuOK, with fresh, anhydrous t-BuOK 
giving higher yield of the product than the stock t-BuOK. The rate at which the propargyl 
bromide is added into the reaction mixture also has some effects on the final yield of the 
product.  It was found that when the propargyl bromide was added too rapidly, a lot of heat 
was generated and a mixture of the allenamide and the propargyl amide was formed. In the 
initial attempt, the ratio of the allenamide to the propargyl amide formed was determined 
from the 1H-NMR spectrum to be 81:19. The signals obtained from the 1H-NMR indicated 
the presence of the two isomers: the 1H-NMR signals of the hydrogen atoms of the allenyl 
group of the allenamide showing at δ 6.84 ppm for the hydrogen atom on the C=C next to the 
nitrogen atom of the ring appearing as triplet due to the coupling effect of the two terminal 
hydrogen atoms of the second C=C whose signal at δ 5.41 ppm appears as a doublet.  The 
hydrogen atoms of the propargyl group for the propargyl amide fraction showed at δ 4.04 
ppm for the two hydrogen atoms on the carbon next to the nitrogen appearing as doublet due 
to the coupling effect of the hydrogen atom on the terminal sp-carbon which appeared triplet 
at δ 2.28 ppm.  However, when the propargyl bromide was added drop-wise over an extended 
period of time the ratio of the allenamide to the propargyl amide increased in favour of higher 
quantity of allenamide.  The time frame of about 45 minutes drop-wise addition gave the 
allenamide with little or no propargyl amide isomer. 
Having successfully prepared N-allenyloxazolidin-2-one 304, we then extended the scope of 
the reaction to other different amide substrates for their conversion to allenamides. The 
substrates included N-methyl-p-toluenesulfonamide, (S)-4-benzyloxazolidin-2-one, (S)-4-
isopropyloxazolidin-2-one, pyrrolidin-2-one, piperidin-2-one and ε-caprolactam all of which 
gave comparable yields (Table 10). 
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The reaction is thought to commence with the deprotonation of dimethyl sulfoxide 380 by the 
tert-butoxide ion 381 forming methylsulfinymethylide ion 382 that in turn deprotonate 
oxazolidin-2-one 114 to give the 2-oxooxazolidin-3-ide anion 383. The 2-oxooxazolidin-3-
ide anion then attacks the alkynyl carbon of propargyl bromide 266 in an SN2 reaction 
pushing a pair of π-electron to move towards bromine for easy elimination as a bromide ion 
being a good leaving group to afford the intermediate 3-propargyl-2-oxazolidinone 384 from 
which the base abstracts a proton and isomerizes to the product 304 (Scheme 105). 
 
Table 10: Synthesis of allenamides 
Entry Substrate Product Yield [%] 
1  
114 
 
304 
72 
119 
 
2 
 
167 
 
384 
51 
3 
 
385 
 
386 
60 
4  
387 
 
388 
78 
5  
265 
 
268 
61 
6  
389 
 
390 
68 
7  
391 
 
392 
80 
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4.4.2 Allenamides: Photoredox Catalysed Transformation Reactions 
The considerable stability of the allenamides as compared to allenamines due to the presence 
of an electron withdrawing group attached to the nitrogen gives allenamides their 
characteristic reactivity profiles that attract attention of synthetic community in the recent 
time.  Allenamides display distinct reactivity from the traditional allenes as a result of the 
presence of the nitrogen atom attached at the α-carbon.  The nitrogen atom of the amide unit 
can donate electron density into the allene central β-carbon.  This exclusive distinct 
characteristic profile can be harnessed in various chemical transformations and has led to its 
use in innovative transformations such as cycloadditions, Aldol additions, cyclizations and 
intermolecular addition reactions. 
The versatility of the allenamide functional group has been exploited by a considerable 
number of researchers, as stated earlier. The radical cyclization reaction reported by Hsung 
and co revealed the chemical transformations of allenamides leading to regiochemical 
confidence in the resulting products. However, no one to our best knowledge has involved 
allenamide in photoredox transformation. 
We started by subjecting our prepared allenamide 304, 3-(propa-1,2-dien-1-yl)oxazolidin-2-
one to the Courant and Masson[53] conditions of photoredox reaction just as we did with the 
enamide. We added our iridium photocatalyst and the allenamide in the reaction vessel with 
degassed anhydrous acetonitrile followed by the addition of the alkylating reagent, diethyl 2-
bromomalonate, triethylamine and the nucleophile, ethanol.  After the irradiation with the 
Kessil® LED blue light (λ = 465 nm), we obtained the adduct product 393 of the type (a) in 
the Scheme 97 where the addition is α,β-adduct with exo-methylene (Scheme 106). 
 
The adduct product, diethyl 2-(3-ethoxy-3-(2-oxooxazolidin-3-yl)prop-1-en-2-yl)malonate 
(393) is very similar to the adduct product 177 of enamide 117 except that the carbon atom 
joining the N,O-acetal moiety and the malonate group is now an sp2 hybridized carbon with a 
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double bond with another carbon.  This feature is significant in its identification and 
confirmation.  The formation of the desired product was confirmed by 1H-NMR, 13C NMR 
and mass spectrometry.  The 1H NMR revealed the disappearance of the signals of the 
hydrogen atoms of the allene group of the allenamide.  The diagnostic signal of the adduct 
product at δ 5.60 ppm for the hydrogen atom of the carbon bearing the nitrogen atom of the 
ring and oxygen atom of the ethoxy group, i.e. the N,O-acetal carbon emerged as singlet and 
the two vinylic protons appeared in the 1H NMR spectrum at δ 5.56 ppm and δ 5.42 ppm, 
respectively. The hydrogen atom on the carbon bearing the malonate moiety appeared at δ 
4.05 ppm as singlet.  The hydrogen atoms of the ethoxy group of the N,O-acetal moiety 
showed at δ 3.54 ppm for O-CH2- which appeared as quadruplet due to the coupling effect of 
the neighbouring methyl group hydrogen atoms (-CH2-CH3) which appear as triplet at δ 1.18 
ppm on the spectrum. 
Having obtained the desired adduct product with the use of ethanol, we then decided to find 
out the scope of the reaction with other oxygen nucleophiles.  We made use of isopropanol 
and methanol. Isopropanol also gave an adduct product with the isolated yield of 33%.    
However, the combination of COSY and HMQC experiments from the NMR, revealed that 
the nucleophilic addition did not occur at the α-carbon to give hemi-aminal product rather it 
was attached to the γ-carbon to give product 372. Therefore this gave the β,γ-adduct product; 
that is the addition product of the path (b) as seen in Figure 16 (Scheme 107). 
 
When methanol was used, the crude 1H NMR showed peaks of the formation of the adduct 
product, however this product could not be isolated from the reaction matrix.  The hemi-
aminal product is unstable in acid condition and decomposed in silica gel, as it is slightly 
acidic.  It protonates the oxygen of the methoxide group of the hemi-aminal and methanol is 
released as a leaving group (scheme 108). Therefore, it could not be isolated from the 
reaction mixture. 
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The allenamide 304 was then subjected to the reaction conditions to investigate its 
performance with a range of aryl amines (Scheme 109). We began with p-toluidine together 
with diethyl 2-bromomalonate 77 under our reaction conditions which gave the exo-
methylene 399 as the only isolable product in 53% yield. This exo-methylene reaction 
product was conclusively identified by the characteristic vinylic protons within the 1H NMR 
at δ 5.48 ppm and δ 5.45 ppm as doublets, respectively. 
 
The reaction was then carried out on a range of electron donating and electron withdrawing 
aryl amines with all the adduct product isolated with exo-methylene products as the only 
isolable products.  The results are as shown in Table 11 below.  2,4-Dimethylaniline reacted 
giving the adduct product 400 with 57% yield.  This yield was marginally higher than that of 
p-toluidine possibly because of its higher nucleophilicity as a result of the positive inductive 
effects of the two methyl groups on the benzene ring. Arylamine with electron withdrawing 
groups as substituents also undergo the reaction with the allenamide but with slightly reduced 
yield.  3,5-Bis(ditrifluoromethyl)aniline, p-bromoaniline and 4-bromo-2-fluoroaniline reacted 
to give products 401, 402 and 403 with isolated yields 45%, 49% and 46% respectively.  
However, o-anisidine and its 2-OCF3 analogue reacted giving the products 404 and 405 with 
isolated yields of 51% and 53%, respectively.  The higher yield obtained in these cases may 
be explained by the positive mesomeric effects over the inductive effects as observed in the 
cases of 3,5-bis(ditrifluoromethyl)aniline and 4-bromo-2-fluoroaniline.  The contribution of 
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the lone pairs on the oxygen atoms in the increased electron density of the ring making the 
arylamine relatively more nucleophilic led to the increase in the yield. 
Table 11: Products of photoredox reaction of allenamide 304 with different arylamines 
 
Entry Nucleophile Product Yield (%) 
1 
 
 
180 
 
399 
53 
2 
 
 
184 
 
400 
57 
3 
 
 
192 
 
401 
45 
4 
 
 
194 
 
402 
49 
124 
 
5 
 
 
198 
 
403 
46 
6 
 
 
202 
 
404 
51 
7 
 
 
204 
 
405 
53 
 
The reaction was also carried out on a range of different allenamides to investigate the 
generality of the reaction using the same arylamine, 2,4-dimethylaniline (184). Allenamides 
268, 390 and 392 gave the N,N′-aminal product with exo-methylene group 406, 407 and 408 
with the yield 54%, 41% and 43%, respectively as shown in Table 12. 
Table 12: Photoredox reaction products with different allenamides 
Entry Allenamide Product Yield (%) 
1 
 
268 
 
406 
54 
125 
 
2 
 
390 
 
407 
41 
3 
 
392 
 
408 
43 
Allenamide 268 reacted with 4-bromo-2-fluoroaniline 198 and gave the adduct product 409 
with 42% isolated yield (Scheme 110). 
 
Attempt was also made to investigate the stereoselectivity of the reaction by using chiral 
allenamides 384 and 386.  We started with (S)-4-benzyl-3-(propa-1,2-dien-1-yl)oxazolidin-2-
one 384, adduct product of the β,γ-addition was obtained 410 with the isolated yield of 41% 
(Scheme 111). 
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The structure of the product obtained from the reaction of 384 with 184 was determined using 
1H NMR, HMQC and NOE experiments.  Analysis of the spectroscopic data confirmed the 
structure to be as shown. The NOE experiments showed a strong interaction (enhancement) 
between the hydrogen atom on the α-carbon (δ 6.38 ppm) and the hydrogen atom (δ 4.28 
ppm) on carbon bearing the carbonyl groups of the malonate moiety when the hydrogen at δ 
6.38 ppm was energized indicating that the two hydrogen atoms are on the same side of the 
C=C double bond adjacent to the nitrogen atom of the ring (Figure 17). Hence, the product is 
the Z-isomer. Similarly, chiral allenamide 386 reacted to give the adduct product 411 in the 
same way allenamide 384 reacted.  386 gave product 411 in isolated yield of 50%. 
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The mechanism of the reaction is presumed to be similar to that of the photoredox reactions 
of the enamide as described in Scheme 67.  The product outcome observed in Scheme 106 
results from addition of electrophilic diethyl malonate radical 157 to the central allenic 
carbon of the allenamide 304 to give the radical 412, this radical is then oxidized by losing an 
electron to either the triethylaminium radical ion 231 or the reduced form of the photoredox 
catalyst to afford the conjugated N-acyl iminium ion 398. This is followed by addition of the 
nucleophile to either the α- or γ-position of the resultant conjugated N-acyl iminium ion 
species 398 (Scheme 112) leading to the observed products 415 or 416, respectively.  This 
approach therefore has the potential to open new opportunities in the application of 
allenamides in complex and total synthesis, outside of these classical activation pathways in 
which the nucleophile attacks only the γ-carbon. 
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However, when carbon nucleophiles were used in this reaction, the desired adduct products 
were not obtained.  For instance, when N-methyl-indole 417 was used, adduct product 418 
was not isolated instead compounds 419 and 420 were obtained.  Similarly, 1,3,5-
trimethoxybenzene did not give the adduct product from the reaction. (Scheme 113) 
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CHAPTER FIVE 
5.0 Future Work 
The important impediments associated with the chemical industries are the exhaustion and 
nonrenewal of fossil fuels, and the global warming. The search for clean, renewable and 
environmentally friendly energy source[4,6] in the preparation of valuable synthetic building 
blocks and biologically important molecules has become essential. In this endeavour, 
photocatalysis using visible light represents a unique strategy because of its inherent “green 
chemistry” features.[40] 
5.1 Enamides 
The vast majority of biologically active molecules and pharmaceutical compounds contain 
nitrogen heterocycles.[126] The photoredox catalysed β-alkylation-α-amination of enamides 
had been developed and used to prepare many varieties of N-acyl-N,N’-aminals compounds 
which have also been cyclized into γ-lactams.  These are compounds that contain nitrogen 
heterocycles. More analogues of these aminals and their corresponding γ-lactams need to be 
prepared to build a library and for biological testing that was the driving for the research 
project. 
The reaction protocol can further be extended by varying the substituent groups around the 
enamides and using substituted malonate 422 to generate quaternary centres.  Future work 
could also be done on the cyclized products, the γ-lactams, such as decarboxylation (Scheme 
114). 
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The application of this newly developed synthetic route could be exploited in the synthesis of 
lamellarins 434 (Scheme 115).  Lamellarin alkaloids are a family of marine natural products 
that contain a pyrrolo[2,1-a]isoquinoline core.  They were found to exhibit a wide spectrum 
of biological activities.[127] 
The main steps in the lamellarin alkaloid shown in the scheme 115 below are the preparation 
of the enamide 430 and the subsequent photoredox catalysed β-alkylation of the enamide 
using diethyl bromomalonate as the alkylating agent (Scheme 115, steps c and d) to obtain 
the product 431 that can be cyclized to the γ-lactam containing product 432.  Since this 
reaction procedure tolerates many functional groups, it should be possible to achieve. 
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5.2 Allenamides 
Addition reaction of allenamides using the photoredox catalysed electrophilic malonate 
radical activation of the central β-carbon of the allenamide with the formation of a conjugated 
N-acyliminium and its subsequent trapping arylamine nucleophiles is a unique and novel 
synthetic method in engaging allenamides in photoredox reactions. The outcome of this 
addition reaction was the formation of N,N′-aminals with exo-methylene group or double 
bond substituted enamides. 
This approach therefore has the potential to open new opportunities in the application of 
allenamides in complex and total synthesis, outside of these classical activation pathways in 
which the nucleophile attacks only the γ-carbon. 
For example, the N,N’-aminal products can be cyclized to give fully substituted lactams like 
the addition product of the enamides. The advantage of the exo-methylene double bond can 
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also be taken in synthesis.  The use and transformation of the enamides has just been 
described, therefore the second group of the products from the addition reactions of 
allenamides can also be subjected to the same reactions to give rise to the synthesis of 
complex natural products. 
 
In this project we examined the addition of bromomalonate to enamides and allenamides. 
Masson has already demonstrated[83,128] the addition of CF3 radical equivalents to enamides, 
and it therefore follows by analogy that similar CF3 additions to allenamides could be 
accomplished (scheme 110). This would greatly expand this chemistry and give a method for 
the addition of the CF3 group to the central allenic carbon of the allenamide which is not 
currently possible using current electrophilic activation methods. 
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CHAPTER SIX 
6.0 Experimental 
All reactions were carried out using commercially available reagents and solvents throughout 
without further purification, except dichloromethane (CH2Cl2) and triethylamine (Et3N) 
which were dried using 4Ǻ molecular sieve.  DMSO and acetonitrile were purchased dry 
from commercial suppliers.  Light petroleum refers to the fraction with bp 40-60 °C.  Thin 
layer chromatography was carried out on Merck Kieselgel 60 GF254 aluminum foil backed 
plates.  The plates were visualized under UV light or with vallinin stain.  Flash 
chromatography was carried out using Merck Kieselgel 60H silica or Matrix silica 60, with 
the eluent as specified in the individual syntheses.  IR spectra were recorded using Perkin 
Elmer FTIR Spectrometer (Paragon 100) as solutions in CH2Cl2, unless otherwise stated.  
1H 
and 13C NMR spectra were recorded using Bruker 400 MHz NMR machine and a JEOL 
ECS-400 MHz NMR machine; chemical shifts are quoted in ppm and coupling constants, J, 
are quoted in Hz; chloroform-d was used throughout unless otherwise stated. 13C-NMR 
spectra are recorded without 19F decoupling.  For compounds containing fluorine line values 
are reported as multiplet signals could not easily be identified. High and low resolution mass 
spectra were carried out on a Thermofisher exactive (orbi) resolution mass spectrometer.  All 
crystal data were measured using a Bruker APEX 2 CCD diffractometer equipped with Mo-
Kα radiation (λ = 0.71073 Å) at 150K, except otherwise stated, with the assistance of Dr. 
Mark J. Elsegood. 
Synthetic Procedures 
N-(Ethenyl)-oxazolidin-2-one (117) 
 
Step 1: Preparation of Intermediate N-(1-ethoxylethyl)-2-oxazolidinone (161) 
A mixture of 2-oxazolidinone 114 (2.05 g, 23.4 mmol), acetaldehyde diethyl acetal (33 mL, 
0.23 mol) and DL-camphorsulfonic acid (0.27 g, 1.17 mmol) was heated for 21 h at 55 °C. 
135 
 
After cooling, aq. NaHCO3 (15 mL) was added and the reaction mixture extracted with Et2O 
(3×10 mL). The organic layer was washed with brine and dried over MgSO4 and filtered. 
Removal of solvent yielded crude N,O-acetal used without further purification (3.65 g, 98%). 
1H-NMR (400 MHz, CDCl3) δ 5.12 (q, J = 6.0 Hz, 1H), 4.27 (dd, J = 13.0, 8.0 Hz, 2H), 3.46 
(t, J = 8.0 Hz, 2H), 3.39 (dd, J = 12.4, 7.0 Hz, 2H), 1.26 (d, J = 6.2 Hz, 3H), 1.09 (t, J = 7.2 
Hz, 3H).  This is in agreement with literature.[67] 
Step 2: Preparation of N-vinyl-2-oxazolidinone (117) 
To a cooled solution (0 °C) of crude N,O-acetal (3.72 g, 23.4 mmol) in anhydrous CH2Cl2 
under nitrogen (22 mL) were dropwise added distilled NEt3 (4.9mL, 37.7mmol) and, 
trimethylsilyl triflate (5.5 mL, 30.4 mmol). After slow return to room temperature and stirring 
for 16 h, the mixture was filtered through basic alumina. Removal of solvent and purification 
by filtration (silica gel 4/1; ether) yielded enamide 117 as a pale yellow oil (2.02 g, 76%). 1H-
NMR (400 MHz, CDCl3) δ 6.77 (dd, J = 15.9, 8.9 Hz, 1H), 4.39 (d, J = 9.5 Hz, 1H), 4.36 (t, J 
= 8.2 Hz, 2H), 4.23 (d, J = 15.7 Hz, 1H), 3.65 (t, J = 8.2 Hz, 2H) ppm.  13C-NMR (100Mz, 
CDCl3) δ 155.44, 129.69, 93.50, 62.39, 41.91; HRMS [M+H] calculated for C5H8NO2 
114.0550 found 114.0550.  This agreed with literature.[67] 
(E)-N-(Hex-1-en-1-yl)-oxazolidin-2-one (171) 
 
The procedure reported by Liu and Floreancig[78] was used for the synthesis of E-vinyl 
oxazolidinones: A solution of 2-oxazolidinone (0.91 g, 10.5mmol), hexanal (1.2 mL, 
10.0mmol) and pyridinium p-toluenesulfonate (0.25 g, 1.0mmol) in toluene (50 mL) was 
heated at reflux in a 100 mL round bottom flask fitted with a Dean-Stark apparatus to trap 
water overnight. After the completion of the reaction, upon disappearance of the starting 
material monitored via TLC, the reaction mixture was allowed to cool to room temperature 
and concentrated in vacuo. Further purification was performed using silica gel flash column 
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chromatography (hexane/EtOAc 7:3) to afford the product 171 as a pale yellow oil (0.868g, 
5.14 mmol). Yield 52%. 1H-NMR (400 MHz, CDCl3) δ 6.56 (d, J = 14.4 Hz, 1H), 4.81-4.70 
(m, 1H), 4.36 (t, J = 8.0 Hz, 2H), 3.63 (t, J = 8.0 Hz, 2H), 2.00 (q, J = 7.1 Hz, 2H), 1.36-1.18 
(m, 4H), 0.83 (t, J = 6.6 Hz, 3H) ppm; 13C-NMR (100 MHz, CDCl3) δ 155.53, 123.74, 
111.43, 62.22, 42.68, 32.23, 29.50, 22.09, 13.93 ppm; HRMS [M+Na] Calculated for 
C9H15NO2Na 192.0995, found 192.0995. 
(S)-4-Benzyl-3-vinyloxazolidin-2-one (169) 
 
Step 1: Preparation of Intermediate (S)-4-Benzyl-3-(1-ethoxylethyl)-2-oxazolidinone 
(168) 
A mixture of S-(-)-4-benzyl-2-oxazolidinone 167 (1.77g, 10 mmol), acetaldehyde diethyl 
acetal (14.1 mL, 100 mmol) and DL-camphorsulfonic acid (0.115g, 0.5 mmol) was placed in a 
50 mL round bottom flask and heated for 3 hours at 55 °C. After cooling and dilution with 
Et2O (40 mL), saturated aqueous NaHCO3 solution (10 mL) was added and the organic phase 
separated from the mixture.  The organic phase was then washed with brine (10 mL) and 
dried over MgSO4 and filtered.  Removal of solvent yielded a crude N,O-acetal which was 
used in the second step without further purification. (S)-4-benzyl-3-(1-Ethoxyethyl)-
oxazolidin-2-one 168 was obtained as a colourless oil. 
Step 2: Preparation of (4S)-4-Benzyl-3-vinyl-2-oxazolidinone (169) 
To a cooled solution (0 °C) of crude N,O-acetal 2 (10 mmol) in anhydrous CH2Cl2 (10 mL) 
was added under nitrogen distilled Et3N (15 mmol), then dropwise, TMSOTf (13 mmol). 
After slowly warming to r.t. and stirring for 18 h, the mixture was treated with basic alumina 
to remove the excess of TMSOTf. After removal of the solvent, the residue was filtered 
through silica gel (Et2O) to remove the ammonium triflate salts and was purified by flash 
chromatography. The chromatographic purification (silica gel; cyclohexane-EtOAc, 7:3) 
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afforded the product 169 (S)-4-benzyl-3-vinyl-2-oxazolidinone (0.93 g, 90%) as a colourless 
viscous oily liquid. Rf 0.37 (Hexane-EtOAc, 7:3).  
1H-NMR (400 MHz, CDCl3) δ 7.40-7.03 
(m, 5H), 6.80 (ddd, J = 16.4, 9.0, 2.8 Hz, 1H), 4.65-4.42 (m, 2H), 4.37-3.96 (m, 3H), 3.18 (d, 
J = 14.0 Hz, 1H), 2.77 (ddd, J = 13.8, 8.7, 2.7 Hz, 1H) ppm; 13C-NMR (100 MHz, CDCl3) δ 
155.18, 135.31, 129.42, 129.04, 128.90, 127.42, 94.22, 66.61, 54.42, 35.89 ppm; HRMS 
[M+H] calculated for C12H14NO2 204.1016, found 204.1019. 
N-(Propa-1,2-dien-1-yl)-2-oxazolidinone (304) 
 
A 100 mL round bottom flask was equipped with a magnetic stir bar and filled with argon to 
evacuate air.  The flask was then charged with 2-oxazolidinone 114 (0.871 g, 10.0 mmol) in 
dry DMSO (20 mL) under an argon atmosphere and t-BuOK (1.683 g, 15.0 mmol) added, 
sealed with a rubber septum and filled with argon to provide an inert atmosphere.  The 
mixture was stirred for 1 hour at room temperature.  To this mixture was added propargyl 
bromide (1.25 mL, 80% solution in toluene, 11.0 mmol) dropwise over 40 minutes using 
syringe pump.  After the addition was complete, the mixture was stirred at room temperature 
overnight under argon.  The reaction mixture was then diluted with distilled water (50 mL) 
and extracted with EtOAc (3 × 50 mL).  The combined organic extracts were washed with 
water (2 × 50 mL) and finally with brine (30 mL) to remove the residual DMSO that might 
still be present.  The organic extracts were dried over Na2SO4, filtered and the solvent 
removed under vacuum. The crude reaction product was then purified by filtration through a 
pad of silica (EtOAc:/petroleum ether, 1:1) to afford the product 304 as a pale yellow solid 
(0.90 g, 72%).  1H-NMR  (400 MHz, CDCl3) δ 6.84 (t, J = 6.4 Hz, 1H), 5.41 (d, J = 6.2 Hz, 
2H), 4.39 (t, J = 8.2 Hz, 2H), 3.58 (t, J = 8.2 Hz, 2H) ppm; 13C-NMR (100 MHz, CDCl3) δ 
201.47, 155.38, 97.02, 87.98, 62.37, 43.17 ppm; HRMS [M+H] Calculated for C6H8NO2 
126.0549 found 126.0550. 
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(S)-4-benzyl-3-(propa-1,2-dien-1-yl)oxazolidin-2-one (384) 
 
A 100mL round bottom flask was equipped with a magnetic stir bar and filled with argon to 
evacuate air.  The flask was then charged with (S)-4-benzyloxazolidin-2-one 167 (1.77 g, 
10.0 mmol) in dry DMSO (20 mL) under an argon atmosphere and t-BuOK (1.68 g, 15.0 
mmol) added, sealed with a rubber septum and filled with argon to provide an inert 
atmosphere.  The mixture was stirred for 1 h at room temperature.  To this mixture was added 
propargyl bromide (1.25 mL, 80% solution in toluene, 11.0 mmol) dropwise over 40 minutes 
using syringe pump.  After the addition was complete, the mixture was stirred at room 
temperature overnight under argon.  The reaction mixture was then diluted with distilled 
water (50 mL) and extracted with EtOAc (3 × 50 mL).  The combined organic extracts were 
washed with water (2 × 50 mL) and finally with brine (30 mL) to remove the residual DMSO 
that might still be present.  The organic extracts were dried over MgSO4, filtered and the 
solvent removed under vacuum. The crude reaction product was then purified by filtration 
through a pad of silica (EtOAc:/petroleum ether, 1:1) to afford the product 384 as pale-yellow 
liquid (oil) (1.08 g, 51%). 1H-NMR (400 MHz, CDCl3) δ 7.35-7.23 (m, 3H), 7.15 (d, J = 7.0 
Hz, 2H), 6.89 (t, J = 6.6 Hz, 1H), 5.53 (ddd, J = 26.6, 10.1, 6.4 Hz, 2H), 4.23 (t, J = 8.4 Hz, 
1H), 4.17-4.05 (m, 2H), 3.24 (dd, J = 13.8, 3.1 Hz, 1H), 2.72 (dd, J = 13.8, 8.9 Hz, 1H) ppm; 
13C-NMR (100 MHz, CDCl3) δ 201.69, 155.06, 135.46, 129.38, 129.01, 127.38, 96.04, 88.07, 
66.73, 55.72, 37.22 ppm; IR ʋ (cm-1) 3056, 2987, 1754, 1410, 1235, 1094, 1030;  HRMS 
[M+Na] Calculated for C13H13NO2Na 238.0838 found 238.0848. 
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(S)-4-isopropyl-3-(propa-1,2-dien-1-yl)oxazolidin-2-one (386) 
 
A 100mL round bottom flask was equipped with a magnetic stir bar and filled with argon to 
evacuate air.  The flask was then charged with (S)-4-isopropyloxazolidin-2-one 385 (1.29 g, 
10.0 mmol) in dry DMSO (20 mL) under an argon atmosphere and t-BuOK (1.68 g, 15.0 
mmol) added, sealed with a rubber septum and filled with argon to provide an inert 
atmosphere.  The mixture was stirred for 1 hour at room temperature.  To this mixture was 
added propargyl bromide (1.25 mL, 80% solution in toluene, 11.0 mmol) dropwise over 40 
minutes using syringe pump.  After the addition was complete, the mixture was stirred at 
room temperature overnight under argon.  The reaction mixture was then diluted with 
distilled water (50 mL) and extracted with EtOAc (3 × 50 mL).  The combined organic 
extracts were washed with water (2 × 50 mL) and finally with brine (30 mL) to remove the 
residual DMSO that might still be present.  The organic extracts were dried over MgSO4, 
filtered and the solvent removed under vacuum. The crude reaction product was then purified 
by filtration through a pad of silica (EtOAc:/petroleum ether, 1:1) to afford product 386 as a 
pale-yellow liquid (oil) (1.00 g, 60%).  1H-NMR (400 MHz, CDCl3) δ 6.75 (t, J = 6.4 Hz, 
1H), 5.34 (ddd, J = 25.2, 10.0, 6.5 Hz, 2H), 4.22 (t, J = 8.9 Hz, 1H), 4.13 (q, J = 4.4 Hz, 1H), 
3.83-3.76 (m, 1H), 2.31-2.21 (m, 1H), 0.80 (dd, J = 11.9, 7.0 Hz, 6H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 201.40, 155.50, 95.69, 87.61, 63.12, 58.90, 26.97, 17.70, 13.79 ppm; IR ʋ 
(cm-1) 2968, 1749, 1409, 1138, 1009; HRMS [M+Na] Calculated for C9H13NO2Na190.0838 
found 190.0848. 
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1-(Propa-1,2-dien-1-yl)pyrrolidin-2-one (268) 
 
A 100mL round bottom flask was equipped with a magnetic stir bar and filled with argon to 
evacuate air.  The flask was then charged with pyrrolidin-2-one 265 (0.851 g, 10.0 mmol) in 
dry DMSO (20 mL) under an argon atmosphere and t-BuOK (1.68 g, 15.0 mmol) added, 
sealed with a rubber septum and filled with argon to provide an inert atmosphere.  The 
mixture was stirred for 1 h at room temperature.  To this mixture was added propargyl 
bromide (1.25 mL, 80% solution in toluene, 11.0 mmol) dropwise over 40 minutes using 
syringe pump.  After the addition was complete, the mixture was stirred at room temperature 
overnight under argon.  The reaction mixture was then diluted with distilled water (50 mL) 
and extracted with EtOAc (3 × 50 mL).  The combined organic extracts were washed with 
water (2 × 50 mL) and finally with brine (30 mL) to remove the residual DMSO that might 
be still present.  The organic extracts were dried over MgSO4, filtered and the solvent 
removed under vacuum. The crude reaction product was then purified by filtration through a 
pad of silica (EtOAc:/petroleum ether, 1:1) to afford product 268 as a pale yellow liquid (oil), 
(0.75 g, 61%).  1H-NMR (400 MHz, CDCl3) δ 6.96 (t, J = 6.4 Hz, 1H), 5.27 (d, J = 6.2 Hz, 
2H), 3.30 (t, J = 7.2 Hz, 2H), 2.35 (t, J = 8.2 Hz, 2H), 2.03-1.91 (m, 2H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 202.68, 172.98, 95.80, 86.63, 45.76, 31.21, 17.43 ppm; IR ʋ (cm-1) 3018, 
1747, 1682, 1415, 1216, 1021; HRMS [M+H] Calculated for C7H10NO 124.0757 found 
124.0765. 
1-(Propa-1,2-dien-1-yl)piperidin-2-one (390) 
 
A 100mL round bottom flask was equipped with a magnetic stir bar and filled with argon to 
evacuate air.  The flask was then charged with piperidin-2-one 389 (0.99 g, 10.0 mmol) in dry 
DMSO (20 mL) under an argon atmosphere and t-BuOK (1.68 g, 15.0 mmol) added, sealed 
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with a rubber septum and filled with argon to provide an inert atmosphere.  The mixture was 
stirred for 1 hour at room temperature.  To this mixture was added propargyl bromide (1.25 
mL, 80% solution in toluene, 11.0 mmol) dropwise over 40 minutes using syringe pump.  
After the addition was complete, the mixture was stirred at room temperature overnight under 
argon.  The reaction mixture was then diluted with distilled water (50 mL) and extracted with 
EtOAc (3 × 50 mL).  The combined organic extracts were washed with water (2 × 50 mL) 
and finally with brine (30 mL) to remove the residual DMSO that might be still present.  The 
organic extracts were dried over MgSO4, filtered and the solvent removed under vacuum. The 
crude reaction product was then purified by filtration through a pad of silica 
(EtOAc:/petroleum ether, 1:1) to afford product 390 as a pale yellow liquid (oil), (0.93 g, 
68%).  1H-NMR (400 MHz, CDCl3) δ 7.57 (t, J = 6.6 Hz, 1H), 5.34 (d, J = 6.6 Hz, 2H), 3.27 
(t, J = 6.0 Hz, 2H), 2.42 (t, J = 6.4 Hz, 2H), 1.80 (d, J = 42.8 Hz, 4H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 202.34, 168.20, 99.04, 87.07, 46.06, 32.81, 22.68, 21.06 ppm; IR ʋ (cm-1) 
3056, 2953, 1717, 1638, 1414, 1267, 1019; HRMS [M+H] Calculated for C8H12NO 138.0913 
found 138.0921. 
1-(Propa-1,2-dien-1-yl)azepan-2-one (392) 
 
A 100mL round bottom flask was equipped with a magnetic stir bar and filled with argon to 
evacuate air.  The flask was then charged with ε-caprolactam 391 (1.13 g, 10.0 mmol) in dry 
DMSO (20 mL) under an argon atmosphere and t-BuOK (1.68 g, 15.0 mmol) added, sealed 
with a rubber septum and filled with argon to provide an inert atmosphere.  The mixture was 
stirred for 1 hour at room temperature.  To this mixture was added propargyl bromide (1.25 
mL, 80% solution in toluene, 11.0 mmol) dropwise over 45 minutes using a syringe pump.  
After the addition was complete, the mixture was stirred at room temperature overnight under 
argon.  The reaction mixture was then diluted with distilled water (50 mL) and extracted with 
EtOAc (3 × 50 mL).  The combined organic extracts were washed with water (2 × 50 mL) 
and finally with brine (30 mL) to remove the residual DMSO that might be still present.  The 
organic extracts were dried over MgSO4, filtered and the solvent removed under vacuum. The 
crude reaction product was then purified by filtration through a pad of silica 
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(EtOAc:/petroleum ether, 1:1) to afford product 392 as a pale-yellow liquid (oil), (1.31 g, 
87%).  1H-NMR (400 MHz, CDCl3) δ 7.37 (t, J = 6.6 Hz, 1H), 5.30 (d, J = 6.2 Hz, 2H), 3.41 
(t, J = 4.9 Hz, 2H), 2.53 (t, J = 5.6 Hz, 2H), 1.75-1.52 (m, 6H) ppm; 13C-NMR (100 MHz, 
CDCl3) δ 201.58, 173.89, 99.57, 87.39, 46.05, 37.22, 29.67, 27.68, 23.47 ppm; IR ʋ (cm-1) 
3043, 2931, 2857, 1958, 1736, 1719, 1215, 1082, 973; HRMS [M+H] Calculated for 
C9H14NO 152.1070 found 152.1053. 
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Procedure for the photoredox synthesis with ethanol: 
Diethyl 2-(2-ethoxy-2-(2-oxooxazolidin-3-yl)ethyl)malonate (177) 
 
An oven dried 50 mL round bottom flask was filled with argon gas and charged with iridium 
photocatalyst (14 mg, 0.015 mmol) and anhydrous acetonitrile (10 mL) and seal with a rubber 
septum.  The flask was evacuated of air and filled again with argon on a Schlenk line.  N-
Vinyl-2-oxazolidinone 117 (0.11 g, 1.0 mmol), diethyl bromomalonate (0.40 mL, 2.0 mmol), 
trimethylamine TEA (0.28 mL, 2.0 mmol) and ethanol (0.59 mL, 10.0 mmol) were added in 
that order to the solution in the flask under argon atmosphere.  The flask was then irradiated 
with a Kessil blue light overnight for 16 hours with stirring at room temperature. 
After the reaction has completed as monitored by TLC, the solvent was removed under a 
reduced pressure to obtain the crude product.  The crude product was purified by flash 
chromatography on silica gel (hexane-EtOAc 4:1 to 1:1) to afford the product 177 as a pale 
yellow liquid (0.21 g, 66%); 1H-NMR (400 MHz, CDCl3) δ 5.06 (dd, J = 7.8, 5.8 Hz, 1H), 
4.45-4.23 (m, 2H), 4.23-4.03 (m, 4H), 3.61-3.30 (m, 5H), 2.41-2.22 (m, 1H), 2.22-2.04 (m, 
1H), 1.29-1.18 (m, 6H), 1.18-1.08 (m, 3H) ppm; 13C-NMR (100 MHz, CDCl3) δ 168.84, 
158.17, 81.67, 64.27-63.71, 62.50, 61.78, 48.67, 38.76, 32.04, 15.10-14.54, 14.07 ppm; 
HRMS [M+H] Calculated for C14H24NO7 318.1541 found 318.1547. 
General procedure for the photoredox syntheses with arylamines: An oven dried 50 mL 
three neck round bottom flask was filled with argon gas and charged with iridium 
photocatalyst (1.5mol%) enamide or allenamide (1.0 eq) and anhydrous acetonitrile (~ 0.1M) 
and seal with a rubber septum in the middle neck and the other two necks closed with glass 
stoppers.  The flask was purged again with argon while one neck was opened. The middle 
neck was then fitted with an argon filled balloon.   Diethyl bromomalonate (2.0 eq), 
trimethylamine TEA (2.0 eq) and arylamine (5.0 eq) were added in that order to the solution 
in the flask under the argon atmosphere.  The flask was then irradiated with a Kessil blue 
light (λ = 467 nm) for 3 hours with stirring at room temperature.  After the reaction had 
completed as monitored by TLC, the solvent was removed under reduced pressure to obtain 
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the crude product.  The crude product was purified by flash chromatography on silica gel 
(hexane-EtOAc 4:1) to afford the product. 
Diethyl 2-(2-(2-oxooxazolidin-3-yl)-2-(phenylamino)ethyl)malonate (179) 
 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 179 as pale yellow liquid (0.26 g, 72%). 1H-NMR (400 MHz, CDCl3) δ 
7.18 (t, J = 8.0 Hz, 2H), 6.78 (t, J = 7.8 Hz, 1H), 6.65 (d, J = 8.7 Hz, 2H), 5.37 (t, J = 7.2 Hz, 
1H), 4.44 (t, J = 8.0 Hz, 1H), 4.26-4.13 (m, 5H), 3.63 (t, J = 7.8 Hz, 1H), 3.53 (t, J = 6.6 Hz, 
1H), 3.45 (dd, J = 14.6, 8.4 Hz, 1H), 3.36 (q, J = 8.5 Hz, 1H), 2.55-2.43 (m, 1H), 2.38-2.28 
(m, 1H), 1.24 (dt, J = 18.5, 7.0 Hz, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.37, 169.03, 
157.84, 144.34, 129.70, 119.30, 113.57, 65.01, 62.61, 62.35, 62.16, 62.05, 49.09, 40.65, 
39.26, 32.22, 14.07 ppm; IR ʋ (cm-1) 3357, 2983, 2956, 1736, 1708, 1601,1520, 1499, 1460, 
1386, 1368, 1325, 1291, 1251, 1093.  HRMS [M+H] calculated for C18H25N2O6 365.1707 
found 365.1701 
Diethyl 2-(2-(2-oxooxazolidin-3-yl)-2-(p-tolylamino)ethyl)malonate (181) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 181 as white solid substance (0.32 g, 84%) and it was recrystallized 
(CH2Cl2-Hexane 1:1) to give colourless crystals.  
1H-NMR (400 MHz, CDCl3) δ 6.98 (d, J = 
7.8 Hz, 2H), 6.56 (d, J = 8.2 Hz, 2H), 5.34 (q, J = 7.7 Hz, 1H), 4.24-4.07 (m, 6H), 3.53 (t, J = 
6.6 Hz, 1H), 3.44 (td, J = 8.5, 6.2 Hz, 1H), 3.34 (q, J = 8.5 Hz, 1H), 2.53-2.43 (m, 1H), 2.37-
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2.28 (m, 1H), 2.21 (s, 3H), 1.25 (dt, J = 16.6, 7.1 Hz, 6H) ppm;  13C-NMR (400 MHz, 
CDCl3) δ 169.38, 169.07, 157.88, 141.93, 130.17, 128.56, 113.68, 62.83, 62.35, 62.13, 62.03, 
49.10, 39.27, 32.22, 20.50, 14.29 ppm;  IR ʋ (cm-1) 3357, 2984, 2918, 1748, 1737, 1706, 
1616, 1517, 1414, 1368, 1251, 1218 1178, 1082, 1008;  HRMS [M+H] calculated for 
C19H27N2O6 379.1864, found 379.1862. 
Diethyl 2-(2-(2-oxooxazolidin-3-yl)-2-(m-tolylamino)ethyl)malonate (183) 
 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 183 as pale yellow oil (0.33 g, 88%). 1H-NMR (400 MHz, CDCl3) δ 7.06 
(t, J = 7.6 Hz, 1H), 6.59 (d, J = 7.4 Hz, 1H), 6.46 (dd, J = 10.7, 2.1 Hz, 2H), 5.36 (q, J = 7.7 
Hz, 1H), 4.25-4.07 (m, 8H), 3.52 (t, J = 6.8 Hz, 1H), 3.44 (td, J = 8.4, 6.5 Hz, 1H), 3.36 (q, J 
= 8.5 Hz, 1H), 2.54-2.40 (m, 1H), 2.40-2.27 (m, 1H), 2.24 (s, 3H), 1.24 (dt, J = 17.2, 7.1 Hz, 
6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.36, 169.06, 157.83, 144.38, 139.54, 129.57, 
120.18, 114.42, 110.58, 62.35, 62.14, 62.03, 49.08, 39.27, 32.22, 21.65, 14.07 ppm;  IR ʋ 
(cm-1) 3366, 2980, 1738, 1704, 1607, 1528, 1367, 1249, 1217, 1125, 1080; HRMS [M+H] 
calculated for C19H27N2O6 379.1864, found 379.1861. 
Diethyl 2-(2-((2,4-dimethylphenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (185) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 185 as a pale yellow oil (0.35 g, 91%).  1H-NMR (400 MHz, CDCl3) δ 
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6.89 (t, J = 7.6 Hz, 2H), 6.58 (d, J = 8.2 Hz, 1H), 5.39 (q, J = 7.6 Hz, 1H), 5.23 (q, J = 6.0 
Hz, 0H), 4.41-4.29 (m, 1H), 4.27-4.08 (m, 6H), 3.99 (d, J = 8.2 Hz, 1H), 3.60-3.41 (m, 4H), 
3.26 (dd, J = 17.3, 7.8 Hz, 1H), 2.60-2.50 (m, 1H), 2.40-2.30 (m, 1H), 2.20 (s, 3H), 2.09 (s, 
3H), 1.25 (dt, J = 16.5, 7.2 Hz, 6H) ppm;  13C-NMR (100 MHz, CDCl3) δ 169.54, 169.13, 
157.79, 139.93, 131.36, 128.06, 127.97, 122.23, 111.37, 62.57, 62.33, 62.12, 62.04, 49.11, 
39.17, 38.62, 32.13, 20.42, 19.32, 17.47, 15.08, 14.08 ppm;  IR ʋ (cm-1) 3337, 1743, 1722, 
1621, 1589, 1300, 1243, 1183, 1080, 1028; HRMS [M+H] calculated for C20H29N2O6 
393.2020, found 393.2018. 
Diethyl 2-(2-(mesitylamino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (187) 
 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 187 as yellow oil (0.26 g, 64%). 1H-NMR (400 MHz, CDCl3) δ 6.76 (s, 
2H), 4.94 (t, J = 7.4 Hz, 1H), 4.25-4.08 (m, 6H), 3.62 (t, J = 7.2 Hz, 1H), 3.48-3.38 (1H), 
3.28 (q, J = 8.4 Hz, 1H), 2.70-2.57 (m, 1H), 2.57-2.44 (m, 1H), 2.27-2.20 (6H), 2.18 (s, 3H), 
1.30-1.21 (m, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.30, 169.14, 157.39, 139.28, 
132.01, 129.96, 129.20, 66.77, 62.28, 61.89, 49.41, 43.28, 32.50, 20.60, 18.71, 14.10 ppm; IR 
ʋ (cm-1) 3368, 2981, 1726, 1483, 1444, 1391, 1370, 1275, 1260, 1096, 1028; HRMS [M+H] 
calculated for C21H31N2O6 407.2177, found 407.2156. 
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Diethyl 2-(2-((2,6-dimethylphenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (189) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 189 as a pale yellow oil (0.23 g, 60%).  1H-NMR (400 MHz, CDCl3) δ 
6.94 (d, J = 7.4 Hz, 2H), 6.81 (t, J = 7.6 Hz, 1H), 5.22 (q, J = 6.0 Hz, 1H), 5.00 (s, 1H), 4.25-
4.06 (m, 7H), 3.63 (t, J = 7.0 Hz, 1H), 3.41 (q, J = 7.7 Hz, 1H), 3.27 (q, J = 8.4 Hz, 1H), 
2.69-2.59 (m, 1H), 2.57-2.48 (m, 1H), 2.29-2.24 (6H), 1.30-1.22 (m, 6H) ppm;  13C-NMR 
(100 MHz, CDCl3) δ 169.29, 169.12, 157.33, 141.90, 129.35, 129.05, 122.65, 66.52, 62.28, 
61.92, 49.37, 43.29, 32.53, 18.85, 14.11 ppm;  IR ʋ (cm-1) 2981, 2359, 2341, 2253, 1739, 
1594, 1558, 1445, 1372, 1247, 1099, 1030; HRMS [M+H] calculated for C20H29N2O6 
393.2020, found 393.2017. 
Diethyl 2-(2-(2-oxooxazolidin-3-yl)-2-((3-(trifluoromethyl)phenyl)amino)ethyl)malonate 
(191) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 191 as a yellow liquid (0.21 g, 97%).  1H-NMR (400 MHz, CDCl3) δ 7.29 
(t, J = 7.8 Hz, 1H), 7.01 (d, J = 7.8 Hz, 1H), 6.85 (t, J = 8.0 Hz, 2H), 5.39 (q, J = 7.6 Hz, 1H), 
4.55 (d, J = 8.2 Hz, 1H), 4.29-4.11 (m, 6H), 3.53 (t, J = 6.8 Hz, 1H), 3.50-3.41 (m, 1H), 3.37 
(q, J = 8.4 Hz, 1H), 2.56-2.45 (m, 1H), 2.40-2.29 (m, 1H), 1.27 (t, J = 7.2 Hz, 3H), 1.22 (t, J 
= 7.2 Hz, 3H) ppm;  13C-NMR (100 MHz, CDCl3) δ 169.29, 168.94, 157.78, 144.76, 130.40, 
115.98, 115.73, 110.63, 62.45, 62.39, 62.28, 62.17, 49.00, 39.28, 32.01, 14.02 ppm; IR ʋ (cm-
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1) 3366, 2984, 2938, 2360, 1726, 1616, 1599, 1483, 1420, 1248, 1120, 1027.  HRMS [M+Na] 
calculated for C19H23F3N2O6Na 455.1400, found 455.1397. 
Diethyl 2-(2-((3,5-bis(trifluoromethyl)phenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl) 
malonate (193) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 193 as a pale yellow liquid (0.15 g, 61%). 1H-NMR (400 MHz, CDCl3) δ 
7.23 (s, 1H), 7.10 (s, 2H), 5.42 (q, J = 7.4 Hz, 1H), 5.14 (d, J = 7.8 Hz, 1H), 4.32-4.25 (m, 
2H), 4.25-4.11 (m, 5H), 3.58-3.46 (m, 3H), 3.46-3.32 (m, 1H), 2.59-2.47 (m, 1H), 2.43-2.33 
(m, 1H), 1.77 (s, 1H), 1.26 (t, J = 7.0 Hz, 3H), 1.21 (t, J = 7.2 Hz, 3H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 169.21, 168.92, 157.82, 145.70, 135.37, 133.05, 132.71, 132.39, 124.73, 
122.01, 113.01, 112.25, 62.44, 62.37, 62.25,  62.19, 48.90, 39.28, 31.74, 14.00 ppm; IR ʋ 
(cm-1) 3330, 2985, 2360, 1732, 1622, 1526, 1475, 1277, 1134, 1029.  HRMS [M+Na] 
calculated for C20H22F6N2O6Na 523.1274, found 523.1267. 
Diethyl 2-(2-((4-bromophenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (195) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 195 as light brown solid (0.31 g, 70%) which was recrystallized (CH2Cl2-
hexane 1:1) to give colourless crystals. 1H-NMR (400 MHz, CDCl3) δ 7.26 (d, J = 7.4 Hz, 
2H), 6.54 (d, J = 8.7 Hz, 2H), 5.32 (q, J = 7.6 Hz, 1H), 4.32-4.08 (m, 6H), 3.52 (t, J = 6.8 Hz, 
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1H), 3.45 (dd, J = 14.8, 8.7 Hz, 1H), 3.37-3.28 (1H), 2.53-2.43 (m, 1H), 2.37-2.27 (1H), 1.65 
(s, 1H), 1.30-1.20 (6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.29, 168.96, 157.82, 143.39, 
132.47, 115.26, 111.26, 62.55, 62.37, 62.23, 62.13, 49.01, 39.20, 32.05, 14.07 ppm;  IR ʋ 
(cm-1) 3356, 2984, 2917, 1736, 1704, 1593, 1370, 1323, 1250, 1083, 1006; HRMS [M+H] 
calculated for C18H24BrN2O6 443.0812, found 443.0805. 
Diethyl 2-(2-((2-fluorophenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (197) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 197 a pale yellow solid (0.28 g, 75%) which was recrystallized (CH2Cl2-
hexane 1:1) to give colourless crystals. 1H-NMR (400 MHz, CDCl3) δ 7.03-6.89 (m, 2H), 
6.82 (t, J = 8.4 Hz, 1H), 6.76-6.65 (m, 1H), 5.41 (q, J = 7.6 Hz, 1H), 4.42 (d, J = 6.2 Hz, 1H), 
4.30-4.11 (m, 6H), 3.52 (t, J = 7.0 Hz, 1H), 3.49-3.44 (m, 1H), 3.34 (q, J = 8.4 Hz, 1H), 2.59-
2.48 (m, 1H), 2.43-2.33 (m, 1H), 1.32-1.18 (m, 6H) ppm;  13C-NMR (100 MHz, CDCl3) δ 
169.07, 168.91, 157.82, 152.55, 150.17, 132.74, 132.64, 125.25, 118.92, 114.89, 114.71, 
113.79, 62.38, 62.20, 62.07, 49.05, 38.82, 32.09, 14.07 ppm; IR ʋ (cm-1) 3382, 2984, 1724, 
1620, 1519, 1418, 1331, 1258, 1156, 1029; HRMS [M+Na] calculated for C18H23FN2O6Na 
405.1432 Found 405.1430. 
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Diethyl 2-(2-((4-bromo-2-fluorophenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate 
(199) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 199 as a colourless solid. (0.37 g, 79%, M.P. 102.5 – 104.3 oC).  It was 
recrystallized (CH2Cl2-hexane 1:1) to afford colourless crystals. 
1H-NMR (400 MHz, CDCl3) 
δ 7.16-7.08 (m, 2H), 6.72 (t, J = 9.1 Hz, 1H), 5.37 (t, J = 7.4 Hz, 1H), 4.31-4.11 (m, 6H), 
3.54-3.44 (m, 2H), 3.32 (q, J = 8.4 Hz, 1H), 2.58-2.48 (m, 1H), 2.42-2.31 (m, 1H), 1.31-1.20 
(m, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.01, 168.83, 157.82, 152.26, 149.83, 
132.03, 128.13, 127.47, 118.46, 118.25, 114.89, 109.67, 65.02, 62.17, 48.97, 40.67, 38.78, 
31.91, 14.07 ppm; IR ʋ (cm-1)  3020, 2434, 1748, 1514, 1392, 1216, 760; HRMS [M+Na] 
calculated for C18H22BrFN2O6Na 483.0537 Found 483.0519. 
Diethyl 2-(2-((3,4-dichlorophenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (201) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 201 a pale yellow liquid which turned solid upon standing (0.25 g, 58%). 
The solid was recrystallized (CH2Cl2-Hexane 1:1) into colourless crystals.  
1H-NMR (400 
MHz, CDCl3) δ 7.18 (d, J = 8.7 Hz, 1H), 6.75 (d, J = 2.5 Hz, 1H), 6.51 (dd, J = 8.7, 2.9 Hz, 
1H), 5.29 (q, J = 7.6 Hz, 1H), 4.63 (d, J = 8.2 Hz, 1H), 4.29-4.09 (m, 6H), 3.57-3.40 (2H), 
3.34 (q, J = 8.5 Hz, 1H), 2.53-2.39 (1H), 2.39-2.26 (m, 1H), 1.30-1.18 (m, 6H) ppm; 13C-
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NMR (100 MHz, CDCl3) δ 169.16, 168.94, 157.87, 144.17, 133.12, 131.16, 121.95, 115.41, 
112.94, 62.44, 48.92, 39.20, 31.88, 14.06 ppm; IR ʋ (cm-1) 3331, 2984, 1725, 1598, 1370, 
1274, 1259, 1050.  HRMS [M+Na] calculated for C18H22
35Cl2N2O6Na 455.0747 Found 
455.0744. 
Diethyl 2-(2-((2-methoxyphenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (203) 
 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 203 a pale yellow oil which crystallised upon standing (0.30 g, 76%).  The 
solid was recrystallized (CH2Cl2-hexane 1:1) to afford colourless crystals.  
1H-NMR (400 
MHz, CDCl3) δ 6.85 (dd, J = 8.2, 6.6 Hz, 1H), 6.80-6.62 (m, 3H), 5.41 (t, J = 7.0 Hz, 1H), 
4.44 (t, J = 8.2 Hz, 1H), 4.28-4.10 (m, 5H), 3.82 (s, 3H), 3.62 (t, J = 7.8 Hz, 1H), 3.54 (t, J = 
6.6 Hz, 1H), 3.49-3.35 (m, 1H), 3.27 (q, J = 8.5 Hz, 1H), 2.60-2.45 (m, 1H), 2.40 (q, J = 7.0 
Hz, 1H), 1.33-1.16 (m, 6H) ppm;  13C-NMR (100 MHz, CDCl3) δ 169.06, 157.93, 146.62, 
133.99, 121.80, 118.53, 111.67, 109.73, 65.01, 62.33, 62.05, 55.56, 49.09, 38.76, 32.33, 
14.08 ppm; IR ʋ (cm-1) 3386, 2975, 2934, 1746, 1723, 1602, 1512, 1250, 1210, 1144, 1016; 
HRMS [M+H] calculated for C19H27N2O7 395.1813 Found 395.1806. 
Diethyl2-(2-(2-oxooxazolidin-3-yl)-2-((2-trifluoromethoxy)phenyl)amino)ethyl)malonate 
(205) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 205 as a yellow oily liquid (0.34 g, 77%).  1H-NMR (400 MHz, CDCl3) δ 
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7.13 (t, J = 7.4 Hz, 2H), 6.83 (d, J = 7.4 Hz, 1H), 6.76-6.70 (m, 1H), 5.41 (q, J = 7.7 Hz, 1H), 
4.68 (d, J = 8.2 Hz, 1H), 4.29-4.10 (m, 6H), 3.53-3.43 (m, 2H), 3.27 (q, J = 8.5 Hz, 1H), 
2.59-2.49 (m, 1H), 2.40-2.30 (m, 1H), 1.24 (dt, J = 14.0, 6.4 Hz, 6H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 169.06, 168.94, 157.84, 136.86, 136.11, 128.37, 121.21, 118.67, 113.49, 
62.41, 62.13, 61.72, 48.89, 38.61, 31.82, 14.04 ppm; IR ʋ (cm-1) 3394, 2982, 2360, 1726, 
1612, 1482, 1420, 1215, 1158, 1026; HRMS [M+H] calculated for C19H24F3N2O7 449.1530, 
found 449.1525. 
Diethyl 2-(2-((3-(ethoxycarbonyl)phenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate 
(207) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 207 as a yellow liquid (0.15 g, 70%).  1H-NMR (400 MHz, CDCl3) δ 7.42 
(d, J = 7.8 Hz, 1H), 7.33 (s, 1H), 7.23 (t, J = 8.2 Hz, 1H), 6.86 (dd, J = 8.2, 2.5 Hz, 1H), 5.39 
(q, J = 7.7 Hz, 1H), 4.61 (d, J = 8.7 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 4.25-4.06 (m, 5H), 
3.56-3.50 (1H), 3.49-3.42 (1H), 3.38-3.29 (1H), 2.54-2.44 (m, 1H), 2.41-2.31 (m, 1H), 1.34 
(t, J = 7.0 Hz, 3H), 1.24 (t, J = 7.0 Hz, 3H), 1.20 (t, J = 7.0 Hz, 3H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 169.21, 169.02, 166.74, 157.86, 144.59, 131.68, 129.84, 120.21, 117.21, 
115.23, 62.44, 62.12, 61.08, 49.01, 39.29, 32.06, 14.36, 14.06 ppm; IR ʋ (cm-1) 2986, 2254, 
1734, 1607, 1591, 1276, 1259, 1049; HRMS [M+H] calculated for C21H29N2O8 437.1918, 
found 437.1915. 
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Diethyl 2-(2-(methyl(phenyl)amino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (209) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 209 as a yellow oil (0.113 g, 61%).  1H-NMR (400 MHz, CDCl3) δ 7.25 (t, 
J = 8.0 Hz, 2H), 6.89 (d, J = 7.8 Hz, 2H), 6.82 (t, J = 7.2 Hz, 1H), 5.58 (dd, J = 8.2, 6.6 Hz, 
1H), 4.27-4.07 (m, 6H), 3.59-3.47 (m, 2H), 3.32 (q, J = 8.2 Hz, 1H), 2.93 (s, 3H), 2.69-2.60 
(m, 1H), 2.54 (dt, J = 14.3, 6.1 Hz, 1H), 1.27-1.19 (m, 6H) ppm; 13C-NMR (100 MHz, 
CDCl3) δ 169.14, 168.86, 157.76, 148.31, 129.50, 119.22, 114.18, 67.74, 62.16, 61.96, 60.49, 
49.00, 41.78, 32.72, 30.42, 14.05 ppm; IR ʋ (cm-1) 2981, 1724, 1599, 1506, 1414, 1390, 
1370, 1225, 1095, 1029; HRMS [M+Na] calculated for C19H26N2O6Na 387.1527, found 
387.1527. 
Diethyl 2-(2-(diphenylamino)-2-(2-oxooxazolidin-3-yl)ethyl)malonate (211) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 211 as a yellow oil which solidified upon standing (0.12 g, 56%). The 
solid was recrystallized (CH2Cl2-hexane 1:1) to give colourless crystals.  
1H-NMR (400 
MHz, CDCl3) δ 7.28 (t, J = 7.6 Hz, 3H), 7.05 (t, J = 6.8 Hz, 2H), 6.97-6.91 (4H), 5.92 (t, J = 
7.4 Hz, 1H), 4.46-4.39 (m, 1H), 4.24-4.07 (m, 5H), 3.69 (t, J = 8.0 Hz, 1H), 3.56-3.43 (m, 
2H), 3.23 (q, J = 8.2 Hz, 1H), 2.22 (t, J = 6.8 Hz, 2H), 1.23 (td, J = 7.1, 1.8 Hz, 6H) ppm; 
13C-NMR (100 MHz, CDCl3) δ 169.26, 168.69, 158.01, 145.19, 129.66, 123.56, 93.57, 65.97, 
62.34, 61.97, 48.76, 41.99, 40.56, 31.65, 14.05 ppm;   IR ʋ (cm-1) 2981, 1741, 1637, 1589, 
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1493, 1370, 1330, 1248, 1097, 1077, 1028; HRMS [M+Na] calculated for C24H28N2O6Na 
463.1840, found 463.1836. 
Diethyl 2-((R)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-(phenylamino)ethyl)malonate 
(216) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 216 as a mixture of diastereomers (dr 52:48) as yellow oil (0.13 g, 56%).  
1H-NMR (400 MHz, CDCl3) δ 7.34-7.16 (m, 5H), 7.09 (t, J = 6.6 Hz, 2H), 6.86-6.76 (m, 
1H), 6.73 (d, J = 7.4 Hz, 1H), 6.62 (d, J = 7.8 Hz, 1H), 5.36-5.23 (m, 1H), 4.59 (d, J = 7.8 
Hz, 1H), 4.26-4.12 (m, 3H), 4.01-3.85 (m, 2H), 3.65-3.54 (m, 1H), 3.29 (dd, 13.5, 3.8 Hz, 
1H), 2.83-2.73 (m, 1H), 2.63-2.52 (m, 1H), 2.49-2.38 (m, 1H), 1.32-1.18 (m, 6H) ppm; 13C-
NMR (100 MHz, CDCl3) δ 169.65, 169.41, 169.10, 158.29, 157.57, 145.40, 144.97, 135.59, 
129.73, 129.05, 127.32, 119.67, 114.79, 113.89, 67.48, 64.45, 64.04, 62.05, 57.23, 54.62, 
49.15, 40.62, 39.77, 34.08, 32.91, 14.07 ppm; IR ʋ (cm-1) 3318, 2981, 1730, 1708, 1601, 
1499, 1411, 1367, 1259, 1180, 1097, 1021; HRMS [M+Na] calculated for C25H30N2O6Na 
477.1996, found 477.1995. 
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Diethyl 2-((R)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-(p-tolylamino)ethyl)malonate 
(217) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 217 as a mixture of diastereomers (dr 87:13) as yellow oil (0.27 g, 58%).  
1H-NMR (400 MHz, CDCl3) δ 7.32-7.23 (m, 2H), 7.09 (d, J = 7.0 Hz, 2H), 7.00 (d, J = 8.2 
Hz, 2H), 6.65 (d, J = 8.7 Hz, 2H), 5.23 (td, J = 10.0, 5.2 Hz, 1H), 4.48 (d, J = 10.7 Hz, 1H), 
4.27-4.12 (m, 4H), 4.03-3.83 (m, 3H), 3.59 (t, J = 7.0 Hz, 1H), 3.32 (dd, J = 13.4, 3.9 Hz, 
1H), 2.82-2.70 (m, 1H), 2.55 (dd, J = 13.6, 9.9 Hz, 1H), 2.44 (qd, J = 7.1, 4.9 Hz, 1H), 2.24 
(s, 3H), 1.25 (q, J = 7.3 Hz, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.42, 169.14, 
157.54, 143.05, 135.66, 130.13, 129.02, 127.29, 115.17, 67.41, 64.62, 61.96, 57.47, 49.20, 
39.77, 32.95, 20.57, 14.13 ppm;  IR ʋ (cm-1) 3348, 3027, 2979, 2872, 2359, 1727, 1637, 
1232, 1155, 1030; HRMS [M+H] calculated for C26H32N2O6 469,2333, found 469.2334. 
Diethyl 2-((R)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-(m-tolylamino)ethyl)malonate 
(218) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 218 as a mixture of diastereomers (dr 70:30) as a yellow oil (0.14 g, 61%)  
1H-NMR (400 MHz, CDCl3) δ 7.34-7.17 (m, 3H), 7.12-7.05 (m, 2H), 6.62 (d, J = 7.8 Hz, 
1H), 6.54 (d, J = 6.2 Hz, 1H), 6.43 (d, J = 10.7 Hz, 1H), 5.28 (td, J = 9.7, 5.4 Hz, 1H), 4.58 
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(d, J = 10.7 Hz, 1H), 4.31-4.12 (m, 4H), 3.97 (t, J = 8.2 Hz, 1H), 3.92-3.83 (m, 1H), 3.64-
3.53 (m, 1H), 3.34 (dd, J = 13.6, 4.1 Hz, 1H), 2.82-2.72 (m, 1H), 2.64-2.51 (m, 1H), 2.50-
2.37 (m, 1H), 2.27 (s, 3H), 1.39-1.15 (m, 6H) ppm;  13C-NMR (100 MHz, CDCl3) δ 169.63, 
169.39, 169.12, 158.31, 157.59, 145.48, 139.46, 135.69, 129.48, 129.01, 127.30, 120.61, 
115.70, 111.71, 67.46, 63.99, 61.98, 57.33, 49.19, 39.77, 32.91, 21.68, 14.11 ppm; IR ʋ (cm-
1) 3365, 2980, 2359, 1731, 1606, 1592, 1175, 1095, 1027, 905; HRMS [M+H] calculated for 
C26H33N2O6 391.1864, found 391.1860. 
Diethyl 2-((R)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-((2,4-dimethylphenyl)amino) 
ethyl)malonate (219) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 219 as a mixture of diastereomers (dr 50:50) as a yellow oil (0.11 g, 53%). 
1H-NMR (400 MHz, CDCl3) δ 7.33-7.19 (m, 4H), 7.12-7.02 (m, 2H), 6.96-6.86 (m, 2H), 
6.74-6.69 (1H), 6.47-6.42 (1H), 5.35-5.24 (m, 1H), 4.53-4.45 (m, 1H), 4.29-4.14 (m, 4H), 
4.11 (q, J = 7.1 Hz, 2H), 3.99-3.84 (m, 1H), 3.64-3.57 (1H), 3.30 (dd, J = 13.4, 3.5 Hz, 1H), 
2.90-2.80 (m, 1H), 2.70-2.41 (m, 2H), 2.28 (d, J = 3.3 Hz, 1H), 2.22, 2.21 (2 x Me, 3H), 2.18, 
2.11 (2 x Me 3H), 1.29-1.23 (m, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 171.25, 169.87, 
169.51, 169.18, 158.26, 157.47, 140.98, 140.47, 135.64, 135.55, 131.64, 128.98, 128.63, 
128.33, 127.94, 127.63, 127.29, 123.94, 122.83, 112.86, 111.46, 67.46, 64.30, 63.98, 62.10, 
61.97, 60.49, 57.53, 54.51, 49.27, 40.87, 39.65, 33.98, 32.93, 21.15, 20.47, 17.53, 14.28, 
14.08.  HRMS [M+H] Calculated 483.2490 Found 483.2487. 
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Diethyl 2-((R)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-((3-(trifluoromethyl)phenyl) 
amino)ethyl)malonate (220) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 220 as a mixture of diastereomers (dr 95:5) as a yellow oil (0.18 g, 54%).  
1H-NMR (400 MHz, CDCl3) δ 7.35-7.22 (m, 4H), 7.11 (d, J = 7.0 Hz, 2H), 7.04 (d, J = 7.4 
Hz, 1H), 6.90 (d, J = 7.4 Hz, 1H), 5.28 (qd, J = 10.0, 5.3 Hz, 1H), 4.85 (d, J = 9.9 Hz, 1H), 
4.26-4.06 (m, 4H), 4.06-3.98 (m, 1H), 3.95-3.88 (m, 1H), 3.53 (t, J = 6.8 Hz, 1H), 3.32 (dd, J 
= 13.6, 4.5 Hz, 1H), 2.83-2.73 (m, 1H), 2.65-2.52 (m, 1H), 2.45 (qd, J = 7.1, 5.1 Hz, 1H), 
1.30-1.18 (6H) ppm;  13C-NMR (100 MHz, CDCl3) δ 169.27, 168.96, 157.58, 145.77, 135.41, 
130.32, 129.14, 128.94, 127.44, 117.46, 116.05, 110.78, 67.52, 63.55, 62.10, 57.07, 49.09, 
40.10, 32.75, 14.05 ppm;  IR ʋ (cm-1) 2984, 2254, 1727, 1616, 1497, 1447, 1370, 1339, 1164, 
1124, 1095, 1071, 1029;  HRMS [M+H] calculated for C26H30F3N2O6 523.2050, found 
523.2044. 
Diethyl 2-((R)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-((3,5-bis(trifluoromethyl)phenyl) 
amino)ethyl)malonate (221) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 221 as a single of stereoisomes as a pale yellow oil (0.18 g, 60%).    1H-
NMR (400 MHz, CDCl3) δ 7.39-7.20 (m, 3H), 7.12 (d, J = 7.8 Hz, 3H), 5.43-5.11 (m, 1H), 
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4.42-3.99 (m, 5H), 3.95 (dd, J = 8.7, 6.2 Hz, 1H), 3.50 (t, J = 6.8 Hz, 1H), 3.31 (dd, J = 13.6, 
4.5 Hz, 1H), 2.94-2.69 (m, 1H), 2.62 (dd, J = 13.6, 9.5 Hz, 1H), 2.53-2.34 (m, 1H), 1.35-1.12 
(m, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.18, 168.86, 157.63, 146.46, 135.25, 
132.88, 129.21, 128.87, 127.56, 124.75, 122.04, 113.46, 112.38, 67.59, 63.03, 62.21, 56.76, 
48.98, 40.07, 32.50, 14.01 ppm; IR ʋ (cm-1) 3329, 2983, 1724, 1621, 1551, 1388, 1274, 1169, 
1127, 1095, 1029; HRMS [M+Na] calculated for C27H28F6N2O6Na 613.1744, found 
613.1740. 
Diethyl 2-((R)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-((2-(trifluoromethoxy)phenyl) 
amino)ethyl)malonate (222) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 222 as a mixture of diastereomers (dr 75:25) as a yellow oil (0.15 g, 58%).  
1H-NMR (400 MHz, CDCl3) δ 7.36-7.21 (m, 4H), 7.21-7.11 (m, 3H), 7.08 (d, J = 7.0 Hz, 
2H), 7.05-6.98 (1H), 6.81-6.74 (m, 1H), 5.51-5.30 (m, 1H), 4.95 (d, J = 8.7 Hz, 1H), 4.30-
4.08 (m, 5H), 4.08-4.03 (m, 1H), 3.99 (t, J = 8.2 Hz, 0H), 3.91 (dd, J = 8.7, 6.2 Hz, 1H), 
3.61-3.49 (m, 1H), 3.40-3.26 (1H), 2.87-2.76 (m, 1H), 2.72-2.57 (m, 1H), 2.51-2.38 (m, 2H), 
1.31-1.21 (m, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.46, 169.26, 168.95, 157.65, 
137.60, 137.39, 136.65, 136.29, 135.62, 135.32, 129.04, 128.91, 128.49, 128.17, 127.30, 
121.23, 118.88, 114.15, 67.56, 67.28, 66.92, 63.51, 63.05, 62.15, 55.43, 54.02, 49.02, 40.86, 
40.28, 39.46, 32.16, 19.18, 14.05 ppm; IR ʋ (cm-1) 3382, 2984, 1730, 1612, 1519, 1411, 
1274, 1257, 1216, 1165, 1095, 1028.  HRMS [M+H] calculated for C26H33N2O7 539.2000, 
found 539.2000. 
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Diethyl 2-((R)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-((3-(ethoxycarbonyl)phenyl) 
amino)ethyl)malonate (223) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 223 as a mixture of diastereomers (dr 55:45) as a yellow oil (0.16 g, 61%).  
1H-NMR (400 MHz, CDCl3) δ 7.47 (d, J = 7.8 Hz, 1H), 7.39 (s, 1H), 7.34 (s, 1H), 7.31-7.17 
(3H), 7.10 (q, J = 6.7 Hz, 2H), 5.29 (qd, J = 9.7, 5.3 Hz, 1H), 4.84 (dd, J = 26.2, 9.7 Hz, 1H), 
4.45-4.26 (m, 2H), 4.26-4.03 (4H), 4.03-3.85 (m, 2H), 3.58 (dt, J = 23.5, 6.9 Hz, 1H), 3.41-
3.20 (m, 1H), 2.88-2.73 (m, 1H), 2.65-2.51 (m, 1H), 2.51-2.38 (m, 1H), 1.35 (tt, J = 7.1, 2.3 
Hz, 3H), 1.30-1.18 (m, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.49, 169.26, 169.03, 
166.66, 158.24, 157.51, 145.50, 145.16, 135.47, 131.79, 129.80, 129.02, 127.35, 120.69, 
118.90, 117.86, 115.20, 67.51, 64.21, 63.62, 62.09, 61.11, 57.36, 54.89, 49.10, 40.32, 39.86, 
33.69, 32.87, 14.35, 14.10 ppm; IR ʋ (cm-1) 3376, 2981, 1715, 1605, 1590, 1392, 1367, 1276, 
1260, 1232, 1103, 1022; HRMS [M+Na] calculated for C28H34N2O8Na 549.2207, found 
549.2215. 
Diethyl 2-((1S,2S)-1-(2-oxooxazolidin-3-yl)-1-(p-tolylamino)hexan-2-yl)malonate (224) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 224 as a single diastereoisomer as a pale yellow viscous liquid which 
turned solid on drying.  Recrystallization with hexane-DCM 1:1 gave colourless crystals. 
(0.23 g, 53%). 1H-NMR (400 MHz, CDCl3) δ 6.99 (d, J = 8.2 Hz, 2H), 6.58 (d, J = 8.2 Hz, 
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2H), 5.30 (t, J = 9.3 Hz, 1H), 4.31-4.05 (m, 8H), 3.64 (d, J = 7.4 Hz, 1H), 3.38 (t, J = 8.0 Hz, 
2H), 2.71-2.61 (m, 1H), 2.22 (s, 3H), 1.70-1.54 (m, 3H), 1.39-1.29 (m, 3H), 1.26 (td, J = 7.1, 
1.4 Hz, 6H), 0.84 (t, J = 7.2 Hz, 3H) ppm; 13C-NMR (100 MHz, CCl3D) δ 169.11, 168.83, 
158.36, 142.63, 130.63, 130.24, 128.53, 113.91, 66.75, 62.47, 61.79, 53.12, 42.26, 41.72, 
29.01, 28.86, 23.08, 20.50, 14.06 ppm; IR ʋ (cm-1) 2252, 1737, 1699, 1514, 1389, 1249, 
1178, 1037. HRMS [M+Na] calculated for C23H24N2O6Na 457.2309, found 457.2305. 
3-((1S,3R)-3-phenyl-1-(p-tolylamino)butyl)oxazolidin-2-one (226) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 226 a mixture of diastereomers (dr 50:50) as a yellow liquid (0.15 g, 48%).  
1H-NMR (400 MHz, CCl3D) δ 7.00 (d, J = 8.2 Hz, 3H), 6.85 (t, J = 7.8 Hz, 1H), 6.77 (s, 1H), 
6.60 (d, J = 8.7 Hz, 3H), 6.45 (d, J = 8.2 Hz, 1H), 5.45 (t, J = 6.0 Hz, 1H), 5.28 (q, J = 6.0 
Hz, 1H), 4.36 (t, J = 8.0 Hz, 2H), 4.31-4.15 (m, 2H), 3.87 (d, J = 4.9 Hz, 1H), 3.57-3.42 (m, 
2H), 3.39 (t, J = 8.0 Hz, 2H), 3.36-3.24 (m, 1H), 2.21 (d, J = 11.5 Hz, 6H), 2.03 (qd, J = 6.2, 
2.1 Hz, 1H), 1.70 (q, J = 11.8 Hz, 1H), 1.47 (d, J = 6.2 Hz, 3H), 1.22 (t, J = 6.0 Hz, 3H);  13C-
NMR (400 MHz, CCl3D) δ 159.02, 157.58, 143.70, 142.37, 130.14, 129.26, 128.21, 127.24, 
118.41, 115.17, 113.49, 62.25, 62.19, 59.89, 50.30, 47.11, 39.75, 38.82, 34.30, 22.37, 20.67, 
20.50, 19.68.  IR ʋ (cm-1) 3350, 2918, 1730, 1617, 1506, 1482, 1423, 1304, 1251, 1171, 
1077, 1057, 1028; HRMS [M+Na] calculated for C20H24N2O2Na 347.1730, found 347.1739. 
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3-((1S,3R)-1-(Diphenylamino)-3-phenylbutyl)oxazolidin-2-one (227) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 5:1) to 
afford the product 227 as a mixture of diastereomers (95:5) as a yellow oil (0.21 g, 53%). 1H-
NMR (400 MHz, CDCl3) δ 7.42 (d, J = 8.2 Hz, 1H), 7.33-7.17 (m, 6H), 7.08 (d, J = 8.2 Hz, 
2H), 6.96-6.84 (m, 2H), 5.43 (q, J = 7.1 Hz, 1H), 4.31 (q, J = 8.5 Hz, 1H), 4.22 (td, J = 9.1, 
5.6 Hz, 1H), 3.59 (td, J = 8.8, 5.6 Hz, 1H), 3.26 (q, J = 8.7 Hz, 1H), 1.67-1.57 (m, 3H) ppm; 
13C-NMR (100 MHz, CDCl3) δ 158.98, 143.55, 141.98, 129.31, 128.79, 127.82, 126.80, 
120.62, 120.43, 118.80, 117.82, 62.50, 46.36, 39.73, 16.93 ppm; IR ʋ (cm-1)  3319, 2980, 
2247, 1716, 1593, 1496, 1424, 1306, 1251, 1130, 1053, 1021; HRMS [M+H] calculated for 
C25H27N2O2 387.2067, found 387.2083. 
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General Procedure for the Cyclization of the Adduct products to the γ-Lactams 
 
In a 25 mL round bottom flask, a solution of the diethylmalonate product (0.15 mmol) and 
acetic acid (0.15 mL) in toluene (2.5 mL) was heated to 80ºC and stirred overnight. The 
reaction was cooled to room temperature, saturated aqueous sodium bicarbonate (1.5 mL) 
was added and the solution extracted by ethyl acetate (5 mL × 2).  The combined organic 
layer was dried over anhydrous sodium sulphate.  The solvent was removed in vacuo and the 
crude mixture was purified via flash chromatography (EtOAc-hexanes 0:1 to 1:1) to yield the 
product as a mixture of diastereomers as a pale yellow oil. 
Ethyl (3R,5R)-2-oxo-5-(2-oxooxazolidin-3-yl)-1-phenylpyrrolidine-3-carboxylate (242) 
 
In a 25 mL round bottom flask, a solution of diethyl 2-(2-(2-oxooxazolidin-3-yl)-2-
(phenylamino)ethyl)malonate (179) (55 mg, 0.15 mmol) and acetic acid (0.15 mL) in toluene 
(2.5 mL) was heated to 80ºC and stirred overnight. The reaction was cooled to room 
temperature, saturated aqueous sodium bicarbonate (1.5 mL) was added and the solution 
extracted by ethyl acetate (5 mL × 2).  The combined organic layer was dried over anhydrous 
sodium sulphate and filtered.  The solvent was removed in vacuo and the crude mixture was 
purified via flash chromatography (EtOAc-hexanes 3:7 to 1:1) to yield the product (242) as a 
mixture of diastereomers (dr 54:46) as a pale yellow oil (31 mg, 64%). 1H-NMR (400 MHz, 
CDCl3) δ 7.50-7.34 (m, 8H), 7.27-7.24 (1H), 7.22 (d, J = 7.0 Hz, 1H), 6.35-6.24 (m, 2H), 
4.34-4.19 (m, 6H), 4.11 (td, J = 9.0, 6.7 Hz, 1H), 4.04 (td, J = 9.1, 6.2 Hz, 1H), 3.76 (td, J = 
9.6, 6.7 Hz, 2H), 3.66 (dd, J = 10.3, 7.4 Hz, 1H), 3.53-3.43 (m, 1H), 3.32-3.23 (m, 1H), 3.18 
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(td, J = 9.0, 7.1 Hz, 1H), 3.00-2.90 (m, 1H), 2.88-2.74 (m, 1H), 2.43 (qd, J = 7.2, 5.3 Hz, 
1H), 2.31-2.21 (m, 1H), 2.16 (d, J = 2.1 Hz, 1H), 1.35 (t, J = 7.2 Hz, 3H), 1.30 (t, J = 7.2 Hz, 
3H), 1.23 (s, 1H) ppm; 13C-NMR (100 MHz, CDCl3) δ 170.22, 168.84, 168.11, 167.78, 
157.569, 157.17, 135.56, 135.13, 129.48, 129.40, 126.94, 126.92, 123.20, 122.98, 67.56, 
66.35, 52.40, 62.35, 62.04, 48.58, 47.85, 39.40, 38.74, 29.35, 27.14, 25.74, 14.26, 14.22 ppm; 
IR ʋ (cm-1)  3019, 2927, 2400, 1753, 1710, 1648, 1598, 1500, 1391, 1334; 1215, 1117, 1043; 
HRMS [M+Na] calculated for C16H18N2O5Na 341.1108, found 341.1106. 
Ethyl (3R,5R)-2-oxo-5-(2-oxooxazolidin-3-yl)-1-(p-tolyl)pyrrolidine-3-carboxylate (243) 
 
In a 25 mL round bottom flask, a solution of diethyl 2-(2-(2-oxooxazolidin-3-yl)-2-(p-
tolylamino)ethyl)malonate (181) (56 mg, 0.15 mmol) and acetic acid (0.15 mL) in toluene 
(2.5 mL) was heated to 80ºC and stirred overnight. The reaction was cooled to room 
temperature, saturated aqueous sodium bicarbonate (1.5 mL) was added and the solution 
extracted by ethyl acetate (5 mL × 2).  The combined organic layer was dried over anhydrous 
sodium sulphate and filtered.  The solvent was removed in vacuo and the crude mixture was 
purified via flash chromatography (EtOAc-hexanes 3:7 to 1:1) to yield the product 223 as a 
mixture of diastereomers (dr 50:50) as a pale yellow oil (29 mg, 60%). 1H-NMR (400 MHz, 
CDCl3) δ 7.32 (dd, J = 12.2, 8.4 Hz, 2H), 7.18 (d, J = 7.8 Hz, 2H), 6.29-6.20 (m, 1H), 4.33-
4.19 (m, 3H), 4.17-4.01 (m, 1H), 3.80-3.71 (m, 1H), 3.65 (dd, J = 10.5, 7.2 Hz, 1H), 3.53-
3.41 (m, 1H), 3.33-3.16 (m, 1H), 3.00-2.88 (m, 1H), 2.85-2.73 (m, 1H), 2.42 (qd, J = 7.3, 5.4 
Hz, 1H), 2.31 (s, 3H), 2.29-2.20 (m, 1H), 1.32 (dt, J = 18.1, 7.2 Hz, 3H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 170.12, 168.92, 167.82, 157.39, 136.90, 132.68, 130.03, 123.12, 67.66, 
66.46, 62.19, 48.51, 47.80, 39.40, 38.76, 27.14, 25.74, 21.11, 14.24 ppm;  IR ʋ (cm-1)  3376, 
2980, 2916, 1732, 1700, 1614, 1516, 1500, 1391, 1252, 1177, 1031; HRMS [M+Na] 
calculated for C17H20N2O5Na 355.1264, found 355.1262. 
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Ethyl (3R,5R)-2-oxo-5-(2-oxooxazolidin-3-yl)-1-(m-tolyl)pyrrolidine-3-carboxylate (244) 
 
In a 25 mL round bottom flask, a solution of diethyl 2-(2-(2-oxooxazolidin-3-yl)-2-(m-
tolylamino)ethyl)malonate (183) (55 mg, 0.15 mmol) and acetic acid (0.25 mL) in toluene 
(2.5 mL) was heated to 80ºC and stirred overnight. The reaction was cooled to room 
temperature, saturated aqueous sodium bicarbonate (1.5 mL) was added and the solution 
extracted by ethyl acetate (5 mL × 2).  The combined organic layer was dried over anhydrous 
sodium sulphate and filtered.  The solvent was removed in vacuo and the crude mixture was 
purified via flash chromatography (EtOAc-hexanes 3:7 to 1:1) to yield the product 244 as a 
mixture of diastereomers (dr 55:45) as a pale yellow oil (32 mg, 65%). 1H-NMR (400 MHz, 
CDCl3) δ 7.35-7.15 (m, 7H), 7.04 (d, J = 7.4 Hz, 2H), 6.32-6.21 (m, 2H), 4.34-4.19 (m, 7H), 
4.17-4.10 (m, 1H), 4.10-4.00 (m, 1H), 3.80-3.70 (m, 2H), 3.65 (dd, J = 10.3, 7.4 Hz, 1H), 
3.47 (dd, J = 15.2, 8.7 Hz, 1H), 3.33-3.15 (m, 2H), 2.98-2.89 (m, 1H), 2.84-2.73 (m, 1H), 
2.42 (qd, J = 7.3, 5.4 Hz, 1H), 2.33 (s, 6H), 2.31-2.19 (m, 1H), 2.18-2.14 (1H), 1.32 (dt, J = 
18.4, 7.1 Hz, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 170.08, 168.90, 168.13, 167.67, 
157.56, 157.17, 139.46, 139.39, 135.47, 135.03, 129.24, 129.16, 127.82, 127.78, 124.00, 
123.75, 120.17, 120.04, 67.66, 66.44, 62.37, 62.34,  62.31, 62.04, 48.59, 47.85, 39.45, 38.76, 
27.16, 25.76, 21.57, 14.24 ppm; IR ʋ (cm-1)  3475, 3019; 2980, 2400, 1750, 1706, 1606, 
1520, 1493, 1392, 1215, 1113, 1043; HRMS [M+Na] calculated for C17H20N2O5Na 
355.1264, found 355.1271. 
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Ethyl (3R,5R)-2-oxo-5-(2-oxooxazolidin-3-yl)-1-(3-(trifluoromethyl)phenyl)pyrrolidine-
3-carboxylate (245) 
 
In a 25 mL round bottom flask, a solution of diethyl 2-(2-(2-oxooxazolidin-3-yl)-2-((3-
(trifluoromethyl)phenyl)amino)ethyl)malonate (193) (65 mg, 0.15 mmol) and acetic acid 
(0.15 mL) in toluene (2.5 mL) was heated to 80ºC and stirred overnight. The reaction was 
cooled to room temperature, saturated aqueous sodium bicarbonate (1.5 mL) was added and 
the solution extracted by ethyl acetate (5 mL × 2).  The combined organic layer was dried 
over anhydrous sodium sulphate and filtered.  The solvent was removed in vacuo and the 
crude mixture was purified via flash chromatography (EtOAc-hexanes 3:7 to 1:1) to yield the 
product 245 as a mixture of diastereomers (dr 53:47) as a pale yellow oil (36 mg, 62%). 1H-
NMR (400 MHz, CDCl3) δ 7.96 (s, 1H), 7.89 (s, 1H), 7.65-7.56 (m, 2H), 7.50 (q, J = 8.0 Hz, 
4H), 6.35 (q, J = 4.0 Hz, 1H), 6.31 (dd, J = 8.2, 5.4 Hz, 1H), 4.20-4.13 (m, 1H), 4.13-4.04 (m, 
1H), 3.83-3.74 (m, 2H), 3.68 (dd, J = 10.5, 7.6 Hz, 1H), 3.55-3.47 (m, 1H), 3.29-3.21 (m, 
1H), 3.13 (td, J = 9.1, 7.4 Hz, 1H), 2.97 (qd, J = 7.4, 6.6 Hz, 1H), 2.88-2.77 (m, 1H), 2.46 
(qd, J = 7.3, 5.4 Hz, 1H), 2.29 (ddd, J = 14.0, 9.5, 3.7 Hz, 1H), 1.35 (t, J = 7.2 Hz, 3H), 1.30 
(t, J = 7.2 Hz, 3H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.68, 168.42, 167.87, 157.48, 
157.12, 136.29, 135.86, 131.83, 130.03, 125.30, 123.41, 122.29, 120.25, 119.81, 67.26, 
66.14, 62.53, 62.07, 53.86, 48.51, 47.79, 39.36, 38.70, 31.81, 31.00, 29.34, 26.98, 25.55, 
14.21 ppm; IR ʋ (cm-1)  3020, 2976, 2400, 1753, 1713, 1598, 1521, 1389, 1216, 1180, 1135, 
1043; HRMS [M+Na] calculated for C17H17N2O5Na 409.0982, found 409.0974. 
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Ethyl (3R,5R)-1-(4-bromophenyl)-2-oxo-5-(2-oxooxazolidin-3-yl)pyrrolidine-3-carboxylate (246) 
 
In a 25 mL round bottom flask, a solution of diethyl 2-(2-((4-bromophenyl)amino)-2-(2-
oxooxazolidin-3-yl)ethyl)malonate (195) (65 mg, 0.15 mmol) and acetic acid (0.25 mL) in 
toluene (2.5 mL) was heated to 80ºC and stirred overnight. The reaction was cooled to room 
temperature, saturated aqueous sodium bicarbonate (1.5 mL) was added and the solution 
extracted by ethyl acetate (5 mL × 2).  The combined organic layer was dried over anhydrous 
sodium sulphate and filtered.  The solvent was removed in vacuo and the crude mixture was 
purified via flash chromatography (EtOAc-hexanes 3:7 to 1:1) to yield the product 246 as a 
mixture of diastereomers (dr 50:50) as a pale yellow oil (31 mg, 53%). 1H-NMR (400 MHz, 
CDCl3) δ 7.32 (dd, J = 12.2, 8.4 Hz, 2H), 7.18 (d, J = 7.8 Hz, 2H), 6.29-6.20 (m, 1H), 4.33-
4.19 (m, 3H), 4.17-4.01 (m, 1H), 3.80-3.71 (m, 1H), 3.65 (dd, J = 10.5, 7.2 Hz, 1H), 3.53-
3.41 (m, 1H), 3.33-3.16 (m, 1H), 3.00-2.88 (m, 1H), 2.85-2.73 (m, 1H), 2.42 (qd, J = 7.3, 5.4 
Hz, 1H), 2.31 (s, 3H), 2.29-2.20 (m, 1H), 1.32 (dt, J = 18.1, 7.2 Hz, 3H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 170.12, 168.92, 167.82, 157.39, 136.90, 132.68, 130.03, 123.12, 67.66, 
66.46, 62.19, 48.51, 47.80, 39.40, 38.76, 27.14, 25.74, 21.11, 14.24 ppm; IR ʋ (cm-1) 2981, 
1739, 1705, 1589, 1491, 1384, 1288, 1179, 1093, 1036, 1010; HRMS [M+Na] calculated for 
C16H17N2O5Na 419.0213, found 419.0213. 
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Ethyl (3R,5R)-1-(2-fluorophenyl)-2-oxo-5-(2-oxooxazolidin-3-yl)pyrrolidine-3-
carboxylate (247) 
 
In a 25 mL round bottom flask, a solution of diethyl 2-(2-((2-fluorophenyl)amino)-2-(2-
oxooxazolidin-3-yl)ethyl)malonate (197) (56 mg, 0.15 mmol) and acetic acid (0.25 mL) in 
toluene (2.5 mL) was heated to 80ºC and stirred overnight. The reaction was cooled to room 
temperature, saturated aqueous sodium bicarbonate (1.5 mL) was added and the solution 
extracted by ethyl acetate (5 mL × 2). The combined organic layer was dried over anhydrous 
sodium sulphate and filtered.  The solvent was removed in vacuo and the crude mixture was 
purified via flash chromatography (EtOAc-hexanes 3:7 to 1:1) to yield the product 247 as a 
mixture of diastereomers (dr 53:47) as a pale yellow oil (29 mg, 61%). 1H-NMR (400 MHz, 
CDCl3) δ 7.40-7.26 (m, 4H), 7.23-7.11 (m, 4H), 6.16 (q, J = 4.5 Hz, 1H), 6.12 (dd, J = 8.2, 
3.3 Hz, 1H), 4.36-4.18 (m, 7H), 4.18-4.09 (m, 1H), 3.86-3.75 (m, 2H), 3.68 (dd, J = 10.5, 6.8 
Hz, 1H), 3.60-3.45 (m, 3H), 3.08-2.97 (m, 1H), 2.90-2.79 (m, 1H), 2.61 (s, 1H), 2.52 (qd, J = 
7.1, 5.0 Hz, 1H), 2.40-2.29 (m, 1H), 2.15 (t, J = 3.1 Hz, 8H), 1.86 (d, J = 1.2 Hz, -1H), 1.37-
1.32 (m, 3H), 1.32-1.27 (m, 3H), 1.23 (s, 3H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.65, 
168.78, 168.32, 167.78, 157.41, 157.08, 130.30, 128.58, 128.33, 125.13, 122.83, 116.98, 
69.59, 68.47, 67.33, 62.40, 62.11, 53.86, 47.53, 47.08, 39.80, 39.01, 31.83, 31.03, 29.35, 
27.39, 25.80, 14.20 ppm; IR ʋ (cm-1)  2982, 2133, 2011, 2003, 1978, 1745, 1706, 1609, 1591, 
1506, 1499, 1428, 1393, 1176, 1092, 763, 757; HRMS [M+Na] calculated for 
C16H17FN2O5Na 359.1014, found 359.0999. 
Ethyl (3R,5R)-1-(4-bromo-2-fluorophenyl)-2-oxo-5-(2-oxooxazolidin-3-yl)pyrrolidine-3-
carboxylate (248). 
168 
 
 
In a 25 mL round bottom flask, a solution of diethyl 2-(2-((4-bromo-2-fluorophenyl)amino)-
2-(2-oxooxazolidin-3-yl)ethyl)malonate (199) (70 mg, 0.15 mmol) and acetic acid (0.25 mL) 
in toluene (2.5 mL) was heated to 80ºC and stirred overnight. The reaction was cooled to 
room temperature, saturated aqueous sodium bicarbonate (1.5 mL) was added and the 
solution extracted by ethyl acetate (5 mL × 2).  The combined organic layer was dried over 
anhydrous sodium sulphate and filtered.  The solvent was removed in vacuo and the crude 
mixture was purified via flash chromatography (EtOAc-hexanes 3:7 to 1:1) to yield the 
product 248 as a mixture of diastereomers (dr 54:46) as a white solid substance (37 mg, 60%, 
M.P. 100.7 – 102.4oC). 1H-NMR (400 MHz, CDCl3) δ 7.41-7.29 (m, 4H), 7.23-7.12 (m, 2H), 
6.13 (q, J = 4.5 Hz, 1H), 6.09 (q, J = 3.8 Hz, 1H), 4.37-4.07 (m, 9H), 3.87-3.72 (m, 2H), 3.67 
(dd, J = 10.7, 6.6 Hz, 1H), 3.57-3.47 (m, 2H), 3.43 (dd, J = 16.1, 9.1 Hz, 1H), 3.07-2.95 (m, 
1H), 2.90-2.78 (m, 1H), 2.57-2.47 (m, 1H), 2.41-2.30 (m, 1H), 1.36-1.31 (m, 3H), 1.31-1.27 
(m, 3H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.48, 168.62, 168.27, 167.69, 159.05, 
157.44, 157.08, 156.50, 129.62, 129.22, 128.61, 128.45, 122.69, 122.12, 120.72, 68.26, 
67.10, 62.45, 62.13, 47.45, 47.02, 39.81, 39.03, 27.35, 25.74, 14.20 ppm; IR ʋ (cm-1)  3155, 
2986, 2254, 1757, 1719, 1603, 1498, 1389, 1181, 1042, 987, 732; HRMS [M+Na] calculated 
for C16H16BrFN2O5Na 437.0119, found 437.0102. 
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Ethyl (3S,5R)-5-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-oxo-1-(3-(trifluoromethyl)phenyl) 
pyrrolidine-3-carboxylate (249) 
 
In a 25 mL round bottom flask, a solution of diethyl 2-(2-((S)-4-benzyl-2-oxooxazolidin-3-
yl)-2-((3-(trifluoromethyl)phenyl)amino)ethyl)malonate (220) (51 mg, 0.10 mmol) and acetic 
acid (0.15 mL) in toluene (2.5 mL) was heated to 80ºC and stirred overnight. The reaction 
was cooled to room temperature, saturated aqueous sodium bicarbonate (1.5 mL) was added 
and the solution extracted by ethyl acetate (5 mL × 2).  The combined organic layer was dried 
over anhydrous sodium sulphate and filtered.  The solvent was removed in vacuo and the 
crude mixture was purified via flash chromatography (EtOAc-hexanes 3:7 to 1:1) to yield the 
product 249 as a mixture of diastereomers (dr 55:45) as a pale yellow oil (21 mg, 44%). 1H-
NMR (400 MHz, CDCl3) δ 7.97 (s, 1H), 7.78-7.73 (m, 1H), 7.69-7.61 (m, 1H), 7.59-7.49 (m, 
3H), 7.39-7.20 (m, 6H), 7.17-7.10 (m, 2H), 7.09-7.03 (m, 1H), 6.47 (t, J = 7.4 Hz, 1H), 5.75-
5.54 (m, 1H), 4.51-4.40 (m, 1H), 4.32-4.18 (m, 1H), 4.15-4.05 (m, 1H), 4.04-3.93 (m, 1H), 
3.87 (ddd, J = 20.0, 9.1, 6.0 Hz, 2H), 3.81-3.72 (m, 1H), 3.24 (dd, J = 13.2, 4.1 Hz, 1H), 2.95 
(q, J = 6.6 Hz, 1H), 2.91-2.80 (m, 2H), 2.64-2.48 (m, 1H), 2.03 (d, J = 3.7 Hz, 1H), 1.97 (dd, 
J = 13.0, 11.3 Hz, 1H), 1.44-1.35 (m, 3H), 1.35-1.27 (m, 3H) ppm; 13C-NMR (100 MHz, 
CDCl3) δ 169.78, 169.33, 168.79, 167.37, 157.68, 156.51, 136.30, 135.11, 134.88, 129.81, 
127.91, 127.46, 125.67, 119.99, 68.77, 67.40, 67.05, 66.84, 62.75, 62.29, 57.44, 53.57, 48.69, 
47.96, 40.64, 39.09, 27.76, 24.11, 14.29, 14.22 ppm; IR ʋ (cm-1)  3020, 2938, 1752, 1712, 
1615, 1596, 1497, 1329, 1216, 1172, 1131; HRMS [M+Na] calculated for C17H17F3N2O5Na 
499.1451, found 499.1461. 
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Ethyl (3S,5R)-5-((S)-4-benzyl-2-oxooxazolidin-3-yl)-1-(3,5-bis(trifluoromethyl)phenyl)-
2-oxopyrrolidine-3-carboxylate (250) 
 
In a 25 mL round bottom flask, a solution of diethyl 2-(2-((S)-4-benzyl-2-oxooxazolidin-3-
yl)-2-((3,5-bis(trifluoromethyl)phenyl)amino)ethyl)malonate (221) (58 mg, 0.10 mmol) and 
acetic acid (0.25 mL) in toluene (2.5 mL) was heated to 80ºC and stirred overnight. The 
reaction was cooled to room temperature, saturated aqueous sodium bicarbonate (1.5 mL) 
was added and the solution extracted by ethyl acetate (5 mL × 2).  The combined organic 
layer was dried over anhydrous sodium sulphate and filtered.  The solvent was removed in 
vacuo and the crude mixture was purified via flash chromatography (EtOAc-hexanes 3:7 to 
1:1) to yield the product 250 as a mixture of diastereomers (dr 58:42) as a pale yellow oil (8 
mg, 15%). 1H-NMR (400 MHz, CCl3D) δ 8.17 (s, 3H), 7.98 (s, 2H), 7.77 (s, 2H), 7.42-7.21 
(m, 12H), 7.12 (q, J = 6.7 Hz, 5H), 6.51 (t, J = 7.2 Hz, 1H), 5.74 (dd, J = 8.9, 2.7 Hz, 1H), 
4.55-4.43 (m, 1H), 4.32-4.18 (m, 3H), 4.15-3.99 (m, 3H), 3.92 (ddd, J = 27.8, 9.1, 5.6 Hz, 
3H), 3.21 (dd, J = 13.0, 3.9 Hz, 1H), 3.02-2.81 (m, 5H), 2.61 (dd, J = 13.6, 7.8 Hz, 1H), 2.57-
2.46 (m, 1H), 2.16 (s, 4H), 2.06-1.91 (m, 2H), 1.61 (d, J = 38.7 Hz, 11H), 1.39 (t, J = 7.2 Hz, 
4H), 1.35-1.20 (m, 8H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.38, 168.80, 167.50, 157.56, 
156.38, 137.86, 137.21, 134.71, 134.60, 132.97, 132.79, 132.64, 132.45, 129.43, 129.06, 
128.97, 128.72, 127.99, 127.50, 124.25, 123.39, 122.56, 121.54, 68.11, 67.31, 66.97, 66.69, 
62.86, 62.42, 57.10, 53.40, 48.64, 47.83, 40.65, 39.05, 30.94, 27.70, 23.91, 14.21 ppm; IR ʋ 
(cm-1) 3020, 2254, 1794, 1755, 1716, 1602, 1474, 1389, 1279, 1216, 1145, 1097; HRMS 
[M+Na] calculated for C18H16F6N2O5Na 567.1325, found 567.1335. 
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General procedure for the photoredox reaction of allenamides with different 
nucleophiles: An oven dried 50 mL three neck round bottom flask was filled with argon gas 
and charged with iridium photocatalyst (1.5 mol%) allenamide (1.0 eq) and anhydrous 
acetonitrile (~ 0.1 M) and seal with a rubber septum in the middle neck and the other two 
necks closed with glass stoppers.  The flask was purged again with argon while one neck was 
opened. The middle neck was then fitted with an argon filled balloon.   Diethyl 
bromomalonate (2.0 eq), trimethylamine TEA (2.0 eq) and the nucleophile (5.0 eq) were 
added in that order to the solution in the flask under the argon atmosphere.  The flask was 
then irradiated with a Kessil blue light (λ = 467 nm) for 3 - 10 h with stirring at room 
temperature.  After the reaction has completed as monitored by TLC, the solvent was 
removed under a reduced pressure to obtain the crude product.  The crude product was 
purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to afford the product. 
Diethyl 2-(3-ethoxy-3-(2-oxooxazolidin-3-yl)prop-1-en-2-yl)malonate (393) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 2:1) to 
afford the product 393 as a pale-yellow oil (65 mg, 40%). 1H-NMR (400 MHz, CDCl3) δ 5.61 
(d, J = 1.6 Hz, 1H), 5.56 (s, 1H), 5.43-5.41 (1H), 4.39-4.25 (m, 2H), 4.22-4.15 (m, 4H), 4.05 
(s, 1H), 3.61-3.47 (m, 2H), 3.43 (dd, J = 8.7, 7.4 Hz, 2H), 1.27 (dt, J = 18.0, 7.1 Hz, 6H), 
1.19 (t, J = 7.0 Hz, 3H) ppm; 13C-NMR (100 MHz, CDCl3) δ 168.46, 167.62, 167.49, 158.63, 
136.87, 118.48, 83.06, 64.34, 63.58, 62.70, 61.99, 61.89, 54.48, 39.00, 14.87, 14.05 ppm; IR 
ʋ (cm-1) 3329, 2969, 2931, 2882, 2657, 1745, 1466, 1378, 1305, 1159, 1127, 1107; HRMS 
[M+Na] calculated for C15H23NO7Na 352.1367, found 352.1367. 
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Diethyl 2-(3-isopropoxy-3-(2-oxooxazolidin-3-yl)prop-1-en-2-yl)malonate (395) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 2:1) to 
afford the product 395 as a pale yellow oil (55 mg, 33%). 1H-NMR (400 MHz, CDCl3) δ 6.27 
(d, J = 7.8 Hz, 1H), 5.42 (d, J = 18.1 Hz, 1H), 4.41 (t, J = 7.8 Hz, 2H), 4.22-4.14 (m, 4H), 
4.07-4.04 (1H), 3.89 (t, J = 8.0 Hz, 2H), 2.42-2.39 (2H), 1.30-1.20 (m, 12H) ppm; 13C-NMR 
(100 MHz, CDCl3) δ 168.14, 157.08, 138.35, 126.52, 123.26, 118.90, 62.68, 61.96, 57.05, 
55.98, 45.84, 28.00, 14.07 ppm; IR ʋ (cm-1) 3055, 2987, 2306, 1755, 1667, 1265, 1155, 1035; 
HRMS [M+Na] calculated for C16H25NO7Na 366.1523, found 366.1411. 
Diethyl 2-(3-(2-oxooxazolidin-3-yl)-3-(p-tolylamino)prop-1-en-2-yl)malonate (399) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 3:7) to 
afford the product 399 as a pale yellow oil (98 mg, 53%). 1H-NMR (400 MHz, CDCl3) δ 6.98 
(d, J = 8.2 Hz, 3H), 6.60 (d, J = 8.7 Hz, 2H), 6.52 (d, J = 8.2 Hz, 1H), 5.96 (d, J = 9.5 Hz, 
1H), 5.47 (dd, J = 8.2, 1.6 Hz, 1H), 4.93 (d, J = 9.5 Hz, 1H), 4.31-4.02 (6H), 3.79 (s, 1H), 
3.50-3.31 (m, 2H), 2.21 (s, 3H), 1.31-1.20 (m, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 
169.01, 168.63, 167.70, 158.34, 141.86, 137.58, 130.12, 128.64, 118.53, 113.80, 113.27, 
65.33, 62.25, 62.03, 55.53, 39.50, 31.66, 22.73, 20.51, 14.05 ppm; IR ʋ (cm-1)  3328, 2969, 
2931, 1750, 1684, 1595, 1466, 1378, 1367, 1306, 1127, 1107, 950; HRMS [M+H] calculated 
for C20H27N2O6 391.1864, found 391.1860. 
 
173 
 
Diethyl 2-(3-((2,4-dimethylphenyl)amino)-3-(2-oxooxazolidin-3-yl)prop-1-en-2-yl)malonate (400) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 3:7) to 
afford the product 400 as a pale yellow oil (109 mg, 57%). 1H-NMR (400 MHz, CDCl3) δ 
7.07-6.79 (m, 2H), 6.68-6.59 (m, 1H), 6.04 (s, 1H), 5.48 (q, J = 2.2 Hz, 1H), 4.94 (d, J = 6.6 
Hz, 1H), 4.34-4.01 (m, 6H), 3.81 (s, 1H), 3.47 (td, J = 8.8, 5.5 Hz, 1H), 3.30 (q, J = 8.8 Hz, 
1H), 2.22 (t, J = 4.7 Hz, 3H), 2.11 (d, J = 9.5 Hz, 3H), 1.27 (dt, J = 28.3, 7.1 Hz, 6H) ppm; 
13C-NMR (100 MHz, CDCl3) δ 169.34, 168,74, 167.84, 158.31, 139.83, 137.65, 131.37, 
131.11, 127.85, 127.30, 122.84, 118.73, 111.01, 109.92, 64.73, 62.70, 62.30, 58.17, 55.64, 
44.44, 42.21, 39.22, 20.45, 17.74, 17.55, 14.07 ppm; IR ʋ (cm-1)  3342, 2969, 2930, 2881, 
1738, 1517, 1466, 1378, 1305, 1159, 1128, 1034, 950; HRMS [M+H] calculated for 
C21H29N2O6 405.2020, found 405.2017. 
Diethyl 2-(3-((3,5-bis(trifluoromethyl)phenyl)amino)-3-(2-oxooxazolidin-3-yl)prop-1-en-2-yl) 
malonate (401) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 7:3) to 
afford the product 401 as a pale yellow liquid (113 mg, 45%). 1H-NMR (400 MHz, CDCl3) δ 
7.27-7.21 (m, 1H), 7.11 (s, 2H), 6.17 (d, J = 8.7 Hz, 1H), 6.07 (d, J = 8.7 Hz, 1H), 5.51 (q, J 
= 1.8 Hz, 2H), 4.37-4.18 (m, 4H), 4.03-3.94 (m, 2H), 3.54-3.39 (m, 2H), 1.31 (t, J = 7.2 Hz, 
3H), 1.11 (t, J = 7.0 Hz, 3H) ppm; 13C-NMR (100 MHz, CDCl3) δ 169.66, 167.09, 158.22, 
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145.63, 136.38, 133.33, 133.01, 132.67, 132.35, 124.73, 122.02, 120.34, 113.19, 112.30, 
64.34, 62.66, 62.52, 55.92, 39.45, 14.02, 13.90 ppm; IR ʋ (cm-1)  3332, 2969, 2931, 1741, 
1622, 1466, 1378, 1306, 1160, 1128, 1107, 1036; HRMS [M+Na] calculated for 
C21H22F6N2O6Na 535.1274, found 535.1276. 
Diethyl 2-(3-((4-bromophenyl)amino)-3-(2-oxooxazolidin-3-yl)prop-1-en-2-yl)malonate 
(402) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 3:7) to 
afford the product 402 as a pale yellow liquid (108 mg, 49%). 1H-NMR (400 MHz, CDCl3) δ 
7.24 (d, J = 8.7 Hz, 2H), 6.57 (d, J = 8.7 Hz, 2H), 5.95 (d, J = 9.1 Hz, 1H), 5.46 (s, 2H), 5.37 
(d, J = 9.5 Hz, 1H), 4.33-4.00 (m, 6H), 3.49-3.30 (m, 2H), 1.22 (t, J = 7.2 Hz, 3H), 1.15 (t, J 
= 7.0 Hz, 3H) ppm; IR ʋ (cm-1) 3370, 2970, 1723, 1593, 1490, 1160, 1098, 1073, 1030, 1014; 
HRMS [M+H] calculated for C19H24BrN2O6 455.0812, found 455.0811. 
Diethyl 2-(3-((4-bromo-2-fluorophenyl)amino)-3-(2-oxooxazolidin-3-yl)prop-1-en-2-
yl)malonate (403) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 7:3) to 
afford the product 403 as a pale yellow liquid (102 mg, 46%). 1H-NMR (400 MHz, CDCl3) δ 
7.16-7.09 (m, 2H), 6.80-6.73 (m, 1H), 6.01 (d, J = 9.1 Hz, 1H), 5.50 (dd, J = 7.2, 1.9 Hz, 
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2H), 5.44 (dd, J = 9.1, 2.9 Hz, 1H), 4.34-4.17 (6H), 4.12-4.05 (2H), 3.47 (dd, J = 14.6, 8.0 
Hz, 1H), 3.35 (q, J = 8.8 Hz, 1H), 1.29 (t, J = 7.2 Hz, 3H), 1.17 (t, J = 7.2 Hz, 3H) ppm; 13C-
NMR (100 MHz, CDCl3) δ 168.85, 167.33, 160.07, 158.26, 136.73, 132.06, 128.09, 119.47, 
118.52, 118.30, 114.76, 109.81, 64.30, 62.43, 55.63, 39.12, 14.00 ppm; IR ʋ (cm-1) 3155, 
2985, 1793, 1748, 1614, 114, 1194, 1096, 1034; HRMS [M+Na] calculated for 
C19H22BrN2O6Na 495.0537, found 495.0559. 
Diethyl 2-(3-((2-methoxyphenyl)amino)-3-(2-oxooxazolidin-3-yl)prop-1-en-2-yl) 
malonate (404) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 3:7) to 
afford the product 404 as a pale yellow liquid (99 mg, 51%). 1H-NMR (400 MHz, CDCl3) δ 
6.87-6.67 (m, 4H), 5.98 (d, J = 8.7 Hz, 1H), 5.52 (d, J = 14.0 Hz, 2H), 5.16 (d, J = 9.5 Hz, 
1H), 4.30-4.07 (m, 7H), 3.81 (s, 3H), 3.43 (td, J = 8.5, 5.5 Hz, 1H), 3.33-3.23 (1H), 1.24 (dt, 
J = 23.8, 7.1 Hz, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 168.21, 167.76, 158.40, 147.08, 
137.44, 134.03, 121.75, 118.82, 118.01, 111.72, 109.99, 65.04, 62.45, 62.16, 55.67, 55.13, 
39.22, 14.05 ppm; IR ʋ (cm-1) 3331, 2969, 2931, 2882, 1739, 1466, 1378, 1367, 1340, 1305, 
1159, 1127, 1031, 950;  HRMS [M+H] calculated for C20H27N2O7 407.1812, found 407.1811. 
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Diethyl 2-(3-(2-oxooxazolidin-3-yl)-3-((2-(trifluoromethoxy)phenyl)amino)prop-1-en-2-
yl)malonate (405) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 7:3) to 
afford the product 405 as a pale yellow liquid (117 mg, 53%).  1H-NMR (400 MHz, CDCl3) δ 
7.16 (t, J = 7.6 Hz, 2H), 6.89 (d, J = 7.4 Hz, 1H), 6.76 (td, J = 7.7, 1.4 Hz, 1H), 6.07 (d, J = 
9.1 Hz, 1H), 5.71-5.61 (m, 1H), 5.50 (dd, J = 13.0, 1.9 Hz, 2H), 4.33-4.01 (m, 6H), 3.48 (td, J 
= 8.7, 5.6 Hz, 1H), 3.31 (q, J = 8.9 Hz, 1H), 1.71 (s, 1H), 1.29 (t, J = 7.2 Hz, 3H), 1.16 (t, J = 
7.0 Hz, 3H) ppm; 13C-NMR (100 MHz, CDCl3) δ 168.92, 167.50, 158.34, 136.94, 136.80, 
136.50, 128.37, 121.36, 119.18, 118.78, 113.37, 64.09, 62.34, 55.39, 38.99, 14.00 ppm; IR ʋ 
(cm-1) 3337, 2969, 2931, 1739, 1613, 1466, 1378, 1308, 1159, 1128, 1107, 1034; HRMS 
[M+H] calculated for C20H24F3N2O7 461.1530, found 461.1532.  
Diethyl 2-(3-((2,4-dimethylphenyl)amino)-3-(2-oxopyrrolidin-1-yl)prop-1-en-2-
yl)malonate (406) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 406 as a pale yellow liquid (106 mg, 54%). 1H-NMR (400 MHz, CDCl3) δ 
6.87 (d, J = 7.4 Hz, 2H), 6.52 (d, J = 8.2 Hz, 1H), 6.20 (d, J = 9.9 Hz, 1H), 5.42 (d, J = 2.1 
Hz, 1H), 5.35 (d, J = 1.6 Hz, 1H), 4.79 (d, J = 10.3 Hz, 1H), 4.31 (s, 1H), 4.29-4.17 (m, 2H), 
4.12-4.02 (m, 2H), 3.28 (td, J = 8.9, 3.7 Hz, 1H), 3.09-3.00 (m, 1H), 2.46-2.37 (2H), 2.20 (s, 
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3H), 2.09 (s, 3H), 2.00-1.85 (m, 2H), 1.29 (t, J = 7.2 Hz, 3H), 1.15 (t, J = 7.2 Hz, 3H) ppm; 
13C-NMR (100 MHz, CDCl3) δ 175.90, 169.19, 168.08, 140.19, 137.65, 131.24, 127.70, 
122.73, 117.83, 110.96, 62.65, 62.14, 55.43, 41.53, 31.37, 20.45, 18.04, 17.53, 14.08 ppm; IR 
ʋ (cm-1) 3018, 2941, 1727, 1677, 1420, 1176, 1096, 1035; HRMS [M+H] calculated for 
C22H31N2O5 425.2047, found 425.2068. 
Diethyl 2-(3-((2,4-dimethylphenyl)amino)-3-(2-oxopiperidin-1-yl)prop-1-en-2-
yl)malonate (407) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 407 as a pale yellow liquid (86 mg, 41%). 1H-NMR (400 MHz, CDCl3) δ 
6.86 (d, J = 6.6 Hz, 2H), 6.77 (d, J = 10.3 Hz, 1H), 6.50 (d, J = 9.1 Hz, 1H), 5.40-5.38 (1H), 
5.30 (d, J = 2.1 Hz, 1H), 4.93 (d, J = 10.3 Hz, 1H), 4.33 (s, 1H), 4.32-3.99 (4H), 3.18-3.09 
(m, 1H), 2.94-2.85 (m, 1H), 2.50-2.41 (m, 2H), 2.20 (s, 3H), 2.09 (s, 3H), 1.82-1.51 (m, 4H), 
1.30 (t, J = 7.2 Hz, 3H), 1.15 (t, J = 7.2 Hz, 3H) ppm; 13C-NMR (100 MHz, CDCl3) δ 170.71, 
169.45, 168.15, 140.25, 137.59, 131.28, 127.55, 122.55, 117.47, 111.07, 64.01, 62.44, 55.44, 
40.55, 32.38, 22.97, 20.63, 17.55, 14.06 ppm; IR ʋ (cm-1)  3018, 2984, 1731, 1660, 1216, 
1371, 1033; HRMS [M+Na] calculated for C23H32N2O5Na 439.2203, found 439.2217. 
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Diethyl 2-(3-((2,4-dimethylphenyl)amino)-3-(2-oxoazepan-1-yl)prop-1-en-2-yl)malonate 
(408) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 408 as a pale yellow liquid (92 mg, 43%). 1H-NMR (400 MHz, CDCl3) δ 
6.89-6.82 (m, 2H), 6.70 (d, J = 9.9 Hz, 1H), 6.56 (d, J = 8.2 Hz, 1H), 5.36 (d, J = 2.1 Hz, 
1H), 5.29 (d, J = 2.1 Hz, 1H), 5.03 (t, J = 4.9 Hz, 1H), 4.31 (s, 1H), 4.29-4.17 (m, 3H), 4.02 
(dd, J = 8.9, 7.2 Hz, 1H), 3.30-3.11 (m, 3H), 2.63-2.42 (m, 3H), 2.19 (s, 3H), 2.08 (s, 4H), 
1.77-1.61 (m, 4H), 1.47-1.36 (m, 2H), 1.30 (t, J = 7.2 Hz, 3H), 1.14 (t, J = 7.2 Hz, 3H) ppm; 
13C-NMR (100 MHz, CDCl3) δ 176.77, 169.54, 168.12, 140.61, 138.50, 131.08, 127.69, 
127.27, 122.21, 117.78, 111.21, 64.96, 62.17, 62.12, 55.43, 43.52, 37.99, 30.21, 28.01, 23.44, 
20.49, 17.66, 14.10, 14.02 ppm; IR ʋ (cm-1) 3386, 3096, 2981, 2934, 2735, 1736, 1636, 1522, 
1311, 1176, 1036; HRMS [M+Na] calculated for C24H34N2O5Na 453.2360, found 453.2309. 
Diethyl 2-(3-((4-bromo-2-fluorophenyl)amino)-3-(2-oxopyrrolidin-1-yl)prop-1-en-2-
yl)malonate (409) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 409 as a pale yellow liquid (97 mg, 42%). 1H-NMR (400 MHz, CDCl3) δ 
7.14 (d, J = 2.1 Hz, 1H), 7.12-7.06 (2H), 6.65 (t, J = 8.9 Hz, 1H), 6.18 (d, J = 9.9 Hz, 1H), 
5.46 (d, J = 2.1 Hz, 1H), 5.37 (d, J = 1.6 Hz, 1H), 5.33 (dd, J = 9.9, 2.9 Hz, 1H), 4.30-4.16 
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(m, 3H), 4.10 (q, J = 7.1 Hz, 3H), 3.31-3.23 (m, 1H), 3.13-3.05 (m, 1H), 2.49-2.33 (m, 2H), 
2.01-1.90 (m, 2H), 1.29 (t, J = 7.2 Hz, 3H), 1.18 (t, J = 7.0 Hz, 3H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 176.09, 168.78, 167.59, 152.56, 150.14, 136.62, 132.33, 127.93, 118.67, 
118.39, 118.18, 114.64, 109.34, 62.33, 61.90, 55.34, 41.47, 31.20, 18.07, 14.05 ppm; IR ʋ 
(cm-1)  3054, 728, 1686, 1614, 1421, 1265, 1154, 1035; HRMS [M+Na] calculated for 
C20H24BrFN2O5Na 493.0745, found 493.0767. 
Diethyl (S,Z)-2-(1-(4-benzyl-2-oxooxazolidin-3-yl)-3-((2,4-dimethylphenyl)amino)prop-
1-en-2-yl)malonate (410) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 7:3) to 
afford the product 410 as a pale yellow liquid (97 mg, 41%). 1H-NMR (400 MHz, CDCl3) δ 
7.28-7.21 (m, 3H), 7.09 (d, J = 6.2 Hz, 2H), 6.90 (t, J = 7.8 Hz, 2H), 6.51 (d, J = 8.2 Hz, 1H), 
6.38 (s, 1H), 4.39-4.31 (m, 1H), 4.28 (s, 1H), 4.22-4.05 (m, 6H), 3.93 (d, J = 9.1 Hz, 2H), 
3.17 (dd, J = 13.8, 3.5 Hz, 1H), 2.71-2.64 (1H), 2.22 (s, 3H), 2.09 (s, 3H), 1.60 (s, 1H), 1.27-
1.19 (m, 6H) ppm; 13C-NMR (100 MHz, CDCl3) δ 168.36, 156.35, 143.79, 135.09, 131.10, 
129.15, 127.10, 126.14, 123.32, 110.02, 77.12, 66.70, 62.07, 57.90, 56.53, 43.76, 38.42, 
20.43, 17.49, 14.12 ppm; IR ʋ (cm-1)  3031, 2985, 1756, 1731, 1516, 1302, 1266, 1032; 
HRMS [M+H] calculated for C28H35N2O6 495.2490, found 495.2487.  
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Diethyl (S,Z)-2-(3-((2,4-dimethylphenyl)amino)-1-(4-isopropyl-2-oxooxazolidin-3-yl) 
prop-1-en-2-yl)malonate (411) 
 
The crude product was purified by flash chromatography on silica gel (hexane-EtOAc 4:1) to 
afford the product 411 as a pale yellow liquid (107 mg, 50%). 1H-NMR (400 MHz, CDCl3) δ 
6.91-6.84 (m, 2H), 6.47 (d, J = 7.8 Hz, 1H), 6.24 (s, 1H), 4.29-4.22 (m, 2H), 4.20-4.04 (m, 
5H), 4.01-3.94 (m, 1H), 3.89 (d, J = 13.6 Hz, 1H), 3.79 (d, J = 13.6 Hz, 1H), 2.20 (s, 3H), 
2.08 (s, 3H), 2.10-2.07 (1H), 1.27-1.17 (m, 6H), 0.87 (t, J = 6.6 Hz, 6H) ppm; 13C-NMR (100 
MHz, CDCl3) δ 168.41, 168.33, 156.68, 143.90, 131.04, 127.24, 126.65, 126.22, 124.34, 
123.06, 109.97, 63.85, 61.98, 61.63, 57.00, 43.77, 29.38, 20.41, 17.91, 17.44, 15.14, 14.03 
ppm; IR ʋ (cm-1)  3157, 2982, 2253, 1746, 1664, 1467, 1261, 1095, 1033; HRMS [M+H] 
calculated for C24H35N2O6 447.2490, found 447.2510. 
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117. Broggini, G.; Bruché, L.; Zecchi, G. J. Chem. Soc., Perkin Trans. 1. 1990, 533. 
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